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Summary 
The nucleolus, the most prominent substructure within the nucleus, is the 
compartment where transcription of hundreds of ribosomal RNA (rRNA) genes, 
rRNA processing, and ribosome subunit assembly takes place. Even though we have 
been aware of the nucleolus for 180 years, our knowledge of nucleolar functions is 
limited.  Indeed, in the past 40-50 years, the major aim of research on nucleolus was 
to define the components and key steps of ribosome synthesis and it was not 
suspected that it could be involved in many other processes.  
In differentiated cells a fraction of the ca. 400 copies of rRNA genes is 
transcriptionally silent and organized in compact heterochromatic structures, 
characterized by DNA methylation and repressive histone marks. The silent 
heterochromatic state of rRNA genes is stably inherited across cell divisions and is 
not affected even in case of high metabolic activities of the cell. Until now, the role of 
silent heterochromatic rRNA genes is not fully understood. 
TIP5, a component of NoRC complex, together with the long non-coding (lnc)RNA 
pRNA establishes heterochromatin at rRNA genes. TIP5 binds to rRNA genes via 
pRNA and recruits DNA methyltransferases and histone modifier enzymes to 
establish silencing. pRNA, which originates from the processing of the intergenic 
spacer (IGS)-rRNA, is necessary for TIP5 recruitment to rRNA genes.  
In embryonic stem cells (ESC) a large portion of the genome is euchromatic, a 
structure that well reflects the plasticity and transcriptional permissiveness of ESC 
genome that has to have the ability to enter any distinct transcriptional programs for 
lineage specification. Upon differentiation, large-scale genome silencing takes place 
and a broad part of ESC chromatin undergoes structural remodeling toward a highly 
condensed heterochromatic and transcriptionally repressed form.  Recent results have 
shown that in ESCs all rRNA genes are euchromatic and acquire heterochromatic 
marks only upon differentiation. In ESCs, TIP5 does not repress rRNA genes due to 
impairment of the precursor lncRNA IGS-rRNA processing into the mature pRNA, 
which is the functional lncRNA required for recruitment of TIP5 to rRNA genes and 
establishment of rRNA gene silencing.  Importantly, addition of mature pRNA in 
ESCs was not only sufficient to recruit TIP5 to nucleoli and silence rRNA genes but 
also induced the establishment of highly condensed chromatin structures outside of 
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the nucleolus, resembling the genome organization that characterizes differentiated 
cells. These results indicated that the nucleolus is not only the cellular compartment 
where ribosomes are produced but it is also able to produce heterochromatin, 
affecting the genome architecture of the rest of the nucleus.   
 In this work, we aimed to (1) identify which factors are implicated in IGS-rRNA 
processing and (2) determine the functional significance for the formation of 
heterochromatin at rRNA genes during ESC differentiation. Using a screening for 
IGS-rRNA-binding proteins we identified the RNA helicase DHX9 as key regulator 
of IGS-rRNA processing. DHX9-mediated pRNA production is required to guide 
TIP5 to rRNA genes and to establish heterochromatin. In ESCs DHX9 is not 
associated with rRNA genes and only upon ESC differentiation it localizes within 
nucleoli and binds to rRNA genes. Depletion of DHX9 in ESCs does not affect self-
renewal and important traits of pluripotency such as expression of pluripotency 
factors.  However, ESCs depleted of DHX9 are unable to differentiate and undergo 
cell death. Strikingly, this phenotype can be reverted by adding mature pRNA before 
induction of differentiation of ESCs depleted of DHX9.  
Taken together these results highlight the role of lncRNA in the regulation of 
chromatin and epigenetic states and suggest that lncRNA processing represents an 
additional level of lncRNA regulation, which modulates distinct features of the same 
lncRNA. Moreover, they demonstrate that the state of nucleolar chromatin at rRNA 
genes is part of the regulatory network that controls exit from pluripotency and 
initiation of differentiation pathways. 
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Zusammenfassung 
 
Der Nukleolus ist die prominenteste  Struktur innerhalb des Zellkerns und ist der Ort 
an dem die Transkription hunderter ribosomaler RNA (rRNA) Gene, rRNA 
Verarbeitung und Ribosom-Zusammensetzung stattfindet. Obwohl Nukleoli bereits 
vor 180 Jahren beschrieben worden sind, ist unser Wissen bezüglich ihrer Funktion 
limitiert. Tatsächlich war das Hauptziel der Forschung der vergangenen 40-50 Jahren 
lediglich auf die Charakterisierung der Komponenten und zentralen Schritte der 
Ribosomsynthese begrenzt, ohne dabei zu ahnen, in welchen Prozessen Nukleoli 
ebenfalls entscheidende Rollen spielen. 
In differenzierten Zellen wird ein wesentlicher Anteil der ca. 400 rRNA Genkopien 
ausgeschaltet und in kompaktem Heterochromatin organisiert, welches durch DNA 
CpG Methylierung und repressive Histonmodifikationen charakterisiert ist. Der 
heterochromatische Genzustand wird dabei auch über die Zellteilung hinaus an die 
nächste Zellgeneration vererbt und bleibt auch von der metabolischen Zellaktivität 
unberührt. Die Rolle der inaktiven heterochromatischen rRNA Gene ist jedoch noch 
nicht vollständig verstanden. 
TIP5, eine Untereinheit des NoRC Komplexes, etabliert in Zusammenarbeit mit einer 
langen nicht-kodierenden RNA (lncRNA), pRNA, Heterochromatin in rRNA Genen. 
TIP5 bindet die rRNA Gene mit Hilfe der pRNA und rekrutiert DNA 
Methyltransferasen und histonmodifizierende Enzyme, die zur Abschaltung der Gene 
führen. Die pRNA, die aus der Verarbeitung der sogenannten intergenic spacer (IGS)-
rRNA stammt, ist dabei für die TIP5-Rekrutierung zu den rRNA Genen 
unentbehrlich. 
In embryonalen Stammzellen (ESC) befindet sich die Mehrheit des Genoms in einem 
euchromatischen  Zustand, welches den Zellen erlaubt, einen hohen genomischen 
Grad an Plastizität und Transkription zu gewährleisten, welches ihnen ermöglicht, 
jedes beliebige zellinienspezifische Transkriptionsprogramm anzunehmen. Auf 
Initiation des Differenzierungsvorgangs finden weiträumige Umstrukturierungen statt, 
bei denen weite Teile des Genoms ausgeschaltet werden, indem die Transkription 
verhindert und Heterochromatin etabliert wird. Jüngste Ergebnisse haben gezeigt, 
dass sämtliche rRNA Gene in ESCs in euchromatischen Zustand vorliegen und erst 
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der Differenzierungsvorgang führt zu einem Übergang in einen heterochromatischen 
Zustand. In ESCs unterdrückt TIP5 die RNA Gene nicht aufgrund der mangelnden 
Verarbeitung der IGS-rRNA in pRNA, die als funktionsfähige lncRNA für die TIP5-
Rekrutierng zu den rRNA Genen nötig ist und es TIP5 erlaubt, dort Heterochromatin 
zu etablieren. Es ist jedoch hervorzuheben, dass die Hinzufügung von pRNA zu den 
ESCs nicht nur ausreichte TIP5 zu den Nukleoli zu rekrutieren und ribosomale Gene 
auszuschalten, sondern auch heterochromatische Strukturen außerhalb der Nukleoli zu 
initiieren, ein Vorgang, der differenzierte Zellen charakterisiert. Diese Ergebnisse 
deuten darauf hin, dass der Nukleolus nicht nur für die Ribosomsynthese 
entscheidend ist, sondern auch Heterochromatin erzeugt, welches die genomische 
Architektur des gesamten Nukleus beeinflusst. 
In der vorliegenden Arbeit haben wir uns zum Ziel gesetzt (1) die Faktoren zu 
identifizieren, die für das Prozessieren der IGS-rRNA verantwortlich sind und (2) die 
funktionelle Signifikanz der Heterochromatin-Formation in rRNA Genen während der 
Differenzierung zu ermitteln. In einem Screening zur Identifizierung von IGS-rRNA-
bindenden Faktoren gelang uns die Bestimmung RNA Helikase DHX9 als einen 
zentralen Regulator der IGS-rRNA Verarbeitung. Die DHX9-vermittelte pRNA 
Produktion ist nötig für die gezielte Führung von TIP5 zu den ribosomalen Genen und 
der Heterochromatin Erzeugung. In ESCs ist DHX9 nicht mit rRNA Genen assoziiert 
und nur durch den Differenzierungsvorgang wird DHX9 in den Nukleoli lokalisiert, 
in denen es dann an die rRNA Gene bindet. Die Erschöpfung von DHX9 in 
Stammzellen führt zu keinem Verlust ihrer Selbsterneuerungsfähigkeit und ändert 
ebenfalls nichts an Pluripotenzmerkmalen. ESCs in denen DHX9 erschöpft wurde, 
sind jedoch nicht mehr im Stande zu differenzieren und weisen hohen Zelltod vor. 
Auffällig ist, dass dieser Phänotyp durch die Zugabe von pRNA vor der 
Zelldifferenzierung rückgängig gemacht werden kann, obwohl DHX9 in den Zellen 
fehlt. 
Zusammengefasst heben diese Ergebnisse die Rolle von lncRNA in der Regulierung 
von Chromatin und epigenetischen Zuständen hervor. Außerdem deuten diese 
Ergebnisse darauf hin, dass das Prozessieren von lncRNA als weiteres 
Regulierungslevel der Eigenschaften der selben lncRNA dienen könnte. Des weiteren 
demonstrieren sie, das der Zustand des nukleolären Chromatins Teil des 
regulatorischen Netzwerks ist, welches den Austritt aus der Pluripotenz  kontrolliert 
und den Differenzierungspfad initiiert.  
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Abbreviations 
 
 
5hmC     5-hydroxymethylcytosine 
5mC      5-methylcytosine 
bp        base pair 
CGI      CpG island 
DC       dosage compensation 
DNMT    DNA methyltransferase 
dsRNA    double stranded RNA 
ESC      embryonic stem cell 
HAT      histone acetyl transferase 
HAT      high affinity site 
HDAC     histone de-acetylase 
HDM     histone de-methylase 
HMT     histone methyl transferase 
ICM      inner cell mass 
IGS-rRNA   intergenic spacer ribosomal RNA 
KTM     lysine methyl transferase 
lincRNA    long intergenic non coding RNA 
lncRNA    long non coding RNA 
miRNA    micro RNA 
MRE      MSL recognition element 
MSL      male-specific lethal 
ncRNA    non coding RNA 
NSL      non-specific lethal 
NOR      nucleolus organizing region 
NoRC     nuclelar remodeling complex 
nt       nucleotides 
pRNA     promoter RNA 
piRNA     PIWI interacting RNA 
PTM      post-translational modification 
RISC     RNA induced silencing complex 
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RNP      ribonucleoprotein 
RTM      arginine methyl transferase 
rDNA     ribosomal DNA 
roX      RNA on X (chromosome) 
rRNA     ribosomal RNA 
SAM      S-adenosyl-L-methionine 
siRNA     small interfering RNA 
snRNA    small nuclear RNA 
snoRNA    small nucleolar RNA 
tiRNA     transcription initiation RNA 
TIP5      TTF1 interacting protein 5 
TSS      transcription start site 
TTF1     transcription termination factor 1 
UBF      upstream binding factor 
UCE      upstream control element 
XCI      X chromosome inactivation 
Xi       inactive X chromosome  
Xic      X inactivation center 
Xist      X inactive specific transcript
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1 Introduction 	  
1.1 Chromatin structure 
 Eukaryotic genomes are organized in linear chromosomes that are enclosed in the 
nucleus of the cells. Each chromosome is composed of genomic DNA and structural 
proteins called histones. The genomic DNA is wrapped around histone proteins 
forming a fundamental structure called nucleosome, which is assembled into a higher-
order structure known as chromatin (Figure 1). Nucleosomes are composed of two 
copies of each core histone, namely H2A, H2B, H3 and H4, forming an octameric 
structure that is able to bind 147 bp of DNA. The DNA is coiled in a left-handed 
super-helical conformation that turns 1.67 times around the histone octamer 
(Ramakrishnan, 1997; Richmond and Davey, 2003). Linker DNA of variable lengths 
connects adjacent nucleosomes resulting in the so-called 10 nm or “beads-on-a-
string” fiber (Olins and Olins, 1974). A fifth histone protein, the histone H1, is not 
included in the core nucleosome structure but can bind 20 bp of the linker DNA and 
increase the DNA associated to the histone octamer to 166 bp, corresponding to two 
super helical turns (Ramakrishnan, 1997; Thoma et al., 1979; Zhou et al., 2015).     
 
Figure 1. Structure of chromatin. DNA molecule wrapped around nucleosomes gives rise to a higher 
order structure allowing for compaction into the characteristic chromatin fiber and chromosomes. DNA 
methylation influences which genes are expressed, and other epigenetic factors (e.g. histone 
modifications) determine the compaction status of chromatin. Hence, both epigenetic marks control the 
transcriptional and compaction state of DNA without changing the underlying DNA sequence. From 
(Marx, 2012) 
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 The 10 nm fiber represents the first layer of chromatin organization. A further step 
of compaction is represented by the 30 nm fiber that has been described under 
physiological salt concentration in vitro. The exact structure of the 30 nm fiber is still 
under debate but two models arose in the past describing a one-start solenoidal helix 
structure (Finch and Klug, 1976; (Robinson et al., 2006) or a two-start helix, in which 
nucleosomes are assembled in a zigzag ribbon that twists or supercoils (Dorigo et al., 
2004; Finch and Klug, 1976; Schalch et al., 2005; Woodcock et al., 1984). It cannot 
be anyway excluded that the two models actually co-exist in vivo, or even that 
interphase chromosomes are assembled through long-range interactions of extended 
10 nm fibers that form irregular interdigitated polymers that do not require the 
assembly of a regular 30 nm fiber (Maeshima et al., 2014; Maeshima et al., 2016). 
This last model is also strongly supported by recent experiments using electron 
spectroscopic imaging combined with electron tomography, which describe how the 
entire genome is organized in 10 nm fibers that are more or less compacted in 
irregular structures (Fussner et al., 2012). Also biochemical approaches based on 
proximity ligation procedure like Hi-C analysis, which explore the three-dimensional 
architecture of the whole genome, excluded further hierarchical order of chromatin 
organization than the 10 nm fiber (Lieberman-Aiden et al., 2009). 
 
1.1.1  Euchromatin and heterochromatin 
 Chromatin has been structurally and functionally classified as euchromatin, which is 
transcriptionally active, structurally loose and characterized by the presence of active 
histone marks (see 1.1.2), and as heterochromatin that by opposite is poorly 
transcribed, is more compact and labeled by repressive histone marks (Felsenfeld and 
Groudine, 2003). However the distinction between the transcriptionally active and 
structurally loose euchromatin and the inactive and more compact heterochromatin 
most likely relies on the polymer melt model (Razin and Gavrilov, 2014) describing a 
disordered compaction of the 10 nm fiber rather than a defined distinction between 
respectively a 10 nm and a 30 nm fiber (Felsenfeld and Groudine, 2003). 
 Chromatin is not only composed of DNA and histone proteins, but it is actually a 
melting pot of regulatory proteins, which are more or less tightly bound to histones or 
DNA, and RNA, which exert a regulatory and also structural function in the 
regulation of chromatin architecture. Despite this complexity, chromatin is indeed a 
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very dynamic structure that contributes to the regulation of gene expression according 
to its degree of compaction. The heterochromatic state is more compact and for this 
reason less accessible to the transcriptional machinery compared to the euchromatic 
state. The degree of compaction is regulated by a cooperation of histone post-
translational modifications (PTMs), DNA methylation and chromatin remodeling 
factors. Together with DNA methylation, histone PTMs are at the basis of the 
epigenetic inheritance of gene function. Epigenetics is by definition “the study of 
mitotically and/or meiotically heritable changes in gene function that cannot be 
explained by changes in DNA sequence” (Russo et al., 1996). This means that gene 
function does not depend exclusively on the DNA sequence that is inherited from a 
mother cell to a daughter cell, but it depends also on the chromatin context in which 
the gene is included and that can be as well inherited during cell division.   
 
1.1.2  Histone post-translational modifications 
 Histones are alkaline proteins containing three alpha helices connected by two 
unstructured loops in a globular motif that allows protein dimerization, assembly of 
the octamer and interaction with DNA (Alva et al., 2007; Luger et al., 1997). Besides 
the globular histone fold domain, histones possess N-terminal unstructured “tails” that 
protrude from the histone octamer and can form additional contacts with DNA and 
chromatin associated proteins. Histones can be post-translational modified both at the 
globular domain (Tessarz and Kouzarides, 2014) and at the N-terminal tail 
(Kouzarides, 2007). PTMs can occur at different residues such as lysine (K), arginine 
(R), threonine (T), tyrosine (Y), serine (S), methionine (M), proline (P) and glutamate 
(E). Most common PTMs are characterized by methylation (me) of lysine and 
arginine; acetylation (ac), ubiquitylation (ub) and sumoylation (su) of lysine residues; 
phosphorylation (ph) of serine, threonine and tyrosine (Basnet et al., 2014); and 
mono- or poly-ADP-ribosylation of glutamate (E) and arginine (R) residues (Hassa et 
al., 2006). Less abundant and less characterized PTMs include citrullination of 
arginine (Cuthbert et al., 2004; Hagiwara et al., 2002), acylation of lysine besides 
acetylation (Rousseaux and Khochbin, 2015), oxidation of methionine (Luense et al., 
2016), glycosylation of serine and threonine (Sakabe et al., 2010) and proline 
isomerization (Nelson et al., 2006). All these PTMs cause changes in the biophysical 
and biochemical properties of histones that ultimately result in the local alteration of 
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chromatin structure and protein association. In the past years the complex array of 
histone modifications and their functional meaning have been simplified in relation to 
the transcriptional status of the associated genes, discriminating between active and 
repressive histone marks (Figure 2). This lead to the concept of “histone code” 
described by Strahl and Allis (Strahl and Allis, 2000). Nowadays this idea has 
evolved due to the fact that several histone modifications revealed to have more 
complex effects that not only correlates with the transcriptional status of the 
associated genes but are also involved in the regulation of other nuclear processes like 
DNA replication, DNA damage response and nuclear architecture.  
 
 
Figure 2. Major histone PTMs. Most common PTMs of lysine (K), arginine (R), serine (S), and 
threonine (T) residues are shown with their respective modifying enzymes (i.e. “writers” or “erasers”). 
Lysine residues can be monomethylated, dimethylated, or trimethylated. Enzymes shown in green are 
associated with transcriptional activation, and enzymes shown in red are associated with transcriptional 
repression. From (Huynh and Casaccia, 2013) 
 
For this reason the concept of “histone code” has been gradually replaced by the more 
suitable concept of “histone language” (Rothbart and Strahl, 2014). Nevertheless 
several histone PTMs have been well characterized in relation to their impact on the 
regulation of gene expression. Therefore for instance H3K4me1/3, H3K9ac, 
H3K14ac, H3K27ac H3K36me3, H4K20me are considered “active” histone marks 
because mainly associated with open euchromatic regions of the genome containing 
actively transcribed genes whereas H3K9me2/3, H3K27me2/3, H3K79me3, 
H2BK5me3 are “repressive” histone marks associated with transcriptionally inactive 
regions of the genome. All these PTMs and many others are added by “writer” and 
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deleted by “eraser” enzymes, and their biological meaning is due to “reader” proteins 
that recognize the modification and trigger a biological output. Histone methylation is 
catalyzed by histone methyltransferases (HMTs). Both lysine methyltransferases 
(KMTs) and arginine methyltransferases (RMTs) use S-adenosyl-L-methionine 
(SAM) as methyl group donor (Black et al., 2012; Morales et al., 2016). Most of the 
KMTs (with the only exception of KTM4/Dot1L, (Okada et al., 2005)) share the same 
catalytic SET domain first described in Su(var)3-9, Enhancer of Zeste and Trithorax 
proteins (Jenuwein, 2006). Lysine methylation can occur as mono-, di- or tri-
methylation and a specific enzyme commonly mediates each modification. For 
instance KMT1C (G9a) and KMT1D (GLP) are responsible for mono- and di-
methylation of H3K9 while tri-methylation is catalyzed by KMT1A/B (SUV39H1/2) 
and KMT1C. H3K27me3 is catalyzed by E(z) in Drosophila and by the homologous 
proteins EZH1/2 in mammals (Grossniklaus and Paro, 2014). Histone demethylases 
(HDM) represent the erasers of histone methylation and belong to two families, LSD 
that use flavin-adenine-dinucleotide (FAD) as cofactor and JmjC that instead use α-
chetoglutarate, molecular oxygen and Fe(II) to oxidize and remove the methyl group 
(Black et al., 2012). Methylated lysine is “read” by proteins containing 
chromodomains, PHD fingers, WD40 domains or ankyrin repeats (Glatt et al., 2011), 
while methylated arginine is recognized by proteins containing Tudor domains (Chen 
et al., 2011).  
 Histone acetylation is mediated by histone acetyltransferases (HATs) belonging to 
five families: HAT1, Gcn5/PCAF, MYST, p300/CBP and RTT109 (Marmorstein and 
Zhou, 2014). All of them catalyze the transfer of an acetyl group from acetyl-CoA to 
an acceptor lysine residue. Acetylated lysine is recognized by bromodomain 
containing proteins while removal of acetylation is mediated by histone deacetylases 
(HDAC). For most of the other histones modifications writers and eraser enzymes as 
well as readers have been described and their number is constantly growing. Because 
of correlations between several human diseases and histone PTMs balance, proteins 
that mediate histone PTMs as well as readers of histone PTMs have become attractive 
drug targets. 
Another layer of complexity in chromatin organization is represented by the presence 
of several histone variants that differ in the amino acid sequence from the canonical 
histones and are linked to specific functions such as transcriptional activation (H3.3), 
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kinetochore assembly (CENPA), DNA repair and recombination (γH2AX) or X 
chromosome inactivation (macroH2A) (Sarma and Reinberg, 2005). 
 
1.1.3  DNA methylation 
 Besides histones also DNA can be covalently modified. The most common 
modification in eukaryotes is the methylation of cytosine at the carbon at the 5th 
position of the pyrimidine ring. Since it does not affect the Watson-Crick base-pairing 
of cytosine, 5-methylcytosine (5meC) is a classical epigenetic modification and it is 
involved in different epigenetically regulated processes like imprinting, X 
chromosome inactivation and silencing of repetitive sequences. This modification 
takes place mainly at CpG dinucleotides and plays a role in the regulation of gene 
expression (Jones, 2012). DNA methylation at GC-rich promoters and close to 
transcription start sites (TSS) is often correlated with transcriptional repression while 
5mC is commonly found in the gene body of transcriptionally active genes (Jones, 
1999).  Roughly 80% of the CpGs are methylated in mammal genomes and this 
modification is particularly enriched at repetitive elements, retrotransposons, gene 
bodies and satellite DNA (Ehrlich et al., 1982; Li and Zhang, 2014). Clusters of CpG 
called CpG island (CGI) are usually found overlapping with promoter sequences in 
particular of housekeeping genes and are mostly unmethylated (Deaton and Bird, 
2011). Methylation of CGI is usually found at promoters of imprinted genes or, in 
somatic cells, at promoters of genes exclusively expressed in germ cells and in both 
cases it is linked to transcriptional repression (Borgel et al., 2010; Li et al., 1993). The 
acquisition of a genome wide program of CpG methylation is essential to determine 
the exit from the pluripotent state of embryonic stem cells and to allow differentiation 
(Gifford et al., 2013; Mohn and Schubeler, 2009; Shipony et al., 2014; Smith et al., 
2012). Cytosine methylation is catalyzed by a group of enzymes called DNA 
methyltransferase (DNMT). In particular DNMT1 has been described as the enzyme 
responsible for maintenance of CpG methylation after replication (Bestor, 2000). 
Upon the passage of the replication fork DNMT1 re-establishes 5meC on the newly 
synthesized strand thus allowing faithful maintenance of the DNA methylation pattern 
over generations (Hermann et al., 2004). DNMT3a and DNMT3b carry out de novo 
establishment of CpG methylation acting preferentially on unmethylated DNA 
(Yokochi and Robertson, 2002). It has been shown that all the DNMTs are essential 
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for correct development both in mouse and in human. Mutations affecting human 
DNMT genes have been linked to several diseases like acute myeloid leukemia 
(AML) and immunodeficiency, centromere instability and facial abnormalities (ICF) 
syndrome (Jin et al., 2008; Shah and Licht, 2011). DNMT1 knockout is embryonic 
lethal in both species and even tough mouse Dnmt1-/- embryonic stem cells (ESCs) 
have been obtained these show global loss of DNA methylation and severe genomic 
instability (Guo et al., 2004; Kim et al., 2004). Dnmt3a and Dnmt3b double knockout 
(dKO) is embryonic lethal in mouse and single KO leads to embryonic (Dnmt3b) or 
postnatal lethality (Dnmt3a) (Okano et al., 1999). Surprisingly, in the same work 
Dnmt3a and Dnmt3b dKO ESCs have been obtained but they displayed absence of de 
novo methylation activity, suggesting that de novo methylation is actually needed 
later than blastocyst stage during embryonic development. Very recently DNMT KO 
human ES cells have been obtained by means of CRISPR/Cas9 genome editing 
technology (Liao et al., 2015). Remarkably DNMT3a and b single or dKO did not 
show defect in pluripotency being able to form teratomas when injected in nude mice, 
but, as expected, had a severe impairment of genome wide de novo methylation. In 
the same work it was shown that DNMT1 is essential for human ES cell viability 
since it was impossible to obtain a DNMT1-/- stable cell line and even conditional KO 
cells underwent massive cell death upon induction of recombination. 
 DNA methylation is a stable epigenetic modification but it can be also removed 
passively or actively. Passive DNA demethylation is achieved during successive 
rounds of DNA replication in which DNMT1 is inhibited or has reduced activity (Wu 
and Zhang, 2010). Active DNA demethylation is still a controversial topic since 
several enzymes and different pathways have been described to be involved in the 
mechanism (Ooi and Bestor, 2008). Nowadays the most acknowledged active 
mechanism involves the iterative oxidation of 5mC into 5-hydroxymethilcytosine 
(5hmC), 5-formylcytosine (5fC) and finally 5-carboxylcytosine (5caC) by the ten-
eleven translocation (TET) enzymes. 5fC and 5caC can be eventually removed by the 
thymine DNA glycosylase (TDG, normally involved in T:G mismatch repair) in the 
context of the base excision repair (BER) pathway, allowing restoring the canonical 
C:G base pair (He et al., 2011; Kohli and Zhang, 2013). A good example in which 
active and passive demethylation mechanisms occur together is immediately after 
oocyte fertilization in mammals. At this stage both paternal and maternal genome are 
widely methylated but immediately undergo substantial demethylation. The maternal 
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DNA goes through passive demethylation during following cell divisions while the 
paternal genome is first massively hydroxymethylated by the maternally stored TET3 
enzyme at the zygote stage and then the oxidation products are diluted through a 
replication dependent process (Inoue and Zhang, 2011). 
 As in the case of histone modifications, also “readers” of methylated DNA have 
been described. These proteins contain a methyl-CpG binding domain (MBD) and are 
involved in the recruitment of additional factors that mediate transcriptional 
repression (Fatemi and Wade, 2006). As an example the methyl-CpG binding protein 
2 (MeCP2) is able to recruit both HDACs and the HMTs SUV39H1 and 2 (which 
catalyze H3K9me3) to establish histone repressive marks and transcriptional 
repression (Fuks et al., 2003; Nan et al., 1998). From the opposite point of view also 
recruitment of DNMTs by histone modifications or histone modifiers have been 
described. The PWWP domain of DNMT3B is for instance able to recognize 
H3K36me3, which is co-transcriptionally deposited by SETD2 at the gene body of 
active genes, and this can explain the recruitment of DNMT3B and the deposition of 
de novo DNA methylation at these sites (Baubec et al., 2015). The G9a HMT, which 
is able to mediate H3K9me1, me2 and me3, is also able to directly recruit DNMT3A 
and DNMT3B by an ankyrin domain independently of the HMT activity reinforcing 
the transcriptional repression of pluripotency related genes during ESC differentiation 
(Epsztejn-Litman et al., 2008). DNA methylation can also inhibit recruitment of DNA 
binding factors. For instance in mouse cells, methylation of a single CpG within the 
UCE (upstream control element) of the ribosomal gene promoter located 133 bp 
upstream the TSS impairs binding of the Pol I transcription factor UBF (upstream 
binding factor) to chromatin, thereby preventing the formation of the initiation 
complex (Santoro and Grummt, 2001). These represent only few examples of the 
interplay between DNA methylation and histone modifications showing how these 
epigenetic mechanisms are actually deeply interconnected to modulate gene 
expression. 
 
1.2 Non-coding RNAs 
 Complexity of organisms does not directly correlate with the size of their genome 
(C-value paradox) neither with the number of their genes (G-value paradox) (Hahn 
and Wray, 2002; Schad et al., 2011). For example according to the animal genome 
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size database (http://www.genomesize.com) the human genome has the same size as 
the common frog (Rana temporaria) and contains roughly the same number of 
protein-coding genes of the plant Arabidopsis thaliana (Pertea and Salzberg, 2010). 
Even taking in consideration events such as alternative splicing of transcripts or post-
translational modifications of proteins it is not possible to justify the differences in 
organismal complexity among these species. Thus it has been proposed that the 
complexity of an organism better correlate with the degree of control of gene 
regulation. This is obtained, in higher organisms, by expansion of cis-acting 
regulatory elements that can regulate transcription but also splicing (Fu and Ares, 
2014), chromatin architecture (Fennessy and Owen-Hughes, 2016; Yang et al., 2016), 
RNA editing (Sapiro et al., 2015) and RNA stability (Taft et al., 2007). A further level 
of complexity in higher organisms is reached by the increase of transcription of non-
protein-coding DNA that can give rise to a wide range of regulatory RNAs, which 
directly exert their function as established molecular entities without being translated 
into protein. Indeed despite only a small portion (ca. 2%) of the mammalian genome 
is transcribed into messenger RNAs encoding for proteins, the vast majority (ca. 80%) 
is actually transcribed (Bertone et al., 2004; Carninci et al., 2005; Cheng et al., 2005; 
Djebali et al., 2012). With the only exception of ribosomal RNA and transfer RNAs, 
whose function was revealed already in the early 1970s (Rich and RajBhandary, 
1976; Schweet and Heintz, 1966), this big amount of ncRNA has been considered in 
the past the result of “transcriptional noise” of what was considered at that time 
“junk” DNA and by analogy considered non-functional “junk” RNAs. Nowadays 
several ncRNAs have been described to have a biological function that ranges from 
regulation of transcription, mRNA degradation, repression of translation, regulation 
of mRNA splicing, scaffold for ribonucleoprotein (RNP) complex formation, 
chromatin regulation and nuclear architecture. This wide range of functions as well as 
the genomic origin has challenged any effort of classifying ncRNAs into functional or 
structural groups. A rudimentary classification relies on their size distinguishing 
between short (or small) and long ncRNA (lncRNA) if respectively shorter or longer 
than 200 nucleotides (Clerget et al., 2015; Kung et al., 2013).  
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1.2.1  Small non coding RNA 
tRNAs, snRNAs snoRNAs, miRNAs, siRNAs, piRNAs and tiRNAs  belong to the 
small ncRNAs class (Clerget et al., 2015). The well-characterized transfer RNAs 
(tRNAs) represent the cornerstone of the mechanism of translation of the genetic code 
into polypeptides chains (Schweet and Heintz, 1966). Small nuclear RNAs (snRNA) 
are found in the nucleoplasm where they exert their function. To this class belong the 
U1, U2, U4, U5 and U6 snRNA that are responsible for the formation of the 
spliceosome and the catalysis of intron removal from pre-mRNA (Valadkhan, 2005). 
Small nucleolar RNAs (snoRNA) were originally described in mediating modification 
and processing of ribosomal RNA inside the nucleolus. Indeed the two families of 
snoRNAs (C/D and H/ACA) guide respectively the 2'-O-ribose methylation and 
pseudouridylation of rRNA, snRNA and mRNA (Matera et al., 2007).  Nevertheless 
snoRNAs, in conjunction with specialized proteins, are also involved in other 
processes outside of the nucleolus. As an example the telomerase RNA TERC 
belongs to the H/ACA snoRNA family and in combination with the reverse 
transcriptase (TERT) is involved in the synthesis and maintenance of telomeres, the 
structure that protects the terminal part of chromosomes (Collins, 2006). Small 
interfering RNA (siRNA; ca. 21 nt in length) and micro RNAs (miRNA ca. 22 nt in 
length) partially share the maturation and assembly machinery and are involved 
respectively in the active degradation and the inhibition of translation of the target 
mRNA (Bartel, 2004; Fire et al., 1998; Hutvagner et al., 2001). The main differences 
between these two classes of small ncRNA reside in the sequence complementarity 
with the target RNA that is perfect in the case of siRNA, while includes some 
mismatches in the case of miRNA, a second difference resides in the origin of the 
precursor double stranded RNA (dsRNA). miRNAs originate from miRNA genes 
whose transcript is partially self complementary and able to form a hairpin structure. 
This can be recognized and processed by the complex Drosha/DGCR8 into a pre-
miRNA that is exported in the cytoplasm and further processed by Dicer to give rise 
to the mature miRNA, which in turn is loaded onto the RNA-induced silencing 
complex (RISC) including the Argonaute 1-4 proteins. siRNAs can originate from 
endogenous sources that are able to form dsRNA as for instance sense-antisense 
transcripts, self complementary RNAs, gene-pseudogene transcript pairs, or from 
exogenous sources like retroviral genomes. These transcripts are directly processed by 
Dicer in the cytoplasm of the cell and loaded onto the effector complex RISC, which 
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mediate the cleavage of the target RNA (Kim et al., 2009). Due to the high efficiency 
and specificity of target degradation siRNAs are nowadays a common tool to down-
regulate protein expression in different experimental approaches. PIWI-interacting 
RNAs (piRNA; 24-31 nt in length) originate from intergenic repetitive elements 
mostly including transposable elements (retrotransposons), which are transcribed in 
single stranded RNA and processed by a not fully characterized complex that includes 
PIWI proteins. Mature piRNAs are then used in a ping-pong reaction that allows their 
amplification using the target retrotransposon RNA (Siomi et al., 2011). The main 
function of piRNA is indeed to silence transposable elements in the germ line both by 
degradation of the RNA product of retrotransposons and by inducing heterochromatin 
formation at genomic loci containing transposable elements (Iwasaki et al., 2016). 
Transcription initiation RNAs (tiRNA) are small ncRNA generated by stalling or 
backtracking of the RNA polymerase II near the transcription start site (TSS). Their 
function, if any, is still unknown and they have been proposed to be involved in 
maintaining chromatin into a transcriptionally active state (Aalto and Pasquinelli, 
2012). 
 
1.2.2  Long non coding RNA 
 In contrast to small ncRNAs, the heterogeneous and multiple functions of lncRNA 
still do not allow a simple classification into functional categories. Additionally, the 
study of lncRNA has revealed to be experimentally very challenging. In fact the 
genetic and biochemical approaches used for studying protein functions, which have 
been improved in several decades of experimental work, are not fully transferable to 
the study of lncRNA. For this reasons the existing techniques have to be wisely 
adapted to this scope and more likely new methods have to be established (Bassett et 
al., 2014; Leone and Santoro, 2016).  
 LncRNA have been implicated in several biological mechanisms like gene 
transcriptional regulation, chromatin modification, scaffold for RNP complexes 
formation, nuclear architecture and many other functions, which currently continue to 
be identified (Guttman and Rinn, 2012; Quinodoz and Guttman, 2014). A relatively 
easy way for classifying lncRNA relies on the distinction of their genomic origin 
(Kung et al., 2013). In particular, lncRNA can (i) originate from specific transcription 
units as in the case of long intergenic ncRNA (lincRNA); (ii) be the product of 
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antisense transcription of a protein coding gene or part of it; (iii) be transcribed from 
non-functional genes (pseudogenes); (iv) derive from introns of coding mRNA after 
splicing; (v) originate from sense or antisense transcription of promoter or enhancer 
regions. Even though quite realistic this classification probably does not cover all the 
possible sources of lncRNA and these categories are not mutually exclusive. 
Furthermore this classification does not take in consideration post-transcriptional 
modifications of RNA, like RNA editing or processing that could produce different 
variants of lncRNA or even new lncRNA derived for instance from processing of 
precursors with different functions (Savic et al., 2014).    
 As recently stated by Quinn and Chang, “perhaps the sooner we dispense with 
categorical definitions of lncRNAs and recognize that they exist on multidimensional 
spectra of biogenesis, form and function, the sooner we can appreciate the enormous 
diversity of these genes.” (Quinn and Chang, 2016). 
 
1.2.2.1  Mechanisms of transcriptional regulation mediated by lncRNA 
 LncRNAs can regulate transcription of protein coding genes acting both in cis, that 
is in proximity to the site of transcription of the lncRNA on the same allele or in 
trans, that is on different allele (Guttman and Rinn, 2012; Ma et al., 2013). Cis-acting 
regulation can be achieved as a consequence of the transcription of the lncRNA itself 
and result in activation or inhibition of the neighboring protein coding genes. Cis-
transcriptional activation is thought to rely on the active chromatin state concurrent to 
the act of transcription of the adjacent or overlapping lncRNA gene and on the 
recruitment of transcriptional activators and chromatin modifiers that deposit active 
histone marks (Guil and Esteller, 2012; Krishnan and Mishra, 2014). Similarly 
transcriptional repression is hypothesized to result from collision of the machineries 
involved in the transcription of coding and non-coding genes respectively (Crampton 
et al., 2006), or from recruitment of transcriptional repressors and repressive histone 
marks writers (Guil and Esteller, 2012). Trans-acting regulation requires the diffusion 
of lncRNA from its site of transcription to the site of action in analogy to trans-acting 
protein factors. However lncRNAs, which are still tethered to their locus of origin, 
can also act in trans if the two genomic loci, the one of origin and the one of action, 
are in close proximity to each other (Guttman and Rinn, 2012). Therefore also the cis-
trans classification is blurry due to the singular nature of lncRNAs. In a very naive 
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mechanistic classification lncRNAs can be described as signaling molecules, decoys, 
scaffolds and guides (Figure 3). 
 
Figure 3 Schematic representations of the four archetypes of lncRNA mechanisms. Archetype I: 
as signals, lncRNA expression can reflect the combinatorial actions of transcription factors (colored 
ovals) or signaling pathways to regulate gene expression in space and time. Here is represented the 
chromatin loop formation mediated by an enhancer RNA. Archetype II: as decoys, lncRNAs can titrate 
transcription factors and other proteins away from chromatin or titrate the protein factors into nuclear 
subdomains. A further example of decoys is lncRNA decoy for miRNA target sites (see section 
1.2.2.4). Archetype III: as scaffolds, lncRNAs can bring together multiple proteins to form 
ribonucleoprotein complexes. The lncRNA-RNP may act on chromatin to affect histone modifications. 
In other instances, the lncRNA scaffold is structural and stabilizes nuclear structures or signaling 
complexes.  Archetype IV: as guides, lncRNAs can recruit chromatin-modifying enzymes to target 
genes, either in cis (near the site of lncRNA production) or in trans to distant target genes. All the 
archetypes can result in activation or repression of gene transcription according to the function of the 
associated proteins. Adapted from (Wang and Chang, 2011) 
 
 LncRNA can act as signaling molecules being transcribed under certain external 
stimuli and contributing in gene expression. An example of signaling lncRNAs is 
enhancer RNAs, which can regulate transcription determining chromatin looping. 
LncRNAs can act as decoys being able to bind and sequester protein targets that are 
involved in transcriptional regulation. LncRNAs can function as molecular scaffolds 
to build RNP complexes and can act as guide if they localize these RNP complexes or 
single factors to specific genomic sites (Wang and Chang, 2011). Also all these 
functions are not mutually exclusive and a single lncRNA can possess all these 
functions at the same time. In the recent years many models for lncRNA function 
have been proposed. I will here describe some well-studied examples of lncRNA-
mediated regulation, which highlight the broad and multifaceted features of lncRNA 
mechanisms of action.  	  
1.2.2.3  LncRNAs in the regulation of sex chromosome dosage compensation: Xist 
and roX RNAs 
 An important example of lncRNAs functions is represented by the mechanism 
through which many animals compensate the aneuploidy of one of the sex 
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chromosomes in order to maintain a balanced expression of the genomes of the two 
sexes, defined as sex chromosome dosage compensation (DC). In mammals and fruit 
flies two X chromosomes characterize females, while males have one X and one Y 
chromosome (Brockdorff and Turner, 2015; Lucchesi and Kuroda, 2015). In female 
mammals, DC is achieved by the transcriptional inactivation of one of the two X 
chromosomes at early stages of embryonic differentiation (X chromosome 
inactivation, XCI). In fruit flies the opposite mechanism takes place that means over 
expression of the single X chromosome in males. Both mechanisms are mediated by 
lncRNAs: Xist in mammals and roX1 and roX2 in Drosophila.  
 In mammals the X inactive specific transcript (Xist) is transcribed from the X 
inactivation center (Xic) of the X chromosome that will be inactivated and is able to 
recruit in cis chromatin-modifying complexes that are responsible for silencing, 
formation of heterochromatin and compaction of the X chromosome. In mice Xist is a 
15 Kb lncRNA transcribed by RNA pol II, spliced, capped and polyadenylated 
(Borsani et al., 1991; Brockdorff et al., 1992). Its sequence is poorly conserved even 
among mammals but its structure is highly similar in different species and is 
characterized by tandem repeats dubbed motif A to F that determine its ability to act 
as a scaffold and as a guide (Brockdorff et al., 1992; Brown et al., 1992). Indeed the C 
motif is essential for the correct targeting of Xist, while the A motif is necessary for 
induction of silencing through binding of specific factors (Sarma et al., 2010; Wutz et 
al., 2002). The mechanism by which Xist determines silencing of the X chromosome 
is still under debate. RNA immunoprecipitation (RIP) experiments showed that the 
PRC2 subunits EZH2 and SUZ12 co-immunoprecipitate with Xist RNA, suggesting 
that Xist can act as a scaffold for the recruitment of the PRC2 repressive complex on 
the X, which results in the observed accumulation of H3K27me3 across the inactive 
X (Zhao et al., 2010; Zhao et al., 2008). However recent studies using more stringent 
techniques to purify RNA-protein complexes, which include a UV-crosslinking step, 
identified others factors that interact more tightly with Xist and can mediate XCI. 
Among those factors HNRNPK was shown to bind the F motif in exon 1 of Xist and 
mediate the recruitment of PRC2 complex (Chu et al., 2015). Additionally SHARP 
(SMRT and HDAC associated repressor protein, also known as SPEN) was found to 
directly bind the A repeat, linking Xist targeting to histone deacetylation activity of 
HDAC3, which is a fundamental step of Xi (Chu et al., 2015; McHugh et al., 2015).  
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 At the onset of XCI, Xist is transcribed from the Xic of the future Xi and rapidly 
spreads and coats the entire chromosome through a not well-known mechanism. 
Bivalent proteins like YY1 and HNRNPU (also known as SAF-A), which are able to 
bind both RNA and DNA, have been described to mediate Xist localization on the Xi 
(Hasegawa et al., 2010; Jeon and Lee, 2011). However spreading of Xist across the X 
chromosome has been recently described to rely on spatial proximity of the Xic to 
some regions of the X chromosome rather than on sequence specificity (Engreitz et 
al., 2013). According to this model Xist exploits the pre-existing three-dimensional 
conformation of the X chromosome to identify target sites at distal regions, binding 
preferentially at the periphery of gene rich regions. This allows to recruit PRC2, 
HDAC and other factors responsible for silencing and compaction of chromatin and 
its repositioning in the Xist RNA compartment close to the nuclear lamina (Chen et 
al., 2016). In this way new chromosome regions are brought in close proximity to the 
Xic allowing the spreading of heterochromatin across the entire X chromosome.  
 Dosage compensation in Drosophila implies up regulation of the single X 
chromosome in males to balance the sex chromosome/autosome ratio. In this case DC 
is mediated by the complex male specific lethal (MSL) composed by the histone 
acetyltransferase MOF (males absent on the first), the scaffold protein MSL1, the E3 
ubiquitin ligase MSL2, the chromodomain containing protein MSL3, the RNA/DNA 
helicase MLE (ortholog of human RHA also known as DHX9) and the two lncRNAs 
RNA on X 1 and 2 (roX1 and roX2) (Lucchesi and Kuroda, 2015). In particular roX1 
and roX2 have a fundamental role in DC. Both are transcribed from the X 
chromosome and differ greatly in size (respectively 3.7 and 0.6 Kb) and sequence but 
share a common secondary stem loop structure called roX-box that could explain their 
redundant function (Meller and Rattner, 2002). This secondary structure is actively 
remodeled by the RNA helicase MLE to allow its recognition by the MSL2 protein 
during MSL complex recruitment on the X chromosome (Ilik et al., 2013; Maenner et 
al., 2013). The mode by which the MSL complex is recruited on the X chromosome is 
not fully understood and it seems to depend both on the ATP-dependent remodeling 
of roXs stem-loops by MLE and on the direct binding of the complex roX-MLE-
MSL2 to high affinity DNA sites (HASs) acting as a platform for recruitment of the 
other components of the MSL complex (Straub et al., 2013). 
Both Xist and roX RNAs represent a perfect paradigm of cis-acting non-coding 
transcripts that can function as scaffolds for the assembly of large RNP complexes 
1	  Introduction	  
	   24	  
and that can guide these complexes to specific chromatin sites. Furthermore they act 
as signaling molecules since their expression is tightly controlled during development 
and involves complex regulatory networks that result in the modification of the 
chromatin status of entire chromosomes and in the establishment of a precise 
transcriptional program. 
 
1.2.2.4  Further examples of lncRNAs functions 
 Though explaining a large number of lncRNA functions and mechanisms of action, 
the examples described so far cover only part of the broad and multifaceted features 
of lncRNA. Without the claim to provide a complete overview, a few other examples 
will be described. 
 HOTAIR, Air, Kcnq1ot1 and SRA are lncRNA that have been described to act as 
scaffold and guide for RNP complex. HOX antisense intergenic RNA (HOTAIR) 
originates from the HOXC gene cluster and acts in trans to repress the transcription of 
the HOXD genes. The mechanism of repression involves the interaction of the 5’ 
region of HOTAIR with the PRC2 repressor complex and the 3’ region with 
LSD1/CoREST complex in order to respectively establish the H3K27me3 repressive 
histone mark and remove the H3K4me3 active histone mark over the HOXD locus 
(Rinn et al., 2007; Tsai et al., 2010). Therefore HOTAIR is another important 
example of lncRNA acting as a modular scaffold and a guide for RNP complex 
formation. Air and Kcnq1ot1 are lncRNAs involved in regulation of imprinted gene 
repression. Both the RNAs are transcribed from the silenced paternal allele, and they 
specifically bind to and recruit in cis the histone H3 lysine 9 methyltransferase G9a to 
mediate H3K9me3 and transcriptional silencing of respectively Kcnq1 or Igf2r loci 
(Nagano et al., 2008; Pandey et al., 2008). Furthermore the 5’ end of Kcnq1ot1 RNA 
is responsible for binding and recruitment of DNMT1 to maintain CpG methylation of 
somatic differentially methylated regions (DMRs) gained during post-implantation 
development, while G9a and PRC2 recruitment by this RNA is necessary to mediate 
the imprinting of placental-specific imprinted genes (Mohammad et al., 2010). The 
lncRNA steroid receptor RNA activator (SRA) is another prominent example of 
modular scaffold RNA. SRA is indeed able to bind both PRC2 and Trithorax group 
(TrxG) complexes and in combination with the DEAD box RNA helicase p68 (also 
known as DDX5) and the MyoD transcription factor is involved in promoting muscle 
gene expression and cellular differentiation (Caretti et al., 2006; Wongtrakoongate et 
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al., 2015). Interestingly the p68/SRA complex is also involved in the stabilization of 
the interaction between cohesin and CTCF, promoting the insulator function of CTCF 
(Yao et al., 2010). Altogether these findings suggest that SRA may function as a 
scaffold to organize multiple factors, which in turn regulate gene expression in a 
context-specific manner. 
 Another function ascribed to some lncRNA is acting as decoy and sequestrate 
proteins in non-functional complexes. This is the case of growth arrest-specific 5 
(GAS5), a lncRNA transcribed upon growth factor starvation. GAS5 contains a 
hairpin sequence motif that resembles the DNA sequence of the glucocorticoid 
response element (GRE) and this allows GAS5 to compete with GRE for the binding 
of the glucocorticoid receptor (GR). Thus upon starvation GAS5 is induced and act as 
a decoy for GR inhibiting the expression of glucocorticoid responsive genes (Kino et 
al., 2010). P21 associated ncRNA DNA damage activated (PANDA) is another 
lncRNA acting as decoy. PANDA is expressed in a p53 dependent manner and it 
binds to NF-YA transcription factor limiting expression of pro-apoptotic genes (Hung 
et al., 2011). 
 LncRNAs can also interact with other RNAs to exert their function. Two examples 
are represented by lincRNA-p21 and by TINCR. lincRNA-p21 was first discovered as 
a p53-induced lincRNA that acts as a transcriptional repressor by binding the nuclear 
factor KNRNPK, thus acting as a scaffold/guide to mediate gene silencing (Huarte et 
al., 2010). Subsequently lincRNA-p21 was also shown to form direct RNA-RNA 
interaction with beta catenin and JunB mRNAs in the absence of the RNA binding 
protein ELAVL1 and this resulted in inhibition of translation of these mRNAs 
mediated also by the interaction with the translational repressor Rck (Yoon et al., 
2012). Another good example of post-transcriptional regulation mediated by lncRNA 
is the terminal differentiation-induced control RNA (TINCR). This cytoplasmic RNA 
controls human epidermal differentiation by stabilizing several mRNAs involved in 
skin development. Stabilization of those mRNAs requires both a direct RNA-RNA 
interaction, which involves a 25 nt motif called TINCR-box that is enriched in all the 
targets of TINCR, and the interaction with the RNA binding protein staufen1 
(STAU1) (Kretz et al., 2013). Some lncRNA can act as sponges of miRNAs or 
proteins. To the first category belongs linc-RoR a competing endogenous RNA 
(ceRNA) specifically expressed in human ESCs. This RNA is transcribed under the 
direct control of the pluripotency factors Oct4, Sox2 and Nanog and it acts as a 
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competitor RNA for binding of the miRNA 145 (miR-145), which targets and down-
regulate the transcripts of Oct4, Sox2 and Nanog via RISC mediated RNA 
degradation. Linc-RoR indeed contains in its sequence some miRNA-responsive 
elements (MRE) analogues to those of the pluripotency factors mRNAs. Thus miR-
145 can target the MREs of linc RoR and this prevents degradation of Oct4, Sox2 and 
Nanog mRNAs and contributes to the maintenance of pluripotency (Wang et al., 
2013). NORAD (ncRNA activated by DNA damage) represents a “protein-sponge” 
RNA. This RNA act as a signaling molecule that is massively induced upon genotoxic 
stress and is able to sequester PUMILIO proteins that specifically bind to RNA 
sequences called pumilio response elements (PRE), which are over-represented in 
NORAD sequence. In the absence of NORAD, PUMILIO proteins can bind to PREs 
present in the 3’ untranslated region (UTR) of many mRNA encoding for factors 
involved in DNA repair and DNA replication. Binding of PUMILIO proteins to these 
targets determine their degradation and this results in genomic instability (Lee et al., 
2016a). 
 The list of lncRNA described to have a biological function is continuously growing 
as well as the possible mechanisms through which they exert those functions. 
Certainly the field of lncRNAs is still in its infancy and much more has to be done 
and discovered to really appreciate the potential of this class of molecules. 
Nonetheless the evaluation of new possible mechanisms of action and biological 
functions of lncRNA has to be carefully and clearly proven in order to really 
understand the importance of these molecules. This consciousness is growing in the 
last years and most probably will lead to the revision of several mechanistic models 
that have been drawn so far using “old” biochemical and genetic approaches (Leone 
and Santoro, 2016). 
 LncRNAs have come a long way from being considered as “junk RNA” to their 
involvement in many biological processes (Cech and Steitz, 2014). Indeed they 
revolutionized the concept of transcriptome as a simple messenger of the genetic 
information towards the vision of it as an active entity that can take part in 
fundamental mechanisms of regulation of genome expression.   
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1.3 RNA helicases 
 Helicases are enzymes able to remodel nucleic acids by using the free energy of 
binding or hydrolyzing triphosphate nucleotides. All helicases, including both DNA 
and RNA helicases, are distributed among six superfamilies (SF1 to 6) according to 
their amino acid sequence and structure. All eukaryotic helicases belong to SF1 and 
SF2 while bacterial and viral helicases are distributed among all the SFs. RNA 
helicases are distributed in six families of which only one belongs to SF1 (Upf1-like) 
while the other five belong to SF2 (DExD, DExH/RHA, Ski2-like, RIG1-like and 
NS3/NPHII) (Fairman-Williams et al., 2010; Jankowsky, 2011) (Figure 4).  
 
 
Figure 4. SF1 and SF2 helicase 
families. Unrooted cladogram 
showing the helicase families of 
the SF1 (right), and the SF2 
(left). Branch lengths are not to 
scale. The oval indicates 
significant uncertainty in 
cladogram topology in this 
region. Boldfaced names show 
families harboring RNA 
helicases. Light grey names 
indicate DNA helicases. From  
(Jankowsky, 2011). 
 
Helicases of SF1 and SF2 contain a structurally conserved helicase core region, 
formed by two highly similar RecA-like helicase domains arranged in tandem. 
Several RNA helicases of both SF1 and SF2 are actually able, at least in vitro to act 
both on DNA and RNA substrates. RNA helicase are believed to perform three 
different activities in the cell: they can unwind RNA duplex or more complex nucleic 
acid structures (proper helicase function); they can actively displace other proteins 
from RNA; and, in contradiction with their name, they can act in facilitating strand 
annealing and RNA folding (Jankowsky and Bowers, 2006; Jankowsky and Fairman, 
2007). All these functions are thought to enable RNA helicases to catalyze disruption 
and formation of RNA secondary or tertiary structures and to remodel RNP 
complexes (Bhaskaran and Russell, 2007; Yang et al., 2007). Furthermore in some 
cases these reactions do not require ATP hydrolysis, which is instead more often 
necessary for efficient release of the helicase from RNA and thus for multiple 
substrate turnovers (Aregger and Klostermeier, 2009; Liu et al., 2008). Most, if not 
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all, RNA helicases work within multi-protein complexes and do not possess any 
sequence or structural preference. These aspects greatly complicate the identification 
of targets and more in general the study of their function in vivo. However sequence 
or site specificity would be most probably incompatible with the wide range of 
possible RNA folding or RNP complexes the RNA helicases have to deal with. 
Moreover there is a large lack of knowledge about the modulation of helicase 
enzymatic activity by other interacting proteins or by RNA structures. 
 The best studied RNA helicases belong to the DExD, DExH/RHA and Ski2-like 
families. Most of the studies on RNA helicases have been focused on mRNA splicing, 
mRNA translation, rRNA maturation and RNA degradation and very little is known 
about the relationship between RNA helicases and lncRNA (Bourgeois et al., 2016; 
Jarmoskaite and Russell, 2014). The DDX5/SRA complex already introduced in the 
section 1.4.2.4 represents one example of a functional RNA helicase/lncRNA 
complex. The interaction of DDX5 with the lncRNA SRA has been described to be 
important to coactivate MyoD-dependent transcription and, as a consequence, to 
enhance muscle differentiation (Caretti et al., 2006). DDX5/SRA is also important to 
mediate the interaction between the DNA-binding insulator protein CTCF and 
cohesin and to stabilize this interaction in order to achieve a proper insulator function 
(Yao et al., 2010). More recently DDX5 and SRA RNA have been shown to function 
as coactivators of Notch signaling by interacting with the CSL transcription factor and 
enhancing the expression of Notch target genes (Jung et al., 2013). DDX5 in 
conjunction with the lncRNA Rmrp also controls differentiation of T helper 17 
lymphocytes (TH17) by interacting with the RORγt transcription factor and 
coordinating the transcription of TH17 specific genes (Huang et al., 2015). The RNA 
helicase DDX3x has been recently described in mice to inhibit maturation of specific 
miRNA in early postnatal retinal photoreceptors by inhibiting the processing of their 
pre-miRNA precursor. Expression of the lncRNA Rnrcr4 at later stages activate the 
processing of the pre-miRNA by directly interacting with the helicase DDX3x and 
allowing the maturation of the miRNA that regulates further steps of retinal 
development (Krol et al., 2015). The helicase DDX21 was described both to facilitate 
rRNA editing by interacting with snoRNAs and to interact with the 7SK snRNA, 
which sequesters the transcription elongator P-TEFb, determining P-TEFb release and 
enhancing Pol II transcription (Calo et al., 2015). All these works describe an intimate 
connection between RNA helicases and lncRNA in the modulation of several 
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processes, nevertheless they do not provide details of the mechanism through which 
helicases and lncRNAs can exert their biological function. As already mentioned 
above this can be ascribed to how little is known about the function of RNA helicases 
in the context of large multi-protein complexes and about their activity in modulating 
nucleic acid structures, which certainly goes beyond simple unwinding reactions. 
 
1.3.1 DHX9 RNA helicase 
 The RNA helicase A (RHA, also known as DHX9 or NDHII) belongs to the SF2 
and in particular to the DExH/RHA helicase family. As all the SF2 members DHX9 
contain two very similar RecA-like domains, which are responsible for the helicase 
activity and the nucleotides triphosphate (NTP) hydrolysis and include the amino acid 
sequence DEIH (namely Asp-Glu-Ile-His) that is responsible for binding of NTP via 
Mg2+ (Lee and Pelletier, 2016). DHX9 is able to unwind in vitro both DNA and RNA 
by using the hydrolysis of any NTP (Zhang and Grosse, 1994). In addition to the 
helicase core domain, DHX9 contains two double stranded RNA-binding domains 
(dsRBDs) at its N-terminus. The minimal transactivation domain (MTAD), is situated 
between dsRBDII and motif I of the helicase core domain. A helicase-associated 
domain 2 (HA2) is adjacent to the C-terminal end of the helicase core domain. At the 
C-terminus are also present an oligonucleotide/oligosaccharide-binding fold (OB-
fold), a nuclear localization signal (NLS) and a glycine rich RGG-box able to bind to 
single stranded nucleic acids with a higher affinity for ssDNA (Zhang and Grosse, 
1997). DHX9 is well conserved among species and the human and murine 
homologues share 90% of amino acid identity while the Drosophila homologue MLE 
is 50% identical to the human DHX9. 
 DHX9 is a nuclear protein mainly localized in the nucleolus of mammal cells 
(Andersen et al., 2002; Fuchsova and Hozak, 2002; Zhang et al., 1999). Homozygous 
DHX9 deletion is embryonic lethal in mouse resulting in an aberrant gastrulation and 
massive cell death of ectodermal cells (Lee et al., 1998). However adult conditional 
knockout mice are not affected by the absence of DHX9 (Lee et al., 2016b). Deletion 
of the DHX9 homologue MLE in Drosophila it is lethal for male zygotes (Fukunaga 
et al., 1975). RHA knockout in C.elegans is linked to the loss of H3K9me3 in the 
germ line that leads to defects in mitosis and meiosis resulting in sterility (Walstrom 
et al., 2005). All these observations suggest that DHX9 is essential for development in 
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different organisms. Several years of research described DHX9 to be involved in 
different biological processes ranging from DNA replication, maintenance of genomic 
stability, mRNA splicing, miRNA biogenesis, RNA transcription and translation 
(Friedemann et al., 2005; Hartman et al., 2006; Hartmuth et al., 2002; Mischo et al., 
2005; Nakajima et al., 1997; Robb and Rana, 2007). Furthermore DHX9 has been 
found implicated in several pathologies including HIV immunodeficiency, influenza 
A, systemic lupus erythematosus (SLE) and different types of cancer (Fujii et al., 
2001; Lin et al., 2012; Mills et al., 2013; Wei et al., 2004). Like for other RNA 
helicases the study of DHX9 is complicated by the absence of sequence specific 
targets and even more by its ability to act both on RNA and DNA. These assumptions 
make difficult to find a precise mode of action for this helicase and suggest that its 
substrates can virtually include any RNA able to form folded structures and any 
complex interacting with those RNAs. Furthermore the action of DHX9 on these 
complexes could result in remodeling of the RNA-protein interaction or in its 
destruction by displacing the protein from the RNA molecule. Lastly DHX9 could 
also bridge the interaction between a RNA molecule and a protein being able to bind 
to both. 
 
1.4  Embryonic stem cells (ESCs) 
 Embryonic stem cells (ESCs) derive from the inner cell mass (ICM) of a blastocyst, 
an early stage of mammalian development corresponding to the pre-implantation 
embryo (in mouse embryonic day 3.5, (E3.5)). ESCs are characterized by the ability 
to differentiate in any of the three germ layers that constitute the embryo of 
vertebrates (i.e. endoderm, mesoderm and ectoderm). This trait is defined as 
pluripotency. Stemness is considered the ability of a cell to self-renew through 
symmetric division, originating identical daughter cells, and to differentiate through 
asymmetrical divisions from which originate a daughter cell with stem features and a 
daughter cell that is “committed” to differentiate. The potency of a stem cell reflects 
the variety of cell types that can potentially originate by differentiation. The potency 
ranges from the totipotency of the zygote, from which originate both embryonic and 
extra-embryonic tissues, to the unipotency of some adult stem cells such as epithelial 
stem cells, which guarantee cell turnover in epithelia (Slack, 2000).   
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Pluripotency together with the self-renewal ability, which means the capability to 
proliferate and maintain an undifferentiated state, make ESCs a perfect tool to dissect 
the molecular mechanisms of cell differentiation and early development. 
 
1.4.1  A short history of ESCs 
 ESCs were originally derived in the early ‘80s from the ICM of early mouse 
embryos at E3.5 and cultured on a “feeder” cell layer (mitotically inactivated 
fibroblast) in medium containing fetal bovine serum (Evans and Kaufman, 1981; 
Martin, 1981). The efficiency of those early attempts was quite low and further 
refinements of the culture conditions allowed establishing more stable and 
homogenous cell lines. A big improvement was achieved by the introduction of the 
leukemia inhibitory factor (LIF) in the culture medium (Smith et al., 1988; Williams 
et al., 1988). LIF was isolated from the cytokine factors produced by the feeder cells 
and it is a member of the IL6 family that binds to the leukemia inhibitory factor 
receptor (LIFR also known as CD118). This binding induces the heterodimerization 
of the LIFR with the glycoprotein 130 (gp130) triggering three different signaling 
pathways. In particular the JAK (Janus Kinase)/STAT3 (signal transducer and 
activator of transcription 3) pathway controls the transcription of genes regulating 
self-renewal; the PI3K (phosphatidylinositol-3-OH kinase)/PKB (protein kinase B) 
promotes ESC survival and cell cycle progression by suppressing the activity of the 
cell cycle inhibitor p27/kip1; the SHP2 (SH2 domain containing tyrosine 
phosphatase)/MAPK (mitogen activated protein kinase) pathway induces a 
phosphorylation cascade of extracellular-signal-related kinases (ERKs) which leads to 
activation of genes involved in differentiation. The SHP2/MAPK pathway counteracts 
the self-renewal signaling of the JAK/STAT pathway, thus inhibition of MAPK by 
the small molecule PD0325901 promotes self-renewal (Burdon et al., 1999). The use 
of this MAPK inhibitor in conjunction with the Wnt signaling activator CHIR99021 
and the bone morphogenic factor 4  (BMP4), which allow omitting serum in the 
culture medium, represents one of the most common serum-free culture conditions 
used to maintain ESCs in culture, commonly referred to as 2i condition (Wray et al., 
2010; Ying et al., 2008).  
 Pluripotent stem cells can be derived from other sources and using different 
techniques. Epiblast stem cells (EpiSCs) can be obtained for instance from post 
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implantation epiblast at E5.5-6.5. These cells are able to form teratomas if injected in 
nude mice but are not able to efficiently contribute to chimera embryos if injected into 
blastocysts (Hayashi et al., 2011). Embryonic germ (EG) cells were derived from 
primordial germ cells (PGCs) from early-somite stage embryos (E7.5-13.5) (Matsui et 
al., 1992). Another approach to obtain stem cells is to induce nuclear reprogramming, 
which consists in the erasure of the epigenetic state of terminally differentiated cells 
to induce the acquisition of a pluripotent state that can direct the development of a 
complete new organism. One technique that allows nuclear reprogramming is the 
somatic cell nuclear transfer (SCNT), which involves the microinjection of the 
nucleus of a donor somatic cell into an enucleated oocyte (Wilmut et al., 1997).  
Reprogramming of somatic cells to an ES-like state can be achieved also by 
overexpression of the so-called “Yamanaka factors” namely the transcription factors 
Oct4, Nanog, c-Myc and Klf4 (Takahashi and Yamanaka, 2006). This approach and 
others derived from it (Malik and Rao, 2013) allowed the generation of induced 
pluripotent stem cells (iPSC). This technology revolutionized the concept of 
personalized medicine giving the opportunity to produce patient specific iPSC that 
can be used to model personalized therapeutic approaches and for cell transplantation 
strategies (Chun et al., 2010; Oh et al., 2012; Sun et al., 2010). 
 
1.4.2  Transcriptional network of pluripotency 
 Pluripotency is maintained through a complex network of transcription factors that 
activate self-renewal related genes and represses pathways that lead to differentiation. 
Some of the master regulators of this network have been identified in the last years 
and in particular Oct4, Sox2 and Nanog are considered the pluripotency core factors 
essential to maintain the undifferentiated state. The Pou5f1 gene encodes for OCT4 
that belongs to the Pic-Oct-Unc (POU) family of transcription factors. In mouse 
OCT4 is exclusively expressed in the totipotent blastomeres, the pluripotent epiblast 
and in the PGCs (Rosner et al., 1990; Scholer et al., 1990). SOX2 belongs to the high 
mobility group (HMG) DNA binding proteins and it is expressed within the ICM and 
the extraembryonic ectoderm of pre-implantation embryos (Avilion et al., 2003). Both 
OCT4 and SOX2 are essential to establish and maintain pluripotency since Oct4 or 
Sox2 KO embryos are not able to form a pluripotent ICM and differentiate into the 
extraembryonic tissue trophectoderm (Avilion et al., 2003; Masui et al., 2007).  
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NANOG is able to support ESC self-renewal in the absence of LIF/Stat3 pathway. 
Even though Nanog KO embryos do not possess a pluripotent ICM, Nanog KO ESC 
can be generated afterwards. They are still pluripotent though prone to differentiate 
and are still able to contribute to chimeras but cannot give rise to PGCs. This suggests 
that NANOG is essential to establish the pluripotent state of the ICM and to safeguard 
the pluripotent status of the germ line (Chambers et al., 2007; Mitsui et al., 2003). 
Several genome-wide approaches described the genomic distribution of the core 
pluripotency factors and revealed that these factors co-occupy the promoters of 
several other transcription factors regulating their expression. In particular OCT4, 
SOX2 and NANOG bind to genes involved either in maintenance of pluripotency or 
in establishing differentiation programs. The binding to these promoters exerts 
differential regulation and determines repression of transcription of genes involved in 
differentiation and maintenance of an active state of pluripotency related genes. 
Interestingly the core pluripotency factors also co-occupy their own promoters and 
enhance their own transcription thereby enforcing the maintenance of pluripotency 
and self-renewal (Boyer et al., 2005; Loh et al., 2006). Thus, OCT4, NANOG and 
SOX2 control a cascade of pathways that are intricately interconnected and control 
pluripotency, self-renewal and cell fate determination (Loh et al., 2006; Wang et al., 
2006). 
 
1.4.3  The epigenetic state of ESC genome 
 The ability to give rise to any cell type of the embryo require a high grade of 
genome plasticity that means the ability to quickly establish a transcriptional program 
allowing for the selection of a specific path of differentiation. The chromatin state of 
ESCs has attracted considerable attention due to its distinct features. Indeed, 
chromatin in ESCs is increasingly being recognized as an open structure compared 
with chromatin in somatic cells, implying that its overall structure is less condensed 
and that the ratio between euchromatin and heterochromatin is higher than in 
differentiating cells (Bhattacharya et al., 2009; Meshorer and Misteli, 2006). The 
euchromatic state of the genome in ESC is associated with a wide range of active 
histone marks like H3K4me3, H3K27ac and H4ac that contribute to keep the 
chromatin accessible (Azuara et al., 2006; Gaspar-Maia et al., 2011; Liang and Zhang, 
2013). This open genome conformation is thought to be linked to the elevated levels 
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of chromatin remodeling factors observed in ESCs. General transcription factors are 
also overexpressed in ESC compared to differentiated cells and this, together with an 
open chromatin conformation, allow stochastic formation of pre-initiation complexes 
determining overall elevated global genome transcription (Efroni et al., 2008; 
Guenther et al., 2007). Intronic and intergenic regions are in particular upregulated in 
ESCs as a consequence of the open chromatin state implying that at least some of 
these transcripts may act as non-coding RNAs that regulate pluripotency (Fatica and 
Bozzoni, 2014; Judson et al., 2009; Lin et al., 2009). Despite the transcriptional 
permissive state of the ESC chromatin a certain grade of gene silencing must take 
place in order to maintain pluripotency and genome stability. Genes related to 
differentiation pathways must indeed be in a silent state and transcription of 
sequences with a high mutagenic potential like retrotransposons must be repressed 
also in ESCs. Developmental genes are silenced in ESCs by the repressive histone 
mark H3K27me deposited by the EZH2 methyltransferase of the PRC2 complex 
(Reik, 2007). Interestingly some of these genes are also marked at their promoter with 
the active histone marks H3K4me3 and for this reason have been defined “bivalent” 
genes (Voigt et al., 2013). These bivalent domains are considered to poise expression 
of developmental genes thus allowing well-timed activation while maintaining 
repression in the absence of differentiation signals. Despite the existence of bivalent 
promoters is controversial, it provides an elegant mechanism to explain the plasticity 
of the ESC genome (Schmitges et al., 2011; Voigt et al., 2012). In contrast with 
developmental genes, which need to be loosely repressed, transposable element, or at 
least most of them, must be completely and tightly repressed in order to avoid 
deleterious genomic recombination events and this is achieved by H3K9 methylation 
and also by CpG methylation (Bourc'his and Bestor, 2004; Schlesinger and Goff, 
2015).  
 ESCs differentiation involves a massive rearrangement of the epigenome that leads 
to repression of pluripotency genes and activation of specific subsets of 
developmental genes according to the differentiation program that is activated 
(Meissner, 2010). Remarkably, upon differentiation, ESC chromatin undergoes 
structural remodeling toward a highly condensed heterochromatic and 
transcriptionally repressed form (Bhattacharya et al., 2009; Meshorer and Misteli, 
2006). The first line of evidence of this process came from the visualization of 
chromatin in ESCs using electron microscopy: heterochromatin was prevalent in 
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differentiated cells but much less in undifferentiated ESCs (Park et al., 2004; Savic et 
al., 2014) (Figure 5).  
 
	  
Figure	   5.	   	   Reorganization	   of	  
chromatin	   during	   ESC	  
differentiation.	   EM	   images	   showing	  the	   formation	   of	   large	  heterochromatin	   blocks	   upon	  differentiation	   of	   ESCs	   into	   neural	  progenitors	  (NPCs).	  Arrows	  indicated	  the	   location	   of	   heterochromatin	   at	  nucleolus	   (red)	   and	   nuclear	  periphery	  (blue).	  Data	   from	  (Savic	  et	  al.,	  2014).	  
 
The majority of chromatin in ESCs is homogeneously spread and largely devoid of 
compact heterochromatin blocks, whereas in differentiated cells chromatin appears 
heterogeneous with distinct blocks of compaction (Efroni et al., 2008). Accordingly, 
while ESC chromatin fibers occupy the entire nuclear volume, the highly compacted 
chromatin of differentiated cells is organized into discrete domains leading to large 
regions of the nucleus devoid of DNA (Fussner et al., 2010). ESC differentiation is 
also accompanied by alterations of nuclear architecture such as formation of large 
organized chromatin regions enriched in the heterochromatic and repressive histone 
modification H3K9 methylation (termed LOCKs) (Wen et al., 2009), maturation and 
compaction of constitutive heterochromatin (such as centric and pericentric repeats) 
and clustering of highly condensed heterochromatin either at the nucleolus or at the 
nuclear periphery (Bartova et al., 2008; Wiblin et al., 2005) (Figure 5).  
The open genome structure of ESCs well reflects the plasticity and transcriptionally 
permissiveness of ESC genome that has to have the ability to enter any distinct 
transcriptional programs for lineage specification (Gaspar-Maia et al., 2011; Gorkin et 
al., 2014) However, it still remains elusive how the switch from a lower to a higher 
order chromatin structure is achieved during ESC differentiation and whether this 
process plays a role in ESC differentiation. 
 
1.5 Nucleolus and ribosomal genes 
 The nucleolus is the nuclear compartment where ribosomal RNA (rRNA) synthesis, 
rRNA maturation and ribosome biogenesis take place. Despite appearing as a dense 
structure in electron microscopy (EM) pictures, this membrane-less nuclear 
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subdomain is a highly dynamic structure that can disassemble and reform during each 
cell cycle around the nucleolus organizer regions (NOR) containing the rRNA gene 
clusters (Dundr et al., 2000; Shaw and Jordan, 1995). The nucleolus is composed of 
structural and functional subdomains that are visible in EM pictures. The fibrillar 
centers (FC) are the sites of active rRNA synthesis while the dense fibrillar 
components (DFC) contain newly synthesized pre-rRNA, which undergo 
modification, processing and partial assembly in pre-ribosomal particles. Later rRNA 
processing and maturation of ribosomes take place at the granular components (GC) 
(Scheer and Hock, 1999). Though the main function of nucleoli is to act as a 
“ribosome factory”, several other tasks have been ascribed to this nuclear 
compartment (Olson et al., 2000). The nucleolus has been involved for instance in the 
assembly of ribonucleoprotein (RNP) machines like the signal recognition particle 
(SRP) (Politz et al., 2000), the spliceosomal small nuclear ribonucleoprotein (Kiss, 
2001) and the telomerase (Etheridge et al., 2002). More recently it has been shown 
how the nucleolus and in particular the nucleolar heterochromatin plays a major role 
in shaping the nuclear architecture during ESC differentiation (Savic et al., 2014) and 
in anchoring the inactive X chromosome to perinuclear compartment in female 
mammals cells (Yang et al., 2015). Thus as stated by the Scottish embryologist C.H. 
Waddington already in 1965: “the nucleolus probably should not be considered a 
relatively simple organelle with a single function, comparable to a machine tool 
turning out a particular part of an automobile. It is not just ‘the organelle where the 
cell manufactures ribosomes.’ It is rather a structure through which materials of 
several different kinds are flowing, comparable more to a whole production line than 
to a single machine tool.” 
 
1.5.1  rRNA genes structure 
 Eukaryotic genomes contain several copies of rRNA genes, ranging from few 
hundreds in lower eukaryotes like S.cerevisiae to few thousands in some plants (Long 
and Dawid, 1980). These genes are organized in tandem arrays that are distributed 
among different chromosomes and each array can act as an independent NOR (Bell et 
al., 1992). Mouse rDNA is spread among the centromeric regions of chromosomes 
12, 15, 16, 18 and 19 while in human is scattered among the short arm and the 
satellite body of the acrocentric chromosomes 13, 14, 15, 21 and 22 (Dev et al., 1977; 
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Henderson et al., 1972). Both mouse and human genomes contain roughly 400 copies 
of rRNA genes and each rDNA unit covers approximately 43 kb in human and 45 kb 
in mouse (Gonzalez and Sylvester, 1995; Grozdanov et al., 2003). Every array is 
composed of several dozens of precursor ribosomal RNA (pre-rRNA) genes separated 
by intergenic spacer sequences (IGS) (Figure 6). Transcription of a gene unit give 
rise to a pre-rRNA (45S in mouse and 47S in human), which is then modified and 
processed into 28S, 18S, and 5.8S rRNA. These rRNAs are then packaged with 
ribosomal proteins to form the scaffold and the catalytic heart of the large and the 
small subunits of ribosomes (Santoro, 2005).  
 
 
Figure 6. Organization of mammalian rDNA repeats. Black arrows indicate the sites of 
transcription initiation of the 45S pre-rRNA (TSS, transcription start site) and of the transcripts 
originating from the intergenic spacer promoter. Red boxes indicate terminator elements (T). Cyan 
boxes represent repetitive enhancer elements located between the spacer promoter and TSS proximal 
core promoter element (CPE). The upstream control element (UCE) located upstream the TSS is also 
shown. The green dot indicates the CpG at position -133, which is critical for rDNA silencing through 
DNA methylation.  
 
Mouse rDNA promoter is composed of a core promoter element (CPE) neighboring 
the TSS and an upstream control element (UCE) roughly 100 bp upstream, which is 
recognized by the upstream binding factor (UBF) (Figure 6). UBF takes part in the 
assembly of the RNA Pol I preinitiation complex on the promoter together with the 
TBP (TATA binding protein) containing promoter selectivity factor TIFIB (SL1 in 
human) (Haltiner et al., 1986; Learned et al., 1986). Furthermore UBF is also 
involved in counteracting the repressive function of the heterochromatin protein 1 
(HP1) at the rRNA genes, in stimulating the RNA pol I promoter escape and in 
promoting transcriptional elongation (Kuhn and Grummt, 1992; Panov et al., 2006; 
Stefanovsky et al., 2006). All these functions contribute in activating and promoting 
rRNA transcription. Methylation of the CpG at the position -133 inside the UCE 
impairs the binding of UBF to rDNA assembled into chromatin resulting in 
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transcriptional repression (Santoro and Grummt, 2001). An alternative rDNA 
promoter, dubbed spacer promoter, is present approximately 2Kb upstream the main 
rDNA promoter (Kuhn and Grummt, 1987). This element share some sequence 
homology with the main promoter and, despite having a reduced binding of TIFIB, it 
shows a threefold enrichment of Pol I compared to the main promoter (Santoro et al., 
2010). From the spacer promoter originates an intergenic transcript that spans, 
codirectionally with the 45S pre-rRNA, through the intergenic sequence between the 
two promoters and overlap at its 3’end with the main promoter and part of the 5’ 
sequence of the 45S pre-rRNA. This transcript, called intergenic spacer rRNA (IGS-
rRNA), is readily processed, in differentiated cells, to give rise to a roughly 200 nt 
long non-coding RNA called promoter RNA (pRNA), which is involved in rRNA 
gene silencing (Mayer et al., 2006; Santoro et al., 2010) (see section 1.5.4). 
 Other cis regulatory elements called terminators (T) are present in ten copies (T1-
T10) at the 3’ end of each rRNA gene and are involved in transcription termination 
and in determining the directionality of the replication fork over the rDNA (Gerber et 
al., 1997; Grummt et al., 1986). Further T sequences are found upstream the rRNA 
gene promoter (T0) and downstream the alternative spacer promoter (T-1) and have 
been described to be involved in promoting rDNA transcription. T sequences are 
bound by the transcription termination factor 1 (TTF1), which was originally 
discovered as the factor responsible for the displacement of Pol I at the 3’ end of 
rRNA genes and for termination of transcription (Grummt et al., 1986; Kuhn et al., 
1990). However binding of TTF1 to the T0 sequence was also proposed to enhance 
transcription through two distinct mechanisms. In one case T0 bound TTF1 was 
shown to recruit an ATP dependent nucleosome remodeling activity close to the 
rDNA promoter that leads to the repositioning of the rDNA promoter associated 
nucleosome from an “off” to an “on” conformation upstream the TSS, which can 
allow transcription initiation (Langst et al., 1998; Langst et al., 1997). In the second 
case dimerization of TTF1 bound both at the T0 and at the T1-T10 sequences can 
determine the formation of a DNA loop that brings in contact the rDNA promoter and 
the 3’ termination region facilitating in theory the direct transfer of Pol I from the 
termination site to the initiation site (Nemeth et al., 2008). The function of the T-1 
sequence downstream the spacer promoter is still unknown. As it will be addressed in 
more detail in section 1.5.3, TTF1 bound to T0 sequence is also able to recruit a 
repressor complex, which repositions the promoter nucleosome to the “off” location 
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and recruit several factors involved in silencing and formation of heterochromatin at a 
subset of rRNA genes.  
 Between the spacer promoter and the rDNA main promoter are located several 
repeated sequences that act as enhancer of rDNA transcription and are also bound by 
UBF (Pikaard et al., 1990). Different variants of rDNA units have been described 
according to the number of enhancer repeats (in mouse 6, 9, 10, 11, 12 and 22) and 
the specific subclass containing 9 repeats has been shown to be important for 
regulating the rRNA epigenetic status in trans (Santoro et al., 2010). 
 
1.5.2  Chromatin organization of rRNA genes 
 In eukaryotic cells, a fraction of rRNA genes is transcriptionally silent. Electron 
microscopy visualization of rDNA units in S. cerevisiae (Miller spreads) revealed two 
different structures: (1) transcribing rRNA genes (active copies) that have a 
characteristic tree-like appearance (referred as “Christmas tree”), with a DNA “trunk” 
from which close-packed ribonucleoprotein “branches” of increasing length extend; 
(2) genes that do not associate with Pol I and are not transcribed (silent copies) 
(Miller and Beatty, 1969). Although the genome complexity of higher eukaryotes 
does not yet allow visualization of rDNA chromatin by Miller spreads, later 
biochemical studies assessed that the coexistence of active and silent rRNA genes in 
each cell is not limited to S. cerevisiae. Psoralen crosslinking, a technique that 
introduces crosslinks into DNA sites that are not protected by nucleosomes, showed 
the presence of a fraction of rRNA genes accessible to psoralen, thus largely devoid 
of nucleosomes and a second fraction that was not crosslinked by psoralen because 
densely compacted with nucleosomes. The demonstration that the nascent rRNA was 
associated with the psoralen crosslinked DNA led to the conclusion that the fraction 
of rDNA with reduced nucleosome content is actively transcribed while the 
nucleosome associated rDNA correspond to silent genes (Conconi et al., 1989; Sogo 
et al., 1984). Moreover, it was shown that the relative amounts of the two types of 
structures are similar in interphase and metaphase, indicating that active and silent 
rDNA repeats are maintained independently of the transcriptional process and are 
stably propagated through the cell cycle (Conconi et al., 1989). 
Later studies showed that active and silent rRNA genes are also characterized by 
specific epigenetic marks. Silent genes are marked with CpG methylation at the UCE 
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and this leads to impairment of UBF binding (Santoro and Grummt, 2001; Stancheva 
et al., 1997). The finding that silent rRNA genes are enriched in CpG methylated 
sequences allowed for the distinction of silent and active rDNA chromatin and for the 
analysis of their chromatin composition. By using chromatin immunoprecipitation 
(ChIP) coupled with CpG methylation analysis employing methylation sensitive 
restriction enzymes (ChIP-chop) it was possible to identify protein factors and 
histones PTMs specifically associated with active (non CpG methylated) or silent 
(CpG methylated) genes (Santoro et al., 2002). This technique allowed showing that 
the promoter of mouse and human active rRNA genes is associated with Pol I 
transcription factors and histones modified with the active marks H4Ac and 
H3K4me2, while silent rRNA genes are associated with the heterochromatin protein 1 
(HP1), TTF1-interacting protein 5 (TIP5), poly-ADP-ribose polymerase 1 (PARP1 
also known as ARTD1) and with repressive histone marks H3K9me2, H3K27me3 
and H4K20me3 (Guetg et al., 2012; Santoro and Grummt, 2001, 2005; Santoro et al., 
2002) (Figure 7).  
 
Figure 7. Schematic representation of active and silent rRNA genes. Transcriptionally active 
rRNA genes are characterized by open chromatin marked with active histone marks (blue lollipops) 
and are bound by UBF and Pol I. Transcriptionally silent genes are present in a compact 
heterochromatic structure marked with silencing histone marks (orange lollipops) and DNA CpG 
methylation (red lollipops). These repressive marks are ensured by the pRNA dependent binding of 
TIP5 to rDNA promoters and the consequent recruitment of histone modifiers and DNA 
methyltransferases (see sections 1.5.3 and 1.5.4). 	  
1.5.3  The nucleolar remodeling complex (NoRC) 
 Previous studies have shown that the nucleolar remodeling complex (NoRC) is the 
key player in establishing and maintaining the heterochromatic state of silent rRNA 
genes. NoRC consists of TIP5 (TTF1-interacting protein 5) and the ATPase SNF2h 
(Li et al., 2005; Santoro et al., 2002; Strohner et al., 2001; Zhou et al., 2002). SNF2h 
is the human homolog of the Drosophila ISWI whose ATPase activity is essential for 
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nucleosome remodeling. TIP5 was identified in a yeast two-hybrid screening for 
TTF1 interacting proteins (Strohner et al., 2001). TIP5 is a member of the 
bromodomain adjacent zinc finger (BAZ) protein family and it is also known as 
BAZ2A (Jones et al., 2000). It shares several domains with other components of 
nucleosome remodeling complexes such as ACF, WCRF, CHRAC and WICH 
(Bochar et al., 2000; Bozhenok et al., 2002; Ito et al., 1999; LeRoy et al., 2000). 
Among these domains a bromodomain at the C-terminus allows the binding to 
acetylated histones and is necessary to mediate HDAC1 recruitment (Zhou et al., 
2002), a plant homeodomain (PHD) allows the binding of SNF2h and other factors 
like HMTs and DNMTs (Zhou and Grummt, 2005; Zhou et al., 2002), a TAM 
(TIP5/ARBD/MBD) domain mediates the binding of RNA and in particular the stem 
loop structure of the lncRNA pRNA (Mayer et al., 2006). Other domains include a 
WAKZ motif, BAZ1 and BAZ2 motifs and several AT-hooks motifs. NoRC is 
targeted to the rDNA promoter via the interaction with pRNA and TTF1 (Mayer et 
al., 2008; Savic et al., 2014) and represses rRNA transcription by recruiting histone 
modifiers and DNA methylating activities (i.e., HDAC1, SETDB1, PARP1, DNMTs) 
(Santoro and Grummt, 2005; Santoro et al., 2002; Zhou et al., 2002; Zhou et al., 
2009). The binding of NoRC to rRNA genes was shown to occur immediately after 
replication of silent rRNA genes in late S phase (Li et al., 2005), suggesting a role of 
NoRC in the maintenance and inheritance of silent rDNA chromatin during cell 
division. NoRC was shown to slide a nucleosome over the rDNA promoter in a sort of 
“inactive” position (from -157/-2 active to −132/+22 inactive) that inhibits rRNA 
transcription (Li et al., 2006). In this configuration the critical CpG dinucleotide 
located 133 bp upstream the TSS, whose methylation prevents binding of UBF, is 
placed at the 5’ boundary of the nucleosome and is exposed to methylation mediated 
by DNMTs associated with NoRC (Santoro and Grummt, 2001; Santoro et al., 2002). 
These findings suggest that NoRC can act through two distinct but not mutually 
exclusive mechanisms to silence rRNA genes: first by nucleosome remodeling at the 
rDNA promoter towards an “off” position and second by recruiting histone modifiers 
and DNA methylating enzymes to establish rDNA heterochromatin. 
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1.5.4  pRNA and the regulation of ribosomal genes 
 The lncRNA pRNA is critical for the establishment of silencing at rRNA genes. 
pRNA is a roughly 200 nt lncRNA that correspond to the rDNA main promoter 
sequence. pRNA is one of the few trans-acting lncRNA that have been described so 
far (Lee, 2012; Vance and Ponting, 2014; Yang et al., 2014). As it will be described in 
1.5.5 pRNA originates from the processing of IGS-rRNA precursor, a transcript 
synthesized from the spacer promoter of a subset of active rRNA genes during early S 
phase (Mayer et al., 2006; Santoro et al., 2010). LNA-mediated knockdown of pRNA 
was shown to induce loss of heterochromatin at rRNA genes in differentiated cells, 
indicating the critical role of this lncRNA (Mayer et al., 2006). pRNA contains a 
secondary stem loop structure that is indispensable to bind the TAM domain of TIP5 
and to recruit the NoRC complex to rDNA promoters (Mayer et al., 2006; Savic et al., 
2014). Furthermore, the stem loop structure of pRNA acts as a scaffold to mediate the 
interaction of TIP5 with several factors including PARP1 and TTF1 (Guetg et al., 
2012; Mayer et al., 2008; Savic et al., 2014). It was recently shown that mutations of 
pRNA sequences involved in the formation of stem loop structure, destroy TIP5-
TTF1 interaction and abolish the recruitment of TIP5 to rDNA (Savic et al., 2014). 
Interestingly deletion of the 5’ region of pRNA did not affect the interaction between 
TIP5 and TTF1 nor the recruitment of TIP5 to rRNA genes, indicating that the sole 
stem loop structure of pRNA is necessary and sufficient to allow TIP5 recruitment to 
rDNA and that the 5’ sequence is actually dispensable (Savic et al., 2014). This result 
is in contrast with the model proposed previously for TIP5 recruitment to rDNA, 
which implicates the formation of a RNA-DNA triple helix through Hoogsteen or 
reverse Hoogsteen base pairing between the 5’ sequence of pRNA and the 
corresponding T0 sequence of the rDNA promoter (Bierhoff et al., 2014; Schmitz et 
al., 2010). Despite being attractive, this model has not been definitely experimentally 
proven and the finding that the stem loop structure of pRNA is the sole necessary 
sequence that TIP5 needs for its recruitment to rDNA depicts a more solid molecular 
model (Leone and Santoro, 2016). 	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1.5.5  IGS-rRNA transcription, pRNA maturation and maintenance of rRNA 
genes silencing 
 As already introduced in the section 1.5.1, RNA Pol I transcribes the 45S pre-rRNA 
starting from the rDNA main promoter and, in the same direction, the intergenic 
sequence rRNA (IGS-rRNA) starting from the spacer promoter that in mouse is 
located 2Kb upstream the rRNA gene main promoter. The IGS-rRNA sequence 
corresponds to the spacer sequence that separates spacer and main promoter and 
includes the sequence of the main promoter and part of the sequence downstream the 
TSS. The synthesis of IGS-rRNA has been shown to take place during a narrow time 
window of the early S phase specifically from a subset of active rRNA genes 
containing nine enhancer repeats between spacer and main promoter (Santoro et al., 
2010). During mid-late S phase IGS-rRNA is processed into pRNA (Santoro et al., 
2010). Interestingly the timing of IGS-rRNA transcription (early S phase) and its 
processing into pRNA (mid-late S phase) correlates with the observation that NoRC 
complex is recruited at mid-late S phase to newly replicated silent genes in order to 
maintain silent chromatin (Guetg et al., 2012; Li et al., 2005). Like other regions of 
the genome also rRNA genes experience a different replication timing according to 
the grade of chromatin compaction, being euchromatic genes replicated in early S 
phase and heterochromatic genes replicated in late S phase (Berger et al., 1997; Guetg 
et al., 2012; Li et al., 2005). Thus the fine-tuning of IGS-rRNA synthesis, pRNA 
maturation and NoRC recruitment represents an attractive model to explain how cells 
maintain the heterochromatic state of silent rRNA genes across cell divisions (Figure 
8). Furthermore this model suggests that pRNA can act in trans, being transcribed 
from a subset of active rRNA genes and acting on late replicating silent rDNA to 
inherit DNA methylation and transcriptional repression. 
 The discovery that transcripts originating from the spacer promoter are necessary to 
silence rRNA genes is in apparent disagreement with previous studies showing that 
the spacer promoter enhances transcription from the main rDNA promoter (Caudy 
and Pikaard, 2002; Grimaldi and Di Nocera, 1988; Paalman et al., 1995). The 
enhancement of transcription has been explained with two mutually exclusive models. 
The first model is based on the concept of “read-through enhancement”. 
In the “read-through enhancement” model, it was proposed that Pol I molecules, 
which are directed by the spacer promoter to transcribe through the enhancers, release 
rDNA transcription factors from the enhancers and make them available to the gene 
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promoter, thereby stimulating gene promoter transcription (De Winter and Moss, 
1987). This model implies that transcription enhancement would be proportional to 
the strength of the spacer promoter. However, replacement of the mouse spacer 
promoter with the more active Chinese hamster spacer promoter did not increase 
rRNA transcription, indicating that enhancement of pre-rRNA synthesis does not 
depend on transcripts originating from spacer promoter and implying that spacer 
promoter affects the main gene promoter using alternative mechanisms (Paalman et 
al., 1995; Santoro, 2011). A second model proposed that it is the spatial proximity 
between spacer and main promoter through the formation of a DNA loop to be 
implicated in spacer-mediated enhancement of 45S pre-rRNA gene transcription 
(Santoro, 2011). The spatial juxtaposition of both promoters was proposed to enhance 
transcription from the main gene promoter by delivering Pol I factors without the 
requirement of IGS-rRNA synthesis. A similar model was proposed for the 
interaction between rDNA main promoter and terminator regions (Nemeth et al., 
2008). As already mentioned in the section 1.5.1, TTF1 binds to T elements and is 
able to form dimers. Thus, two TTF1 molecules, bound respectively at T-1 and the T0 
element, might dimerize and bring spacer and main promoter in close proximity by 
forming a loop, in analogy to what has been described for rDNA promoter and 
terminator regions T1-T10 (Nemeth et al., 2008). In this model, the involvement of 
TTF1 in forming the spacer-main gene promoter loop does not only suggest that IGS 
 
 
 
Figure 8. Model for the inheritance of silent rDNA heterochromatin. Transcriptionally active 
rRNA genes are replicated during the early S-phase. From these genes originates the IGS-rRNA that is 
processed during mid-late S phase giving rise to the mature pRNA. TIP5 associates with pRNA and is 
recruited to silent rRNA genes after their replication, which occurs at mid-late S-phase, ensuring the 
maintenance of the silent state by interacting with histone modifiers and DNA methyltransferase 1 
(DNMT1). 
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rRNA synthesis is not required to enhance rRNA synthesis from the main promoter 
but also that it might not occur at all. Indeed, the ability of TTF1 to terminate Pol I 
transcription would represent a major obstacle for Pol I to elongate from spacer 
promoter toward the main gene promoter (Grummt et al., 1986; Kuhn et al., 1990). 
Consequently, in the “read-through enhancement” model TTF1 should not be bound 
to either T0 and/or T-1 elements, an assumption that is in contrast with previous results 
showing that the binding of TTF1 to T0 element is a prerequisite for 45S pre-rRNA 
synthesis (Langst et al., 1998). Taken together, all these observations suggest that the 
dual role of spacer promoter in regulating rRNA transcription can be distinguished by 
its capacity either to form a loop or to drive IGS rRNA synthesis: in the first case, it 
stimulates pre-rRNA synthesis; in the second case, it is required for NoRC-mediated 
rDNA silencing (Santoro, 2011).  
 
1.5.6  Establishment of rDNA heterochromatin 
 Recent results have shown that, in contrast to somatic cells, in ESCs all the rRNA 
genes are active and devoid of heterochromatic marks (Savic et al., 2014). Though it 
is well known that ESC genome is highly euchromatic (see section 1.4) this 
observation was very surprising since it is also well known that reduction of rDNA 
heterochromatin in differentiated cells results in genomic instability due to 
recombination events between repetitive rDNA sequences (Guetg et al., 2010; Peng 
and Karpen, 2007; Straight et al., 1999). How stem cells can cope with such a high 
risk of deleterious recombination events is still not known. 
It was recently shown that impairment of TIP5 association with rRNA genes is 
determinant for the lack of rDNA heterochromatin in ESCs. It is only upon 
differentiation that TIP5 re-localizes within nucleoli, binds and silences rRNA genes 
(Savic et al., 2014). This work also determined that a lncRNA-based mechanism 
mediates the switch of function of TIP5 (silencing rRNA genes in differentiated cells 
but not in ESCs). It was shown that in ESCs processing of IGS-rRNA into pRNA is 
impaired and it is only upon differentiation that this process is activated to produce 
mature pRNA. This study revealed that maturation of IGS-rRNA into pRNA is 
critical for the formation of rDNA heterochromatin. Indeed, transfection of mature 
pRNA into ESCs was sufficient to promote recruitment of TIP5 to rDNA and 
formation of rDNA heterochromatin. Importantly, Savic and colleagues showed that 
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only in its mature form pRNA allows the association of TIP5 with TTF1 at rDNA 
whereas the binding of TIP5 to the unprocessed transcript abolishes this process. 
Thus, the results described in Savic et al (Savic et al., 2014) indicated that the 
recruitment of TIP5 to rDNA promoter occurs via a protein-RNA-protein-DNA 
module (Fig. 9), which is in contrast with a previous model proposing that the T0 
sequence of pRNA form a triple helix with the T0 element at rDNA promoter and is 
required to guide TIP5 to rRNA genes (Bierhoff et al., 2014; Schmitz et al., 2010). 
The analysis of pRNA T0 sequence mutants did not reveal the involvement of triplex 
formation in TIP5 recruitment and rDNA silencing. In contrast, pRNA mutants with 
impaired stem-loop structure formation abolished the recruitment of TIP5 to rDNA. 
Taken together the results described in Savic et al. indicate that pRNA guides TIP5 to 
rDNA in trans through the hairpin structure that allows the interaction with TTF1. 
Thus, the impairment of IGS-rRNA processing, which abrogates the formation of 
mature pRNA, is the major determinant causing the euchromatic state of all rRNA 
genes in ESCs (Savic et al., 2014). How the activation of IGS-rRNA processing 
during ESC differentiation is regulated will be addressed in this thesis. Together these 
studies highlighted the role of lncRNA in the regulation of chromatin and epigenetic 
states and suggest that lncRNA processing represents an additional level of lncRNA 
regulation by modulating distinct features of the same lncRNA.  
 
Figure 9. Model for the establishment of rDNA chromatin. In ESCs the IGS-rRNA is not processed 
and sequestrates TIP5 in an inactive complex. This results in the absence of rDNA heterochromatin. 
During differentiation IGS-rRNA is processed and the mature pRNA can accumulate, recruiting TIP5 
to the rRNA genes promoter and establishing rDNA heterochromatin. Modified from Savic et al. 2014. 
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An important readout of Savic et al. was that the addition of mature pRNA in ESCs 
was not only sufficient to recruit TIP5 to nucleoli and silence rRNA genes but also 
induced the establishment of highly condensed chromatin structures outside of the 
nucleolus, resembling the genome organization that characterizes differentiated cells.  
These changes were also accompanied by a global increase in H3K9me2, maturation 
of heterochromatin at repetitive sequences - such as major and minor satellites - and 
their transcriptional repression as found in differentiated cells. Moreover, such 
heterochromatic ESCs were primed for differentiation due to up regulation of genes 
implicated in differentiation and developmental processes. Thus, these results suggest 
that the nucleolus is not only the cellular compartment where ribosomes are produced 
but it is also able to produce heterochromatin, affecting the genome architecture of the 
rest of the nucleus. The aim of this PhD thesis was to understand whether formation 
of heterochromatin in nucleolus plays a role for the ability of ESCs to enter into 
differentiation programs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   48	  
2	  Aims	  
	   49	  
2 Aims 
Increasing evidence indicates that genome architecture is important to ensure the 
correct execution of gene expression programs. An important example is provided by 
the spatiotemporal organization of ESC genome. The genome of ESCs is 
characterized by an overall open chromatin conformation, largely devoid of compact 
heterochromatin blocks, whereas in differentiated cells chromatin appears 
heterogeneous with distinct blocks of condensed structures. ESC differentiation is 
accompanied by alterations of nuclear architecture such as maturation and compaction 
of constitutive heterochromatin (i.e. centric and pericentric repeats) and clustering of 
highly condensed heterochromatin either at the nucleolus or at the nuclear periphery. 
The open genome structure of ESCs well reflects the plasticity and transcriptional 
permissiveness that that has to have the ability to enter any distinct transcriptional 
program for lineage specification. However, it still remains elusive how the switch 
from a lower to a higher order chromatin structure is achieved during ESC 
differentiation and whether this process plays a role in ESC differentiation. 
Recent results from our laboratory (Savic et al., 2014) have shown that in embryonic 
stem cells rRNA genes are all euchromatic and acquire heterochromatic features only 
upon differentiation. Formation of rDNA heterochromatin during ESC differentiation 
is regulated by processing of the lncRNA IGS-rRNA into the mature pRNA and 
consequent recruitment of TIP5 to rRNA genes. Importantly, addition of mature 
pRNA in ESCs was not only sufficient to recruit TIP5 to nucleoli and silence rRNA 
genes but also induced the establishment of highly condensed chromatin structures 
outside of the nucleolus, resembling the genome organization that characterizes 
differentiated cells.  
 
The aims of this work were to (1) identify factors implicated in IGS-rRNA processing 
and (2) determine the functional significance for the formation of rDNA 
heterochromatin during ESC differentiation.  
 
	  	   50	  
 
3	  Results	  
	   51	  
3. Results  
3.1 Research articles 
3.1.1 Establishment of heterochromatin at rRNA genes is required for 
embryonic stem cell differentiation 
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3.1.2 lncRNA maturation to initiate heterochromatin formation in the nucleolus 
is required for exit from pluripotency in ESCs 
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3.2 Review articles 
3.2.1 Challenges in the analysis of long noncoding RNA functionality 
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SUMMARY
The open chromatin of embryonic stem cells (ESCs)
condenses into repressive heterochromatin as cells
exit the pluripotent state. How the 3D genome orga-
nization is orchestrated and implicated in pluripo-
tency and lineage specification is not understood.
Here, we find that maturation of the long noncoding
RNA (lncRNA) pRNA is required for establishment
of heterochromatin at ribosomal RNA genes, the
genetic component of nucleoli, and this process is
inactivated in pluripotent ESCs. By using mature
pRNA to tether heterochromatin at nucleoli of
ESCs, we find that localized heterochromatin
condensation of ribosomal RNA genes initiates
establishment of highly condensed chromatin struc-
tures outside of the nucleolus. Moreover, we reveal
that formation of such highly condensed, transcrip-
tionally repressed heterochromatin promotes tran-
scriptional activation of differentiation genes and
loss of pluripotency. Our findings unravel the nucle-
olus as an active regulator of chromatin plasticity
and pluripotency and challenge current views on
heterochromatin regulation and function in ESCs.
INTRODUCTION
The spatiotemporal organization of the genome has been recog-
nized as an additional regulatory layer of chromatin, important
for gene regulation and transcriptional competence (Gonzalez-
Sandoval et al., 2013; Splinter and de Laat, 2011). Pluripotent
stem cells such as embryonic stem cells (ESCs) are integral to
the study of genome organization (Gorkin et al., 2014). Although
ESCs organize their chromosomes into topological-associating
domains that are largely invariant between cell types (Dixon
et al., 2012; Nora et al., 2012), chromatin is generally less
condensed and largely devoid of compact heterochromatin
blocks compared to lineage-committed cells (Efroni et al.,
2008; Jørgensen et al., 2007; Melcer et al., 2012; Meshorer
et al., 2006). While ESC chromatin fibers occupy the entire nu-
clear volume, the highly compacted chromatin of differentiated
cells is organized into discrete domains leading to large regions
of the nucleus devoid of DNA (Fussner et al., 2010). Transcrip-
tionally inactive chromatin in ESCs is unusually disorganized
and tends to participate in fewer specific long-range interactions
than in differentiated cells (de Wit et al., 2013). These results are
consistent with a chromatin conformation that is particularly
malleable and transcriptionally permissive in pluripotent cells
and thatmay allowmaintenance of a plastic state for the different
transcriptional programs required for lineage specification (de
Wit et al., 2013; Gaspar-Maia et al., 2011; Gorkin et al., 2014).
Upon ESC differentiation, large-scale genome silencing takes
place and ESC chromatin undergoes structural remodelling
toward a highly condensed heterochromatic and transcription-
ally repressed form (Bhattacharya et al., 2009; Meshorer and
Misteli, 2006). These changes are also accompanied by alter-
ations of nuclear architecture such as formation of large orga-
nized chromatin regions enriched in the heterochromatic and
repressive histone modification H3K9 methylation (termed
LOCKs) (Wen et al., 2009), maturation and compaction of consti-
tutive heterochromatin (such as centric and pericentric repeats)
and clustering of highly condensed heterochromatin either at the
nucleolus or at the nuclear periphery (Aoto et al., 2006; Ba´rtova´
et al., 2008a, 2008b; Efroni et al., 2008). However, how ESCs
mediate the switch from a lower to a higher order chromatin
structure remains elusive and calls for studies aimed at under-
standing the mechanism and function of this process.
An important component of nuclear architecture is the nucle-
olus, the compartment where transcription of hundreds of
ribosomal RNA (rRNA) genes, rRNA processing, and ribosome
subunit assembly take place (Moss and Stefanovsky, 2002).
Clustering of highly condensed heterochromatin at nucleoli is a
phenomenon known to occur in all somatic cells, yet neither
the factors involved nor their physiological relevance is under-
stood. Previous studies have however started to define a
functional link between nuclear heterochromatin positioned
in proximity to nucleoli and rRNA genes (rDNA), the genetic
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component of the nucleolus. The nucleolar repressor factor
TIP5 (TTF1-interacting protein 5, also known as BAZ2A) is
required for heterochromatin formation of a fraction of rRNA
genes through association with the long noncoding (lnc)RNA
pRNA, DNA methyltransferases (DNMT1, DNMT3b), histone de-
acetylase HDAC1, and poly(ADP-ribose)-polymerase-1 (PARP1)
(Guetg et al., 2012; Mayer et al., 2006; Santoro et al., 2002, 2010;
Zhou et al., 2002). pRNA is a 250–300 nucleotide transcript cor-
responding to main rDNA promoter sequences and originates
from processing of the 2 kb long IGS-rRNA (intergenic spacer
rRNA) whose synthesis is driven by an alternative rDNA promoter
located upstream of themain rDNA promoter (Mayer et al., 2006;
Santoro et al., 2010). TIP5-pRNA interaction is necessary to form
rDNAheterochromatin bymediating TIP5 nucleolar retention and
association with rDNA and PARP1 (Guetg et al., 2012; Mayer
et al., 2006). Depletion of TIP5 reduces silent epigenetic marks
at rDNA and heterochromatic centric and pericentric repeats,
and abrogates formation of condensed heterochromatic struc-
tures within and in proximity to the nucleolus (Guetg et al.,
2010). Strikingly, this structural organization closely resembles
the open chromatin of ESCs, prompting us to investigate if the
chromatin state of the nucleolus regulates ESC chromatin plas-
ticity and commitment to specific lineages.
RESULTS
Establishment of rDNA Heterochromatin Occurs during
ESC Differentiation
We profiled the epigenetic state of the nucleolus, at rDNA, in
ESCs and during differentiation into neural progenitor cells
(NPCs) that are Pax-6, Nestin, and brain lipid-binding protein
(BLBP) positive and do not express the pluripotency factor
Nanog (Figure 1A; Figure S1A available online). Previous work
showed that methylation of the two unique CpG dinucleotides
at the mouse rDNA promoter distinguishes heterochromatic
and silent rRNA genes from euchromatic, transcriptionally active
rDNA (Santoro and Grummt, 2001). We quantified silent rDNA by
measuring CpG methylation at rDNA promoter of ESCs, NPCs,
and mouse somatic cells from brain tissue using HpaII digestion
followed by qPCR, a method that accurately quantifies the
amounts of silent rDNA (Santoro et al., 2002). Consistent with a
previous bisulfite analysis (Schlesinger et al., 2009), rDNA pro-
moter in ESCs displays very low meCpG levels, confirming the
accuracy of our method. After 8 days of differentiation, a fraction
of rRNA genes (25%–30%) acquired CpG methylation at levels
comparable to brain tissue (Figure 1B). Similar results were ob-
tained with a different ESC line and differentiation protocol (Fig-
ure S1B), indicating that rDNA is de novomethylated during early
ESC differentiation. Consistent with these results, rDNA tran-
scription levels were similar in NPCs and mouse fibroblast NIH
3T3 cells and lower than in ESCs (Figure 1C). Remarkably,
rDNA methylation in induced pluripotent stem cells (iPSC)
decreased to about one half when compared to the original
fibroblasts (Figure 1D), implying a link between cell pluripotency
and rDNA methylation levels. Upon differentiation, heterochro-
matin-related histone modifications H3K9me2, H3K9me3, and
H3K27me3 increased at rDNA promoter and coding regions (Fig-
ure 1E; Figure S1C). In contrast, active histone modifications
such as H3K4me2 and H3K4me3 were not greatly affected (Fig-
ure S1D). Consistent with previous reports, major and minor sat-
ellite repeats that compose centric and pericentric heterochro-
matin increased H3K9me3 levels during differentiation (Martens
et al., 2005; Meshorer et al., 2006; Wong et al., 2009), whereas
H3K9me2 occupancy was not greatly affected. These changes
were accompanied by a reduction of major and minor satellite
transcripts (Figure S1E), which are normally repressed in differ-
entiated cells (Efroni et al., 2008). We conclude that formation
of rDNA heterochromatin takes place during ESC-NPC transition
and timely coincides with the switch to a higher condensed het-
erochromatic form of centric and pericentric repeats.
TIP5 Is Recruited to rDNA during ESC Differentiation
To determine how rDNA heterochromatin is established during
ESC differentiation, we measured the association of upstream
binding factor UBF, an essential rDNA transcription factor that
exclusively binds to unmethylated, euchromatic rRNA genes,
and of TIP5, which associates with methylated silent rDNA (San-
toro and Grummt, 2001; Santoro et al., 2002). UBF occupancy at
rDNA was lower in NPCs than in ESCs (Figure 1F), a further indi-
cation that the number of euchromatic active rRNA genes de-
creases during differentiation. In contrast, TIP5 binds to rDNA
only in NPCs but not in ESCs (Figure 1F). Similarly, PARP1, pre-
viously shown to interact with TIP5 and implicated in the forma-
tion of rDNA heterochromatin (Guetg et al., 2012), increases its
association with the rDNA promoter in NPCs. Thus, establish-
ment of rDNA heterochromatin in ESC-NPC transcription is
accompanied by a decrease in the association of factors specific
to active genes and an increase in the binding of components of
the rDNA silencing machinery.
TIP5 protein and mRNA levels were higher in ESCs than in
NPCs (Figure 1G), implying that the lack of rDNA heterochro-
matin in ESC is independent of TIP5 amounts. We then analyzed
the TIP5 cellular localization (Figure 1H; Figure S2). Consistent
with previous results, TIP5 was exclusively localized within
nucleoli of somatic MEFs, as indicated by the colocalization
with the nucleolar protein UBF (Strohner et al., 2001). In contrast,
the cellular localization of TIP5 in ESCs was predominantly
nucleoplasmic and often excluded from the nucleoli. Upon differ-
entiation, TIP5 was drastically reduced in the nucleoplasm and
exclusively localized within the nucleoli of NPCs, showing a
cellular localization that is characteristic of somatic cells (Fig-
ure 1H; Figure S2). We conclude that TIP5 association with
rDNA is impaired in ESCs and its recruitment to rDNA is achieved
upon ESC differentiation.
Processing of pRNA Mediates Formation of rDNA
Heterochromatin
We reasoned that impairment of TIP5 binding to rDNA might be
responsible for the lack of rDNA heterochromatin in ESCs. Previ-
ous studies implicated the lncRNA pRNA in TIP5 nucleolar reten-
tion and association with rDNA (Mayer et al., 2006). pRNA is a
250–300 nucleotide transcript corresponding to main rDNA pro-
moter sequences and derives from processing of the 2 kb long
IGS-rRNA (Mayer et al., 2006; Santoro et al., 2010) (Figure 2A).
Measurements of pRNA sequences in ESCs and at different
times of differentiation did not reveal remarkable differences be-
tween ESCs andNPCs (Figure 2B). However, this approach does
not allow distinguishing between IGS-rRNA and mature pRNA.
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Figure 1. Establishment of rDNA Heterochromatin Occurs during ESC Differentiation and Correlates with the Recruitment of TIP5 to rDNA
(A) qRT-PCR. Nanog and Pax6 mRNA levels in ESCs and NPCs. Data were normalized to Rps12 mRNA.
(B) CpG methylation levels at rDNA promoter in ESCs, NPCs, and mouse brain tissues.
(legend continued on next page)
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Quantification of 50- and internal IGS-rRNA regions determined
that unprocessed transcript levels were higher in ESCs than in
NPCs (Figure 2B), suggesting that IGS-rRNA processing is less
efficient in ESCs than in NPCs. To support these results, we
measured ectopic IGS-rRNA and pRNA derived from an IGS-
rRNA reporter gene plasmid that was transfected in NIH 3T3
cells, proficient for IGS-rRNA processing (Santoro et al., 2010),
and in ESCs. Whereas ectopic IGS-rRNA was efficiently pro-
cessed in NIH 3T3 cells (80%), maturation of pRNA was strongly
reduced in ESCs (Figure 2C). Taken together, these results indi-
cate that IGS-rRNA is not efficiently processed in ESCs and is
thus less abundant in NPCs than in ESCs.
To test whether the lack of IGS-rRNA processing is the deter-
minant that impairs formation of rDNA heterochromatin in ESCs,
we transfected in vitro synthesized mature pRNA in ESCs and
monitored TIP5 cellular localization, rDNA methylation, rDNA
transcription, and H3K9me2 and H3K9me3 levels at rDNA (Fig-
ure 3). In ESCs transfected with pRNA, TIP5 decreased in the
nucleoplasm and accumulated within nucleoli, as indicated by
the colocalization with the nucleolar protein UBF (Figure 3A; Fig-
ure S3). Remarkably, the addition of pRNA in ESCs induced
formation of heterochromatic rDNA as demonstrated by the
reduction of rDNA transcription and the increase of both
H3K9me2 and CpG methylation levels at the rDNA promoter
(Figures 3B–3D; Figure S4). The modest increase in CpGmethyl-
ation (from 1.7% to 4.4%) can also be attributed to the 2i
conditions, recently described to lead to pronounced reduction
in DNA methylation due to the downregulation of the de novo
methyltransferases DNMT3a and DNMT3b (Leitch et al., 2013).
Consistent with previous studies showing that TIP5 mediates di-
methylation but not trimethylation of H3K9 at rRNA genes (Guetg
et al., 2010; Santoro and Grummt, 2005), ectopic pRNA did not
increase H3K9me3 levels at rDNA (Figure 3D; Figure S4). These
results indicate that addition of pRNA in ESCs is sufficient to
guide TIP5 to rDNA and to establish rDNA heterochromatin.
To determine how pRNA guides TIP5 to rDNA, we mutated
pRNA sequences that were previously implicated in rDNA
methylation and TIP5 association in somatic cells (Mayer et al.,
2008; Schmitz et al., 2010). We mutated the T0 element
(pRNADT0) that was previously described to form dsDNA:RNA
triplex, a structure implicated in de novo rDNA methylation
through recruitment of DNMT3b (Schmitz et al., 2010) and pro-
posed as guiding module for TIP5 targeting to rDNA (Bierhoff
et al., 2013). Similarly to wild-type pRNA, pRNADT0 induced
recruitment of TIP5 to nucleoli, promoted rDNA methylation
and reduced rDNA transcription (Figures 3A–3C; Figure S3).
Thus, pRNA-mediated nucleolar targeting of TIP5 and establish-
ment of rDNA heterochromatin formation in ESCs is not medi-
ated by rDNA:pRNA triplex. Accordingly, replacement of the
50-pRNA region, including T0 element, (hybrid, Control-pRNA)
induced TIP5 nucleolar localization (Figure 3E; Figure S3). In
contrast, replacement of 30-pRNA sequences (hybrid, pRNA-
Control), important for stem loop structure formation and the
association with TIP5 in vitro (Mayer et al., 2008), impaired nucle-
olar localization of TIP5. Remarkably, point mutations that
disrupt the stem loop structure (pRNA loop destroyed) were
not efficient in recruiting TIP5 to the nucleoli whereas a compen-
satorymutation allowing hairpin formation did (pRNA loop recov-
ered). Together, these results indicate that pRNA guides TIP5 to
rDNA in trans through the hairpin structure and that addition of
mature pRNA to ESCs is sufficient to establish rDNA heterochro-
matin. We conclude that the impairment of IGS-rRNA processing
that abrogates formation of mature pRNA is the major determi-
nant causing the euchromatic state of all rRNA genes in ESCs.
TIP5-TTF1 Association Is Mediated by pRNA and
Impaired by IGS-rRNA
To determine why IGS-rRNA is unable to promote recruitment of
TIP5 to rDNA, we determined whether TIP5 binds to IGS-rRNA
using EMSA competition assays. Consistent with previous re-
sults, pRNA had a higher affinity for TIP5 compared to control
RNA (Mayer et al., 2006) (Figure 4A). Surprisingly, TIP5 associ-
ates better with IGS-rRNA than with pRNA. To determine
whether TIP5 preferentially associates with other IGS-rRNA
sequences than pRNA, we analyzed TIP5 binding to IGS-rRNA
sequences located upstream of the pRNA region. Spacer and
enhancer RNA associate with TIP5 much less efficiently than
pRNA (Figure S5A), suggesting that TIP5 binds to IGS-rRNA
through the pRNA sequence and that upstream sequences
might stabilize the complex throughweak interactions. Together,
these results indicate that TIP5 binds to IGS-rRNA and suggest
that impairment of TIP5 recruitment to rDNA in ESCs might
depend on the context of this interaction.
The requirement of the pRNA loop structure for nucleolar tar-
geting of TIP5 (Figure 3) let us hypothesize that pRNA binding to
TIP5 might favor the association with a docking protein for the
recruitment to rDNA promoter and that IGS-rRNA might hinder
this process. One important TIP5 interacting protein is the tran-
scription terminator factor TTF1 (Ne´meth et al., 2004; Strohner
et al., 2001). TTF1 is a nucleolar protein that binds to terminator
(T) elements, including the T0 sequences at rDNA promoter, and
is implicated in several rDNA regulatory processes (Evers and
Grummt, 1995; Gerber et al., 1997; La¨ngst et al., 1997). The
association of TIP5 with TTF1 and its dependency on TTF1 for
rDNA promoter binding proposed that TTF1 recruits TIP5 to
rDNA (Ne´meth et al., 2004; Santoro and Grummt, 2005; Strohner
et al., 2001). However, whether and how pRNA is implicated in
this process has so far not been investigated. TTF1 binds to
RNA (Figure 4B), forming high-molecular-weight complexes.
However, in contrast to TIP5, TTF1 did not display any
(C) qRT-PCR. rRNA transcription (45S pre-rRNA levels) in ESCs, NPCs, and NIH 3T3. Data were normalized to Rps12 mRNA.
(D) CpG methylation levels at rDNA promoter in mouse fibroblasts and iPSCs.
(E and F) ChIP. H3K9me2, H3K9me3 and H3K27me3, UBF, TIP5, and PARP1 occupancy. Evx1, Zfpm2, and Gapdh represent control genes. Data of two
independent experiments were normalized to input and rDNA promoter value in ESCs.
(G) Tip5 mRNA (qRT-PCR) and protein levels (immunoblot) of ESCs and NPCs. Data were normalized to Rps12 mRNA or PARP1 protein levels. Protein level
titration was loaded and only the lanes with same protein amounts are shown.
(H) TIP5 cellular localization in MEFs, ESCs, and NPCs after 8 days of differentiation by immunofluorescence. Nucleoli are depicted by UBF signal.
All error bars represent the SD of two (when indicated) or three independent experiments. See also Figures S1 and S2.
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preferential binding to pRNA sequences (Figure 4C). In ESCs,
TTF1 is bound to rDNA promoter and is localized within nucleoli
as in differentiated cells (Figures S5B and S5C). To determine
whether the association of TIP5 with TTF1 is regulated by
pRNA or IGS-rRNA, we performed pull-down assays using puri-
fied RNA-free His-tagged TTF1 (aa.1-210, containing TIP5-inter-
acting region) and GST-tagged-TIP5 (aa. 332-723, comprising
the RNA- and TTF1-interacting regions) (Mayer et al., 2006;
Ne´meth et al., 2004). Immobilized GST-TIP5332–723 was incu-
bated with no RNA, or with equivalent moles of RNAs and
analyzed for the interaction with His-TTF11–210. In the absence
of RNA and in the presence of RNA control, TIP5 and TTF1 did
not associate (Figure 4D). In contrast, TIP5-pRNA complexes
displayed a strong interaction with TTF1, indicating that pRNA
is required for TIP5-TTF1 association. Remarkably, TIP5 bound
to IGS-rRNA did not interact with TTF1. Consistent with the
role of 30-pRNA sequences in TIP5 nucleolar targeting, this re-
gion was sufficient for TIP5-TTF1 interaction while the 50-pRNA
A
B
C
Figure 2. IGS-rRNA Is Not Efficiently Processed in ESCs
(A) Schema representing the mouse 50-rDNA organization: Spacer promoter (gray), intergenic spacer region (blue), rDNA main promoter (red), and transcription
start sites of IGS-rRNA (!1997) and 45S pre-rRNA (+1). Arrows represent primers used to perform RT (1;!20/!1) and to quantitatively amplify the indicated rDNA
sequences (2–7).
(B) qRT-PCR. Levels IGS-rRNA and pRNA sequences of ESCs and NPCs (from days 2 to 6, from the beginning of differentiation). Data of two independent
experiments were normalized to Rps12 mRNA and to ESC values.
(C) Schema depicts the IGS-rRNA reporter plasmid. Black arrows represent primers used to perform RT (10) and to amplify plasmid sequences (8 and 9). Blue and
red arrows (2 and 6) indicate primers hybridizing to rRNA sequences as described in (A). NIH 3T3 and ES cells were transfected with IGS-rRNA reporter plasmid.
Data from three experiments are represented as values of amplifications with primers 2 and 8 (IGS-rRNA) normalized to amplifications with primers 6 and 9
(IGS-rRNA+pRNA).
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region was not. We conclude that pRNA mediates the associa-
tion of TIP5 with TTF1 and that unprocessed IGS-rRNA prevents
this interaction. Based on these results, we propose that the un-
processed IGS-rRNA in ESCs abolishes the interaction of TIP5
with TTF1, thus preventing TIP5 targeting to rDNA and nucleolar
heterochromatin formation.
The Epigenetic State of Nucleolar Chromatin Affects
ESC Chromatin and Pluripotency
Our previous studies showed that somatic cells depleted of TIP5
reduced silent epigenetic modifications at rDNA and at major
and minor satellites and lack condensed heterochromatin adja-
cent to nucleoli (Guetg et al., 2010). Further structural alterations
observed upon TIP5 knockdown, such as enlargement of nucle-
olar surfaces, reduction of nucleoli number, and formation of few
decondensed DAPI-stained heterochromatic foci, resembled
ESC chromatin organization (Figure 5A). To determine whether
formation of rDNA heterochromatin affects the open chromatin
of ESCs, we performed transmission electron microscopy to
analyze and quantify the volume of heterochromatin associated
to nucleoli in ESCs upon addition of pRNA (ESCs+pRNA) (Fig-
ure 5B; Figure S5D). Consistent with the loss of perinucleolar het-
erochromatin upon TIP5 knockdown in somatic cells (Guetg
et al., 2010), ESCs+pRNA increased the amounts of condensed
heterochromatin around nucleoli, displaying a structural organi-
zation like it is found in NPCs (Figure S5E). In line with these re-
sults, ESCs+pRNA increased H3K9me2 not only at rDNA, but
also at major and minor repeats and at LINE elements while
IAP transposons were not significantly affected (Figure 3D; Fig-
ure S4). H3K9me3 levels drastically increased atminor andmajor
satellites while remaining unchanged at LINE L1 elements and
IAP transposons and, as expected, at rDNA. Among the four
performed experiments, we observed an inverse correlation
between H3K9me2 and H3K9me3 levels at minor and major
repeats (Figure S2), suggesting a two-step process that is initi-
ated with H3K9me2 (the activity brought to rDNA by TIP5 (San-
toro and Grummt, 2005)) and is further completed at major and
minor satellite sequences with the establishment of H3K9me3.
ESCs+pRNA increased the total amount of H3K9me2 to levels
similar to those observed during ESC-NPC transition (Figure 5C).
This result is in agreement with a previous work showing acqui-
sition of large regions of H3K9 methylation during differentiation,
which affects at least 30% of the genome (Wen et al., 2009). In
contrast, the global H3K9me3 content was not altered in NPCs
and ESCs+pRNA. Because terminally differentiated cells were
previously described to contain elevated H3K9me3 levels (Haw-
kins et al., 2010), our results with NPCs most likely represent the
epigenetic state at early differentiation time points. The elevated
heterochromatic content of ESCs+pRNAwas also accompanied
by a reduction of minor satellites transcription as found during
ESC differentiation (Figure S1E), whereas transcription of LINE
and IAP elements was not greatly affected (Figure 5C). Taken
together, these results suggest that tethering heterochromatin
at rDNA via pRNA in ESCs initiates structural remodeling toward
a highly condensed nuclear heterochromatin, a structure that
ESCs normally acquire during differentiation.
We next addressed how the increased heterochromatic con-
tent mediated by pRNA affects ESC properties. ESCs+pRNA
did not show alterations in important molecular features of the
undifferentiated state such as cell proliferation, expression of
the pluripotency genes Oct4, Nanog, and stage-specific embry-
onic antigen 1 (SSEA1), cell morphology, and alkaline phospha-
tase (AP) staining (Figures 6A–6D, and data not shown). To
determine whether addition of pRNA affects pluripotency in vivo,
we performed teratoma formation assays. ESCs+pRNA mark-
edly decreased their capability to form teratoma compared to
ESCs transfected with RNA control or with a pRNA mutant that
is unable to recruit TIP5 to nucleoli (Figure 6E). Remarkably, ter-
atomas derived from ESCs+pRNA showed a drastic reduced
volume but displayed differentiation into all three germ layers
(Figures S6A and S6B). Because ESCs were transiently trans-
fected, we assume that teratomas obtained from ESCs+pRNA
originated from untransfected cells, which is supported by the
reduction in volume of these teratomas. To get insights into
the loss of pluripotency, we analyzed transcription profiles of
ESCs+pRNA and ESCs+RNA-control by RNaseq and found up-
regulation of 532 transcripts and downregulation of 509 tran-
scripts in ESCs+pRNA (Table S1 available online). We carried
out functional annotation analysis of transcripts whose levels
were altered in ESCs+pRNA using DAVID tools (Huang et al.,
2009) (Figure 6E; Table S1). The top eight gene ontology terms
were all related to cell developmental and differentiation pro-
cesses. Enrichment for these processes was particularly evident
for transcripts upregulated in ESCs+pRNA, suggesting that
addition of pRNA promotes expression of genes involved in
cell differentiation and developmental processes. To exclude
the possibility of pRNA off-target effects, we transfected a
mutant pRNA unable to associate with TIP5 and analyzed
transcription of Btg3 and Rdh10, two genes upregulated in
ESCs+pRNA and known to be implicated in neurogenesis and
embryonic differentiation (Cammas et al., 2007; Yoshida et al.,
1998). In contrast to pRNA, the pRNA mutant was unable to
affect Btg3 and Rdh10 transcript levels (Figure S6C), indicating
that upregulation of genes implicated in cell differentiation and
the developmental processes is specifically mediated by a fully
functional pRNA that is able to associate with TIP5, guide it to
Figure 3. Mature pRNA Is Required for the Establishment of rDNA Heterochromatin
(A) Mature pRNA induced recruitment of TIP5 to ESC nucleoli. Immunofluorescence with anti-TIP5 and anti-UBF antibodies in ESCs transfected with in vitro
synthesized RNA control, pRNA, and pRNADT0.
(B) Mature pRNA promotes rDNA promoter CpG methylation in ESCs. Error bars represent the SD of three independent experiments.
(C) Mature pRNA decreased rRNA synthesis in ESCs. rDNA transcription weremeasured by qRT-PCR and normalized toRps12mRNA. Error bars indicate the SD
of two independent experiments.
(D) Mature pRNA increased silent histone modifications at rDNA and centric-pericentric sequences of ESCs. Box-and-whisker plot of four independent ChIP
experiments. Data are represented as bound over input in ESCs+pRNA normalized to values measured in ESCs+RNA control.
(E) pRNA loop structure mediates TIP5 recruitment to ESC nucleoli. Immunofluorescence with anti-TIP5 and anti-UBF antibodies of ESCs transfected with the
indicated pRNA mutants.
See also Figure S3.
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rDNA, and establish rDNA heterochromatin. Together, these re-
sults indicate that the elevated heterochromatic content induced
by formation of nucleolar heterochromatin through pRNA impairs
pluripotency and highlight the role of the nucleolus in the control
of ESC chromatin plasticity that is required for the maintenance
of the undifferentiated state.
To further explore the role of nucleolar chromatin in ESCs, we
analyzed the differentiation capacity of cells depleted of TIP5.
ESCs depleted of TIP5 by siRNA reduced TIP5 levels to 50%
(Figures 7A and 7B). Upon TIP5 knockdown, ESCs proliferated
A
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Figure 4. pRNA Mediates TIP5-TTF1 Inter-
action
(A) TIP5 binds to IGS-rRNA. Increasing equal
moles of in vitro transcripts corresponding to
control, pRNA, and IGS-rRNA sequences were
used to compete for binding of TIP5332–723 to
radiolabelled run-off transcripts from pBluescript
(MCS-RNA). RNA/protein complexes were
analyzed by EMSA.
(B) TTF1 binds to RNA. Increasing equal moles of
full-length TTF1 and TIP5332–723 were analyzed for
binding to radiolabeled MCS-RNA by EMSA.
(C) TTF1 does not show preferential binding to
pRNA. Binding of full-length TTF1 to radiolabeled
MCS-RNA was completed with increasing equal
moles of RNA control and pRNA.
(D) TIP5-TTF1 interaction is mediated by pRNA
and impaired by IGS-rRNA. Schema representing
the GST-pull-down strategy used to analyze TIP5-
TTF1 interaction in the presence of equivalent
moles of RNAs. Pull-down assay. Bound proteins,
GST, GST-TIP5, and His-TTF1, were detected with
anti-GST and anti-His antibodies, respectively.
See also Figures S5A–S5C.
less but displayed unaltered expression
of Oct4, Nanog, and Rex1, exhibited the
typical cell morphology of ESCs and
were positive for AP staining (Figures
7B–7E). Similar results were obtained
with other siRNA-TIP5 sequences (data
not shown). To determine whether TIP5
depletion affects ESC differentiation, we
treated an equal number of siRNA-control
and -Tip5 treated ESCs with their respec-
tive siRNAs and induced monolayer dif-
ferentiation upon withdrawal of 2i and
LIF (Figure 7A). After 3 days, control
cells displayed morphological structures
typical of differentiated cells, whereas
cells depleted of TIP5 underwent cell
death and detached from the plate (Fig-
ures 7F–7H). The majority of the few
siRNA-TIP5 cells that remained attached
to plates showed ESC-like morphology
and were positive for AP staining (Figures
7G and 7H; Figure S7). The effects
observed with TIP5 depletion were spe-
cific for differentiated cells because
ESCs double-treated with siRNA-Tip5
and cultured in 2i and LIF did not show any defect in viability
(data not shown). These results indicate that TIP5 is required
for ESC differentiation and suggest that the establishment
of nucleolar heterochromatin is an event required for early
differentiation.
DISCUSSION
The remodeling of the open and euchromatic genome structure
of ESCs toward a highly condensed heterochromatic form
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characterizes the exit from pluripotency and the progression into
differentiated states. ESC open chromatin correlates with a glob-
ally permissive transcriptional state contributing to the develop-
mental plasticity and pluripotency of the ESC genome that has to
have the ability to enter any distinct differentiation pathway
(Gaspar-Maia et al., 2011). We determined here that the nucle-
olus is not only the place where ribosomes are produced, but it
also plays a role in regulating genome architecture and pluripo-
tency. Using mature pRNA as a mean to specifically tether het-
erochromatin at nucleoli of ESCs, we showed that the formation
of heterochromatin at rRNA genes, the genetic component of
nucleoli, has the ability to initiate the establishment of repressive
chromatin structures at regions of the genome located outside of
the nucleolus (Figure 7I). This process includes the formation of
A
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Figure 5. Mature pRNA Induces Global Remodelling toward Heterochromatic Structures
(A) Immunofluorescence showing heterochromatin (DAPI) and nucleoli (UBF) of NIH 3T3 cells stably expressing shRNA-control and -Tip5 sequences, and ESCs.
(B) Mature pRNA induced formation of condensed heterochromatin in ESCs. Transmission electron microscopy analysis. Representative images showing
nucleolus-associated heterochromatin in ESCs+Control and ESCs+pRNA. The contrast procedure reveals in dark condensed heterochromatic structures (Het);
25–34 nucleoli of ESCs+RNA control and ESCs+pRNA of two independent experiments were selected at random. The volume of nucleolus-associated
heterochromatin was expressed as a percentage of the volume of the nucleolus (Nu). Heteroscedastic two-tailed t test was used to compare the groups. See also
Figures S5D and S5E.
(C) Immunoblot of H3K9me2, H3K9me3, and histone H3 of chromatin fractions of ESCs, NPCs, ESCs+RNA-control, and ESCs+pRNA. Values from three in-
dependent experiments were normalized to histone H3 levels. Protein level titration was loaded and only the lanes with same histone amounts are shown.
(D) qRT-PCR of major and minor satellite, LINE, and IAP retrotrasposon transcripts in ESCs+RNA-control and ESCs+pRNA. Values from two independent
experiments were normalized to Rps12 mRNA.
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highly condensed heterochromatic structures clustering in
proximity to nucleoli as found in differentiated cells. Such archi-
tectural remodeling is also evidenced by a global increase
in H3K9me2, maturation of heterochromatin at repetitive
sequences, and their transcriptional repression. These are
characteristic features of the switch between pluripotency and
differentiation. Although we cannot define which is the first event
that globally initiates the formation of heterochromatin at the exit
from pluripotency and entry into differentiation, our results place
the nucleolus as an important regulator of this process. The
establishment of rDNA heterochromatin during differentiation
timely coincides with the formation of highly condensed hetero-
chromatic structures and LOCKs (Meshorer and Misteli, 2006;
Wen et al., 2009). This was particularly evident for the maturation
of constitutive heterochromatin at major and minor satellite re-
peats, which displayed the same timing as rDNA for the acquisi-
tion of histone repressive marks and transcriptional repression
upon ESC differentiation.
While showing some of the molecular outlines of the undiffer-
entiated cells, pRNA-mediated heterochromatic ESCs tran-
scribe genes implicated in differentiation processes and are no
longer pluripotent. This observation highlights the role of the
euchromatic organization in ESC identity and suggests that
nucleolar chromatin is an important regulator of the pluripotent
state. Likewise, impairing the formation of rDNA heterochromat-
in by TIP5 knockdown inhibits ESC differentiation, suggesting
that the establishment of nucleolar heterochromatin is a neces-
sary step for the switch from a lower to a higher order chromatin
structure and lineage commitment.
How does the nucleolus influence heterochromatin formation?
Due to the proximity of rDNA and centromeric sequences at
rDNA-bearing chromosomes (Dev et al., 1977; Kurihara et al.,
1994), the effect of rDNA heterochromatin on chromatin struc-
tures at major and minor repeats might in part be explained
through spreading mechanisms. However, centromeres of chro-
mosomes not containing rRNA genes also associate with the
nucleolus at a frequency more than expected for a random dis-
tribution (Carvalho et al., 2001), indicating the existence of alter-
native mechanisms that establish heterochromatin at sequences
that are further away from rDNA loci. In this case, the establish-
ment of rDNA heterochromatin might allow the formation of a
nucleolar/perinucleolar compartment enriched in chromatin
repressor complexes that would be attractive for genomic re-
gions that need to be repressed. Anchoring of heterochromatin
at the nucleolus might have similar function like the ones
described for the nuclear periphery that is responsible for the
integrity of mammalian heterochromatin (Pinheiro et al., 2012;
Towbin et al., 2012). Consistent with this, genomic regions local-
ized at the lamina (LADs) were shown to relocate after cell divi-
sion either at the lamina or at the nucleolus (Kind et al., 2013),
suggesting interchangeable roles in establishing andmaintaining
heterochromatic states.
This study also provides evidence that rRNA genes do not only
function in synthesizing rRNA. Silent rRNA repeats, present in all
somatic cells, maintain their heterochromatic state indepen-
dently of transcriptional activity, and are stably propagated
throughout the cell cycle (Conconi et al., 1989). Our results indi-
cated that the epigenetic state of rRNA genes contributes to nu-
clear architecture and cellular functions such as pluripotency
and differentiation by controlling the balance between hetero-
chromatin and euchromatin. Interestingly, rDNA deletions in
Drosophila result in reduced heterochromatin elsewhere in the
genome and the extent of the rDNA deletion correlates with the
loss of silencing in much the same manner as mutations in
known protein heterochromatin components (Paredes andMag-
gert, 2009).
Very little is understood about how specific lncRNAs selec-
tively seek out interaction sites in the genome, the nature of
lncRNA-chromatin interactions, and their possible functional
roles (Rinn and Chang, 2012). This work underlined the role of
lncRNA in targeting epigenetic regulatory processes at specific
genomic loci leading to the establishment of chromatin confor-
mation patterns that ultimately result in the fine control of genes.
We show that the regulation of pRNA precursor IGS-rRNA pro-
cessing is a key determinant for the control of the epigenetic
state at rDNA and propose that the processing represents a
mean of lncRNA regulation to modulate distinct functions of
the same lncRNA. We determined that IGS-rRNA processing is
a developmentally regulated process and that its impairment in
ESCs prevents recruitment of TIP5 to rDNA and formation of
rDNA heterochromatin. Although the mechanisms that impair
IGS-rRNA processing in ESCs are yet to be determined, our re-
sults demonstrated that mature pRNA is necessary to establish
rDNA heterochromatin. We showed that pRNA-mediated target-
ing of TIP5 occurs through DNA-protein recognition rules.
Whereas IGS-rRNA abolishes the association of TIP5 with
TTF1, pRNA promotes this interaction that serves to guide the
complex to the rDNA promoter and to establish nucleolar hetero-
chromatin. Thus, the same lncRNA can prevent or promote pro-
tein complex assembly and its processing controls the switch
between these functions. Based on these results, it would not
be surprising if processing emerges as a more general mecha-
nism of lncRNA regulation.
In summary, our data underline the contribution of chromatin
structure in ESC pluripotency and differentiation potential and
indicate that the nucleolus is a key regulator of nuclear architec-
ture and chromatin structure, which serves to control cell plurip-
otency and lineage commitment.
Figure 6. pRNA Impairs ESC Pluripotency
(A) Nanog and Oct4 mRNA levels in ESCs+RNA control and ESCs+pRNA (qRT-PCR). Values from two independent experiments were normalized to
Rps12 mRNA.
(B–D) (B) SSEA-1 immunostaining, (C) cell morphology, and (D) AP staining of ESCs+RNA control and ESCs+pRNA.
(E) ESCs+pRNA are not pluripotent. Efficiency of teratoma formation was assessed by the number of teratomas generated versus expected (injections) and by
tumor volumes measured at the time when control animals were killed.
(F) Mature pRNA induced expression of genes implicated in cell differentiation and development. Top eight biological process gene ontology terms as determined
using DAVID for genes regulated, and upregulated and downregulated in ESCs+pRNA.
See also Figure S6.
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EXPERIMENTAL PROCEDURES
mESC Culture
One hundred twenty-nine mouse embryonic stem cells (E14 line) were
cultured in N2B27 media (Dulbecco’s modified Eagle’s medium [DMEM]
F12, neurobasal medium, N2/B27 supplements, 2 mM L-glutamine with
Pen/Strep, b-Mercaptoethanol) supplemented with recombinant leukemia
inhibitory factor, LIF (ESGRO, 1000 U/ml) and MEK and GSK3b inhibitors,
2i (Stemolecule CHIR99021 and PD0325901, 3 mM and 1 mM, respectively).
Cells were seeded at a density of 50,000 cells/cm2 in culture dishes (Corning
CellBIND surface) treated with 0.1% gelatine without feeder layer. Propaga-
tion of cells was carried out every 2 days using Trypsin 0.53 for enzymatic
cell dissociation.
mESC Differentiation
mESCs were differentiated to neural progenitor cells according to a previ-
ously established protocol (Bibel et al., 2004). In brief, differentiation used a
suspension-based embryoid bodies formation (Bacteriological Petri Dishes,
Bio-one with vents, Greiner). The neural differentiation media (DMEM, 10%
fetal calf serum, 13 MEM NEAA, 2 mM L-glutamine with Pen/Strep, b-mer-
captoethanol) was filtered through 0.22 mm filters and stored at 4!C. During
the 8-day differentiation procedure, media was exchanged every 2 days. In
the last 4 days of differentiation, the media was supplemented with 2 mM
retinoic acid to generate neural precursors that are Pax-6-positive radial
glial cells.
Immunocytochemistry
ESCs or differentiated cells were grown on gelatin-coated coverslips and per-
meabilized with 0.05% Triton X-100 in 20 mMTris-HCl (pH 8), 5 mM MgCl2,
0.5 mM EDTA, and 25% glycerol. After washing, cells were fixed with cold
methanol (7 min) and stained with anti-TIP5 (Diagenode) and anti-UBF
(SantaCruz) antibodies and DAPI (Molecular Probes), and immunofluorescent
images were digitally recorded.
Transmission Electron Microscopy
Cells were first fixed with 2.5% glutaraldehyde, dehydrated in an ethanol
series, transferred to methanol, and immersed into a freshly prepared mixture
of methanol and acetic anhydride (5:1, v/v) at 25!C for 24 hr in the dark (Tandler
and Solari, 1982; Testillano et al., 1991). Cells were then washed in pure
methanol for 20 min, transferred in ethanol and embedded in Epon (Sigma).
Ultrathin (50 nm) sections were contrasted with 5% aqueous uranyl acetate
for 60 min at room temperature and examined with a CM100 transmission
electron microscope (FEI).
The volume of nucleolus-associated heterochromatin was estimated using
the Cavalieri-estimator (Gundersen et al., 1988; West, 2012). Volume esti-
mates were performed for samples of 25 to 34 nucleoli selected at random
from each electron microscopy sample of two independent experiments.
Nucleoli were selected independent of their size or shape in the electronmicro-
scopy montages. The volume of nucleolus-associated heterochromatin was
expressed as a percentage of the volume of the corresponding nucleolus.
Due to unequal variances of heterochromatin volumes in control and experi-
mental cells, a heteroscedastic two-tailed t test was used to compare the
groups (p = 7.6 3 10"9).
EMSA
Radiolabeled MCS-RNA was synthesized by T7 RNA polymerase using
pBluescript-KS(+)/EcoRI as template. After treatment with DNase I, transcripts
were purified and 50,000 cpm of MCS-RNA were incubated for 15 min on ice
with 40 ng recombinant TIP5 or TTF1 in EMSA buffer (20 mM Tris-HCl [pH 8.0],
5 mM MgCl2, 100 mM KCl, and 0.2 mM EDTA). Cold competitor RNA was
added, and incubation was continued for 30 min. RNA-protein complexes
were analyzed by electrophoresis on 6% (w/v) native polyacrylamide gels
and depicted with autoradiography.
For detailed methods, list of antibodies, and tables of primers, see the Sup-
plemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2014.10.005.
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Figure S4
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Supplemental Figure Legends 
 
Figure S1. Establishment of rDNA heterochromatin occurs during ESC differentiation. Related to 
Figure 1. 
(A) qRT-PCR. Nestin and Blbp (neural precursor markers) mRNA levels in ESCs and NPCs. Data 
were normalized to Rps12 mRNA. Error bars indicate the SD of three independent experiments. 
(B) CpG methylation levels at rDNA promoter in ESCs (JM8N4) and during 7 days of 
differentiation into NPCs. ESCs were cultivated on monolayer and differentiation was induced 
with N2B27 medium supplemented with RA. Error bars indicate the SD of two independent 
experiments. 
(C) ChIP. H3K9me2 and H3K9me3 occupancy at rDNA promoter and coding sequences, major 
and minor satellites and control gene Evx1 monitored during different time points (days) of 
differentiation. Data were normalized to input and rDNA promoter values in ESCs. 
(D) ChIP. H3K4me2 and H3K4me3 occupancy in ESCs and NPCs. Evx1, Zfpm2 and Dlx1 
represent control genes. Data were normalized to input and rDNA promoter values in ESCs. 
(E) Major and minor satellite transcript levels in ESCs and NPCs were measured by qRT-PCR 
and normalized to Rps12 mRNA. Error bars indicate the SD of two independent experiments. 
 
Figure S2. Establishment of rDNA heterochromatin during ESC differentiation correlates with the 
recruitment of TIP5 to rDNA. Related to Figure 1. 
(A) TIP5 localizes within nucleoli shortly after ESC differentiation. Immunofluorescence showing 
TIP5 nucleolar localization in ESCs after 2 and 4 days differentiation. Nucleoli are visualized by 
UBF signal.  
(B) Quantification of TIP5, UBF and DAPI colocalization measured using Fiji image analysis 
software.  
 
Figure S3. The stem-loop structure of pRNA is sufficient to target TIP5 to nucleoli. Related to 
Figure 3. 
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Quantification of nucleolar localization of TIP5 in ESCs transfected with RNA Control, pRNA, 
pRNA and pRNA mutants (pRNAΔT0, Control-pRNA, pRNA-Control, pRNA-loop destroyed and 
pRNA-loop recovered). TIP5, UBF and DAPI signals were measured using Fiji image analysis 
software. 
 
Figure S4. Mature pRNA increases H3K9me2 and H3K9me3 at rDNA and centric-pericentric 
heterochromatin in ESCs. Related to Figure 3. 
(A) Scatter plot of the four ChIP experiments shown in Figure 3D.  
(B) Results of the single four ChIP experiments showing an inverse correlation in the enrichment 
between H3K9me2 and H3K9me3 levels at minor and major repeats in ESCs+pRNA when 
compared to ESCs+RNA-control. Data are represented as bound over input in ESCs+pRNA 
normalized to values measured in ESCs+RNA-control.  
 
Figure S5. Mature pRNA mediates TIP5-TTF1 interaction and induces global remodelling toward 
heterochromatic structures pRNA. Related to Figure 4 and 5. 
(A) TIP5 binds to IGS-rRNA and it has a stronger affinity for pRNA sequences. Increasing equal 
moles of in vitro transcripts corresponding to pRNA, spacer promoter and enhancer repeat RNA 
were used to compete for binding of TIP5332-723 to radiolabelled run-off transcripts from pBluescript 
(MCS-RNA). RNA/protein complexes were analyzed by EMSA. 
(B) TTF1 binds to the rDNA promoter of ESCs. ChIP showing association of TTF1 with rDNA 
promoter in ESCs and NIH3T3 cells. Data of two independent experiments were normalized to 
input and rDNA promoter values. The low levels of TTF1 association with +8 Kb rDNA sequences 
(that do not contain T elements) demonstrated the specificity of the assay.  
(C) TTF1 is localized within nucleoli of ESCs and differentiated cells. Immunofluorescence 
showing TTF1 nucleolar localization in ESCs and 2 days after differentiation. Nucleoli are 
visualized by UBF signal.  
(D) Box-and-whisker plot of nucleoli size in ESCs+Control and ESCs+pRNA. 25 to 34 nucleoli of 
ESCs+RNA control and ESCs+pRNA of two independent experiments were selected at random 
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and independent of their size or shape in the EM montages. Volumes were estimated using the 
Cavalieri-estimator (Gundersen et al., 1988; West, 2012). Nucleoli volumes did not differ among 
control and ESCs+pRNA while heterochromatin associated to nucleoli did. The volume of 
nucleolus-associated heterochromatin was expressed as a percentage of the volume of the 
nucleolus (Nu) that was associated with and shown in main Figure 5B. 
(E) Transmission electron microscopy analysis of ESCs and NPCs. The contrast procedure 
reveals in dark condensed heterochromatic structures (Het) and nucleoli (Nu).  
 
Figure S6. pRNA impairs ESC pluripotency. Related to Figure 6. 
(A) Kinetics of teratoma growth from the time of injection to euthanasia of control animals. In this 
experiment, tumors derived from ESCs+RNA-control (2), ESCs+pRNA (6) and ESCs+mutant 
pRNA-Control (7) were analysed.  
(B) Histological analysis of teratomas derived from ESCs transfected with RNA-control, pRNA 
and mutant pRNA-Control revealed that ESCs differentiate into all three germ layers as shown by 
the presence of ectoderm (B, F, J), endoderm (C) and mesoderm (A,E,I). C,D,G,H,K,L 
haematoxylin staining. Immunostaining for bIII tubulin (TuJ1) (B,F,J), and smooth muscle actin 
(SMA) (A,E,I). Inserts show higher magnification. Scale bars, 50 µm.  
(C) Box-and-whisker plot of three independent experiments showing mRNA levels of Btg3, Rdh10 
and Oct4 measured in ESCs transfected with RNA-control, pRNA and mutant pRNA loop-
destroyed. Btg3 and Rdh10 are known to be implicated in neurogenesis and embryonic 
differentiation (Cammas et al., 2007; Yoshida et al., 1998). Consistent with the results of Fig. 6A, 
Oct4 mRNA levels remained unaffected in all three conditions. 
 
Figure S7. Depletion of TIP5 impairs ESC differentiation. Related to Figure 7. 
(A) Cell morphology and (B) AP staining of differentiated ESCs treated with siRNA-control and -
Tip5. 
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Supplemental Table Legends 
 
Supplemental Table S1. Related to Figure 6. 
Total RNA of ESCs+RNA-Control and ESCs+pRNA from two biological replicates were purified 
and analyzed by RNA seq. The table includes the list of genes whose transcript levels were 
altered in ESCs+pRNA when compared to control cells (defined as regulated, upregulated and 
downregulated) and gene onthology analysis using DAVID tools. 
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Supplemental Experimental procedures  
Reprogramming into iPSC 
Reprogramming was performed as previously described (Weber et al., 2013). Breifly, mouse 
embryonic fibroblasts (MEF) were isolated from 14.5 day-pregnant C57BL/6 mice and cultured in 
DMEM supplemented with 10% FBS (PAA) and 1% L-glutamin/penicillin/streptomycin (10,000 
U/ml penicillin G sodium; 10,000µg /ml streptomycin sulphate; 29.2mg/ml L-glutamine; 10mM 
sodium citrate in 0.14% NaCl, Gibco). The reprogramming of the MEFs was performed according 
to Yamanaka’s protocol (Takahashi et al., 2007) using the pMXs retroviral vectors producing 
murine Oct4, Sox2, Klf4 and c-Myc (Addgene, cat. nos. 13366, 13367, 13370 and 13375). Two 
days after infection, MEFs were cultured in DMEM containing 15% FBS, 1% L-
glutamin/penicillin/streptomycin, 1x MEM non-essential amino acids (GIBCO) and 50 mM ß-
mercaptoethanol (GIBCO) supplemented with 1000 U/ml ESGRO murine Leukemia inhibitory 
factor (LIF, Chemicon Int.). The iPSC cell line used for the experiment of Figure 1D has the ability 
to generate teratoma (data not shown).  
 
Transfections 
ESCs were seeded at a density of 20,000 cells/cm
2
 and transfected with the indicated siRNAs (50 
nM siRNA) or synthetic RNAs (1 mg/ml) using Lipofectamine® RNAiMAX (Life Techonlogies) in 
Opti-MEM® GlutaMAX™ (GIBCO) reduced-serum medium. Analysis of differentiated transfected 
ESCs was performed using consecutive transfections. Three days after the first transfection, 
equal amounts of ESCs (e.g. siRNA-control and siTIP5 treated cells) were again transfected and 
induced to differentiate in complete media (G-MEM, 10%FCS, Sodium Pyruvate 100mM, 1xMEM 
NEAA, L-Glutamine) by withdrawal of LIF and 2i. Efficiencies of siRNA-mediated depletions and 
synthetic RNA levels were monitored by qRT-PCR 3-4 days post-transfection. 
 
In Vitro Transcription 
The indicated pRNA and control sequences were cloned by PCR into pJET1/2 plasmids. pRNA : 
mrDNA from -232 to -1; Control-pRNA: control sequences at 5’, mrDNA from -140 to -1 at 3’; 
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pRNA-Control: mrDNA from -232 to -140 at 5’, control sequences at 3’ ; pRNA-loop destroyed: 
mrDNA from -232 to -1 sequences where GGG (-115/-113) were replaced with AAA; pRNA-loop 
recovered: mrDNA from -232 to -1 sequences where CCC (-60/-58) were replaced with TTT. All 
plasmids were verified by sequencing. Synthetic RNAs were synthesized using T7 polymerase 
and as substrate Xba I linearized pJET1/2 vectors containing the indicated sequences. After 
treatment with DNase I, transcripts were double purified using TRIzol reagent (Invitrogen) 
according to the manufacture’s protocol.  
 
Chromatin Immunoprecipitation 
The chromatin immunoprecipitation (ChIP) protocol was previously described (Santoro, 2014). 
Briefly, formaldehyde 1% was added to cultured cells to cross-link proteins to DNA. Isolated 
nuclei were then lysed in 300µl lysis buffer (50 mM Tris-HCl [pH 8.1], 10 mM EDTA, 1% SDS) 
and sonicated using a Bioruptor ultrasonic cell disruptor to shear genomic DNA to an average 
fragment size of 200bp. 20 to 40 mg chromatin was diluted tenfold with IP buffer (16.7 mM Tris-
HCl [pH 8.1]), 167 mM NaCl, 1.2 mM EDTA, 0.01% SDS, 1.1% Triton X-100) and than 
immunoprecipitated overnight with ChIP-grade antibodies. After elution and reversion of 
crosslinks, the precipitated DNA was purified with phenol/chloroform, ethanol precipitated and 
than quantified by qPCR. rDNA, major and minor satellite sequences were amplified with 
previously reported primers (Martens et al., 2005) (Martens et al., 2005; Santoro et al., 2002). 
Primers are listed in Table S2.   
 
RNA Extraction, reverse transcription and quantitative PCR (RT-qPCR)  
RNA was purified with Trizol reagent (Life Technologies) . Residual contaminating genomic DNA 
was removed with Ambion® TURBO™ DNase according to manufacture’s instructions. RNA was 
primed with random hexamers and reverse-transcribed to first-strand cDNA. Reverse 
transcription of pRNA and IGS-rRNA was performed using DNA oligo -20/-1 Rev or random 
primers. qRT-PCR was performed with SensiMix SYBR Hi-ROX Mix (Bioline) on a Rotor-Gene Q 
(Qiagen). Amplification of samples without reverse transcriptase assured absence of DNA (data 
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not shown). The relative transcription levels were determined by normalizing to Rps12 mRNA 
levels. Statistical significance (P-values) of the difference in expression levels between genes 
was calculated using the two-sample paired t-test. Primer sequences used in qRT-PCR are listed 
in Table S2. 
 
CpG methylation 
rDNA CpG methylation was measured as previously described (Santoro, 2014; Santoro et al., 
2002)). 2 µg genomic DNA were digested with HpaII (NEB) in the presence of 5 ng of 
unmethylated pBluescript KS(+) plasmid. rDNA CpG methylation levels were measured by 
quantitative amplification using primer pairs (-165/-145 Forw and -20/-1 Rev) that flank the 
restriction sites CCGG at -142 of rDNA promoter or primers that amplify neighbouring sequences 
lacking HpaII sites (+1/+20 Forw and +111/+130 Rev). Values were obtained using  logarithmic 
dilutions of mouse genomic DNA as standard curve. CpG methylation levels were calculated as 
resistance to HpaII digestion by normalizing the amounts of rDNA amplified from -165 to -1 to the 
levels of amplicons from +1 to +130. To verify HpaII digestion efficiency, pBluescript KS(+) 
plasmid was analyzed by qPCR using one forward primer that is complementary to sequences 
upstream of the CCGG site of β-lactamase gene (at 2580) and two different reverse primers that 
map upstream and downstream the HpaII sites (see Table S2). All analyzed samples displayed 
96-98% digestion efficiency. 
 
GST-Pulldown 
5 µg of GST-TIP5235-741 were incubated with 15µl of GST beads (Glutathione Sepharose 4B, GE 
Healthcare) in AM100 buffer (100mM KCl, 20mM Tris-HCl pH 8.0, 5mM MgCl2, 0.2mM EDTA, 1X 
Protease Inhibitor (Roche)) for 12-16 hours at 4°C. After two washes with EMSA buffer containing 
3% Glycerol, bound GST-TIP5235-741 was incubated with 25 nmoles of the indicated RNAs for 1h 
at 4°C. After a double wash with AM200 buffer (200mM KCl, 20mM Tris-HCl pH 8.0, 5mM MgCl2, 
0.2mM EDTA, 1X cOmplete Protease Inhibitor Cocktail (Roche)), bound GST-TIP5/RNA 
complexes were incubated with 0.5 µg of His-TTF11-210 for 2h at 4°C. Samples were then washed 
3	  Results	  
	   126	    
three times with EBC buffer (250mM NaCl, 50mM Tris-HCl pH8.0, 0.5% NONIDET P-40, 5mM 
DTT, 1X cOmplete Protease Inhibitor Cocktail), run on a 12% SDS polyacrylamide gel and 
analyzed by Western blot with anti-GST and anti-RGS.HIS antibodies. 
 
AP staining 
Cells were fixed in 4% paraformaldehyde for 10min, washed with AP Buffer (100mM TrisCl pH 
9.5, 100mM NaCl, 50mM MgCl2) and then incubated for 30 min in AP Buffer containing NBT (37 
mg/ml) and 3.5µl BCIP (175 mg/ml). The staining was blocked with Tris-EDTA (Sigma) for 10min. 
 
Whole-Transcriptome Shotgun Sequencing (RNA-Seq) and Data Analyses  
Total RNA of ESCs+Control-RNA and ESCs+pRNA from two biological replicates were purified 
and analyzed by RNA seq. 100bp paired-end reads have been sequenced with illumina Hiseq. 
The reads were quality filtered and submitted to RSEM for expression quantitation (Li and Dewey, 
2011). Expression counts were further analyzed with the glm method in the edgeR package to 
compute the significance of differential expression (Robinson et al., 2010). 
 
Teratoma analysis  
Teratoma samples were fixed in 4% buffered paraformaldehyde and embedded in paraffin. For 
immunostainings, 5 µm thickness paraffin sections were deparaffinized and rehydrated and 
subsequently subjected to the antigen retrieval (Citrate buffer pH 6.0 for 10 minutes at 110°C in 
rapid microwave histoprocessor, Milestone, USA). The following primary antibodies were used: 
anti-bIII tubulin (Sigma), anti-GFAP (DAKO) and anti-SMA (Sigma). Nuclei were stained with 
DAPI and slides were mounted with Fluorescent Mounting Medium (DAKO) to avoid bleaching. 
Images were captured with a Leica DMI 6000B Microscope and using LAS AF (Leica Application 
Suite Advanced Fluorescence) software. Animal experiments were performed in accordance with 
Swiss law and have been approved by the veterinary authorities of Zurich.  
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Antibodies  
The following antibodies were used: anti-TIP5 (CS-090-100-Diagenode); anti-UBF (sc-13125), 
anti-GST (sc-459) and anti-PARP1 (sc-53643) from Santa Cruz; anti-H3K9me2 (17-648), anti-
H3K9me3 (17-625), and anti-H3K27me3 (17-622) and anti-SSEA-1 from Millipore; anti-H3 
(ab1791) from Abcam; anti-RGS.HIS (34610) from Qiagen. Anti-TTF1 antibody was produced 
with Genosphere.   
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List of primers 
 
mouse rDNA CpG methylation primers 
Name For/Rev Sequence 
rDNA promoter  -165/-145 For GACCAGTTGTTCCTTTGAGG 
rDNA promoter  -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
rDNA coding  +1/+20 For ACTGACACGCTGTCCTTTCC 
rDNA coding  +111/+130 Rev GACAGCTTCAGGCACCGCGA 
 
 
mouse cDNA primers 
Name For/Rev Sequence 
Tip5  For AAGATGTGTGGCTACAATGG  
Tip5  Rev TCTGCACCCATCAGCTCCG 
Nanog  For AAGCAGAAGATGCGGACTGT 
Nanog Rev ATCTGCTGGAGGCTGAGGTA 
Pax6 For GCACATGCAAACACACATGA 
Pax6 Rev ACTTGGACGGGAACTGACAC 
Nestin For AGGCTGAGAACTCTCGCTTGC  
Nestin Rev GGTGCTGGTCCTCTGGTATCC  
Blbp For AGGTGGCAAAGTGGTGATCC 
Blbp Rev TCCAACCGAACCACAGACTTAC  
Minor satellites For CATGGAAAATGATAAAAACC 
Minor satellites Rev CATCTAATATGTTCTACAGTGTGG 
Major satellites For GACGACTTGAAAAATGACGAAATC 
Major satellites Rev CATATTCCAGGTCCTTCAGTGTGC 
rDNA spacer -1994/1975 For GCAGACCGAGTTGCTGTAC 
rDNA spacer -1922/1905  Rev GGGTAGGACTTAAGCCTT 
rDNA enhancer -554/-535 For GAAGCCCTCTTGTCCCCGTC 
rDNA enhancer -466/-447 Rev GATCCAAAGCTCCAGCTGAC 
rDNA promoter -165/-145  For GACCAGTTGTTCCTTTGAGG 
rDNA promoter -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
45S pre-rRNA +550/570 For CTCTTGTTCTGTGTCTGCC 
45S pre-rRNA +745/765 Rev GCCCGCTGGCAGAACGAGAAG 
Line L1 ORF2  For TTTGGGACACAATGAAAGCA 
Line L1 ORF2 Rev CTGCCGTCTACTCCTCTTGG 
IAPgag  For AGCAGGTGAAGCCACTG 
IAPgag  Rev CTTGCCACACTTAGAGC 
Btg3 For AAGGTCAGGCCTACAGATGC  
Btg3 Rev GGTCACCTTATCCAGAGCCC  
Rdh10 For GAAATCCTGCCCCCGTGTAA  
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Rdh10 Rev TAGTGGTCCAGAAGTGTGCG  
Oct-4 For GGCGTTCGCTTTGGAAAGGTGTTC 
Oct-4 Rev CTCGAACCACATCCTTCTCT 
Rex1 For AGAAAGCAGGATCGCCTCAC 
Rex1 Rev AGGGAACTCGCTTCCAGAAC 
Rps12 For GAAGCTGCCAAAGCCTTAGA 
Rps12 Rev AACTGCAACCAACCACCTTC 
Gapdh For TGCACCACCAACTGCTTAGC 
Gapdh Rev GGCATGGACTGTGGTCATGAG 
 
 
 
ChIP primers 
Name For/Rev Sequence 
rDNA promoter  -165/-145 For GACCAGTTGTTCCTTTGAGG 
rDNA promoter  -21/-1 Rev ACCTATCTCCAGGTCCAATAG 
rDNA  coding +2251/70 For GCATCGGTGTGTCGGCATCG 
rDNA  coding +2346/65 Rev CTGAGCAGTCCCACCACACC 
rDNA  coding  +8124/145 For GCGACCTCAGATCAGACGTGG 
rDNA  coding  +8203/224 Rev CTGTTCACTCGCCGTTACTGAG 
Minor satellites For CATGGAAAATGATAAAAACC 
Minor satellites Rev CATCTAATATGTTCTACAGTGTGG 
Major satellites For GACGACTTGAAAAATGACGAAATC 
Major satellites Rev CATATTCCAGGTCCTTCAGTGTGC 
Evx1 TSS For TACACAGCATCTGGGGAGTG 
Evx1 TSS Rev GTGTGCTGGGTTAAGGGAGA 
Zfpm2 TSS For GGATGAAGTTCTCAGAGCTGGT  
Zfpm2 TSS Rev GCGCGAACTTTTACACCTACTT  
Dlx1 TSS For ATGTCTCCTTCTCCCATGTCC  
Dlx1 TSS Rev ACTGCACGGAACTGATGTAGG  
Gapdh promoter For GGTTGCTGTGTCACTACCGAAGAA 
Gapdh promoter Rev AAATGGAGAAGTGTGGGTCTCCCT 
Line L1 ORF2  For TTTGGGACACAATGAAAGCA 
Line L1 ORF2 Rev CTGCCGTCTACTCCTCTTGG 
IAPgag  For AGCAGGTGAAGCCACTG 
IAPgag  Rev CTTGCCACACTTAGAGC 
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Long noncoding RNA (lncRNA) are emerging as important regulators of
diverse biological functions. Although mechanistic models are starting to
emerge, it is also clear that the lncRNA field needs appropriate model sys-
tems in order to better elucidate the functions of lncRNA and their roles in
both physiological and pathological conditions. The field of lncRNA is new,
and the biochemical and genetic methods used to address function and mecha-
nisms of lncRNA have only recently been developed or adapted from tech-
niques used to investigate protein-coding genes. In this review, we discuss the
strengths and weaknesses of available techniques for the analysis of chro-
matin-associated lncRNA and emerging models for the recruitment to specific
genomic sites such as triple-helix, RNA–protein–DNA recognition and prox-
imity-guided search models.
Keywords: chromatin; epigenetics; genome organization; lncRNA; triple
helix
The G-value paradox refers to the observation that
the number of protein-coding genes in different
organisms does not correlate with their relative bio-
logical complexity [1]. The degree of organismal com-
plexity among species has been proposed to better
correlate with the proportion of each genome that is
transcribed into noncoding RNA(ncRNA) than with
the number of protein-coding genes, even when pro-
tein diversification by both alternative splicing and
post-translational modifications are taken into
account [2,3]. Recently, long noncoding RNA
(lncRNA), a class of ncRNA longer than 200 nucleo-
tides, have emerged as important regulators of diverse
biological functions. This distinction, although based
on technical aspects of RNA isolation methods, is a
good compromise to distinguish this class of ncRNA
from microRNA, piwi-interacting RNA, short inter-
fering RNA, small nucleolar RNA, etc.
Long noncoding RNA have been shown to be dif-
ferentially expressed across various stages of differenti-
ation and development, which may suggest important
regulatory roles in cell physiology and pathology [3,4].
Assigning functional categories to lncRNA is in itself
not an easy task. Indeed, a single 1 kb lncRNA can
fulfill a large number of functions, which perhaps can
be active only in a defined cell type and at different
Abbreviations
CLIP, UV crosslinking and immunoprecipitation; CHART, capture hybridization analysis of RNA targets; ChIRP, chromatin isolation by RNA
purification; HOTAIR, HOX antisense intergenic RNA; iCLIP, individual-nucleotide resolution CLIP; IGS-rRNA, intergenic spacer region of
rRNA genes; lncRNA, long noncoding RNA; LNA, locked nucleic acids; MRE ,MSL recognition element; MSL, male-specific-lethal dosage
compensation complex; ncRNA, noncoding RNA; NoRC, nucleolar remodeling complex; RNAi, RNA interference; PRC2, polycomb repressive
complex 2; PAR-CLIP, photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation; pRNA, promoter rRNA; RAP-MS,
RNA antisense purification with mass spectrometry; roX1, roX2: RNA on the X 1,2; TAD, topologically associating domain; TIP5, TTF1 inter-
acting protein 5, Baz2a; TTF1, transcription terminator factor 1; Xi, inactive X chromosome.
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development stages [5]. Accordingly, despite the large
amount of data published in the last few years, little is
known about the function of lncRNA.
In this review, we focus exclusively on lncRNA
enriched in the nucleus and, specifically, within the
chromatin-associated fraction. This class of lncRNA
has generally been implicated in the regulation of gene
expression and establishment of epigenetic and chro-
matin states [6]. Although functional and mechanistic
models are starting to emerge, at the core of lncRNA
studies is the need for appropriate experimental sys-
tems, which should allow a better understanding of the
functions of lncRNA, and their roles in both physio-
logical and pathological conditions. In this review, we
discuss the strengths and weaknesses of available tech-
niques for the analysis of chromatin-associated
lncRNA. Furthermore, we discuss the evidence that
lncRNA can interact with chromatin regulatory pro-
teins and emerging models by which lncRNA can
recruit regulatory factors to specific genomic sites such
as triple-helix, RNA–protein–DNA recognition and
proximity-guided search models.
Toolbox to analyze lncRNA function
and mechanisms in chromatin
The intimate connection between RNA and chromatin
was recognized over 40 years ago in a seeding article
proposing a regulatory role in gene expression of
RNA found exclusively present in the nucleus and
absent in the cytoplasmic fraction [7]. In the past
years, a plethora of lncRNA has been identified
through the application of high-throughput transcrip-
tome analysis, and this has led to an intensive search
for possible biological functions that these transcript
can eventually carry. Nevertheless, molecular effects
and functional significance have proven difficult to
determine [8].
The field of lncRNA is new, and the biochemical
and genetic methods used to address function and
mechanisms of lncRNA have only recently been devel-
oped or adapted from biochemical and genetic tech-
niques applied to study protein-coding genes. It is now
clear that, to dissect the modes of action of lncRNA
in the regulation of chromatin and gene expression,
methods employed for the analysis of protein-coding
genes must be used with caution and with appropriate
controls and additional experimental strategies and
methods have to be developed.
One of the most powerful techniques to study the
function of a gene in vivo is to disrupt its expression,
which can be done either using knockdown methods
or through alterations of the gene locus.
Downregulation of lncRNA expression through
knockdown methods is usually taken as first choice to
start to determine whether a given lncRNA has a func-
tion. The advantages of this method are the high effi-
ciency of gene knockdown and the ability to easily
target the gene of interest. Moreover, this method
allows evaluating the role of the transcript without
altering the gene locus. However, a considerable atten-
tion has to be given to the correct choice of methods
to knockdown. The assessment of lncRNA localization
has to be taken into consideration since depletion of
lncRNA by shRNA or siRNA may be heavily
impacted by their localization in the cell (Fig. 1).
While this method well adapts to downregulate expres-
sion of proteins, there is a certain concern in the use
of cytoplasmic RNAi machinery to knockdown
nuclear lncRNA [8,9]. Instead, locked nucleic acids
(LNA) or chemically modified RNA aptamers may
represent a suitable method to analyze the function of
nuclear lncRNA since they act by forming a DNA/
RNA hybrid with the nascent RNA transcript and
trigger RNase H-dependent degradation of the RNA
in the nucleus [10]. Nevertheless, knockdown of low-
expressed lncRNA as well as repetitive sequences
might result particularly inefficient. An alternative
method to destroy expression of lncRNA is through
modifications of its gene locus. In this regard, and as
recently discussed [8], it has to be considered that phe-
notypes observed from deletion of an entire genomic
locus cannot be unequivocally attributed either to the
loss of the lncRNA per se or to overlapping genomic
elements. Moreover, it cannot be excluded that the act
of transcription per se through a lncRNA locus can
also generate changes in chromatin structure. There-
fore, additional experimental evidences that can dis-
criminate the role of the genomic locus from that of
its RNA products are needed to confirm or reject the
hypothesis of functionality of a lncRNA as molecular
species. In this context, the recent advances in genome
editing using designer site-specific nucleases such as
CRISPR/Cas9 and TALENs could be very helpful to
allow an adequate dissection of lncRNA function and
mechanisms in vivo (Fig. 1). These tools can allow for
instance the fine regulation of lncRNA transcription
by targeting directly regulatory regions without affect-
ing the transcriptional regulation of the neighboring
genes and help to perform direct perturbation experi-
ments such as loss-of-function and gain-of-function.
The analysis of lncRNA function often relies on the
identification of interacting proteins or nucleic acids
by RNA–protein immunoprecipitation. However,
many assays generally used for protein analyses might
be prone to nonspecific binding in the context of
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RNA–protein interaction. Although methods using
‘native purification’ (purification of RNA–protein
complexes under physiological conditions) have been
often used in the past due to the advantage to preserve
the native complexes present in the cell, they have sev-
eral limitations, including the potential to identify
RNA–protein interactions that form only during the
preparation of cell extracts but do not occur in the cell
[11]. The use of new techniques designed to identify
direct lncRNA-interactors by cross-linking and subse-
quent purification upon denaturing conditions to
remove nonspecific interactions (iCLIP, PAR-CLIP) is
Method Outcome Limitations 
RNA interference 
Cytoplasmic 
lncRNA 
degradation 
Limited to cytoplasmic 
lncRNA 
Possible off-targets 
Antisense oligonucleotides  
(e.g. LNA gapmers) 
Cytoplasmic 
and nuclear 
lncRNA 
degradation 
Must be provided 
exogenously (no stable 
transgenic cell lines) 
Possible off-targets 
WT lncRNA locus 
Deletions 
Locus 
Promoter  
Lack of lncRNA 
expression 
Disruption of genomic 
context 
Alteration of regulatory 
sequences of 
neighboring genes 
Inversions
Promoter 
lncRNA 
Lack of lncRNA 
expression  
Non-functional 
lncRNA 
expression 
Disruption of genomic 
context 
Alteration of regulatory 
sequences of 
neighboring genes 
Insertions 
Termination sequence 
Reduction of 
lncRNA 
expression 
Transcriptional 
terminator efficiency 
depends on genomic 
context 
CRISP or TALE-TF regulation Reduction of 
lncRNA 
expression 
Possible regulation of 
neighboring genes 
siRNA 
Ago2 
LNA 
gapmer 
Rnase H 
Rep 
X
Fig. 1. Strategies to analyze lncRNA loss of function. Strategies to alter lncRNA expression. The lncRNA locus is indicated in orange,
neighboring protein-coding gene in blue, and the process of transcription by dotted lines. Knockdown of lncRNA can be achieved by RNA
interference (RNAi), a process activated by dsRNA species delivered to the cytoplasm of cells. Downregulation of nuclear lncRNA can be
achieved using antisense oligonucleotides (LNA or chemically modified RNA aptamers), which bind to nascent transcripts forming a DNA/
RNA hybrid, triggering RNase H-dependent degradation of the RNA in the nucleus. Examples how to alter lncRNA gene locus are also
depicted. Another possibility is genome engineering using dCas9 and TALENs fused to a repressor (Rep), which can establish transcriptional
silencing of lncRNA genes. Outcome and limitations of the method chosen to alter lncRNA expression are described.
3FEBS Letters (2016) ª 2016 Federation of European Biochemical Societies
S. Leone and R. Santoro Strategies for the analysis of long noncoding RNAs
3	  Results	  
	   134	    
clearly necessary to demonstrate the interaction of a
protein with a lncRNA in cells [12–14] (Fig. 2A).
Along this line, analyses based on purification by
antisense biotinylated probes have been recently devel-
oped to study RNA–protein interactions also in the
context of chromatin (RAP-MS, ChIRP, CHART)
A 
Identification of proteins interacting with lncRNA
(crosslinking and denaturating conditions) 
iCLIP
RT 
UV 
(254 nm) 
PAR-CLIP 
U U 
C C 
RT 
4-thiouridine (4SU) 
UV 
(365 nm) 
Identification of lncRNAs interacting with proteins 
(crosslinking and denaturating conditions)
Biochemical analyses to identify  
RNA sequences implicated in protein interaction 
Biochemical analyses to identify  
protein domains interacting with lncRNA
RNA pulldown Protein IP 
Functional analyses of lncRNA-protein association  
+
Mutation/deletion of lncRNA sequences  
implicated in the association with proteins  
Mutation/deletion of  
lncRNA-interacting protein domains 
Tagged RNA  
pull-down 
RNA antisense 
purification 
UV UV 
B 
Confirmation or rejection of triplex functionality  
in the recruitment of proteins to genomic sites 
1. Prediction of triplex (in silico analysis) 
2. Validation of triplex (in vitro assays, i.e. EMSA) 
3. Validation of RNA binding to genomic sites  
    (DNA pull-down with labeled RNA oligos) 
Functional analyses of protein recruitment  
to genomic sites via triplex 
Workflow to identify triplex sequences 
1. Identification of lncRNA sequences critical for triplex 
formation (Biochemical analysis) 
2. Assessment of genomic occupancy of chromatin 
regulators in the presence of lncRNA mutants with 
impaired ability to form triplex (ChIP) 
? 
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[15–17]. Finally, the identification of a lncRNA-inter-
actor should be accompanied by biochemical assays to
measure the affinity of a defined protein for a lncRNA
and determine whether the association depends on the
RNA sequence or its structure. Indeed, the lncRNA
field will benefit on the analysis of lncRNA mutants
with impaired ability to associate with a defined chro-
matin regulator or target genes to verify the function-
ality of lncRNA–protein interaction and/or their
association with genomic sites (Fig. 2).
Thus, it is clear that to fully resolve the true in vivo
functions of lncRNA, it is necessary to take into
account the strengths and weaknesses of the available
techniques.
lncRNA as scaffold for protein
complexes
A major recurrent theme in lncRNA biology is the
ability to act as scaffold for the assembly of chromatin
regulator complexes, which in turn might serve a
guider function for the recruitment at specific genomic
loci. A RNA scaffold may have a selectable advantage
over protein for many applications. A typical RNA
‘arm’ of 50 base pairs (with bulges and internal loops)
extends for 13 nm, whereas a 50-amino-acid alpha
helix extends for 7.5 nm [5]. Thus, lncRNA may easily
bind multiple proteins and act as scaffold for the
assembly of chromatin regulatory complexes and other
protein complexes.
Initial evidence for the role of lncRNA in gene regu-
lation came from studies of mammalian X-chromo-
some inactivation, a process regulated by the Xist
lncRNA, which is transcribed exclusively from the
inactive X-chromosome (Xi) [18,19]. Genetic deletion
of Xist prevents X chromosome inactivation [20], and
transgenic Xist RNA caused long-range transcriptional
repression in cis [21]. The role of Xist in silencing
depends on a conserved repeat sequence, the A-repeat
domain, whose deletion prevents transcriptional silenc-
ing without affecting its association with chromatin
and spreading over the X-chromosome [22]. A direct
association of polycomb repressive complex 2 (PRC2)
with lncRNA has been proposed as a mechanism for
recruitment and establishment of H3 lysine 27 methy-
lation (H3K27me3) at Xi [23]. Indeed, the timing of
PRC2 recruitment on X chromosome tightly coincides
with the induction of Xist during development and is
strictly dependent on continuous Xist RNA transcrip-
tion [24–26]. Initial analyses obtained by RIP and
pull-down assays with biotinylated RNA have sup-
ported a model where EZH2, a component of PRC2,
directly interacts with Xist [23,27]. However, recent
results have started to challenge the current model
based on Xist-PRC2 association due to the promiscu-
ous binding of PRC2 to RNA substrates, inhibition of
EHZ2 activity by RNA and spatial separation of Xist
RNA and polycomb proteins as revealed by super-
resolution microscopy [28–30]. At the basis of this
debate is clearly the weakness of ‘native purification’
methods, which have been initially used to detect the
Xist-PRC2 interaction. Recently, a novel method
(RAP-MS) based on long biotinylated antisense
probes, which form very stable RNA–DNA hybrids,
has been used to purify lncRNA complexes in denatur-
ing and reducing conditions [15]. Ten proteins were
identified that specifically associate with Xist, three of
these proteins (SHARP, SAF-A and LBR) are
required for Xist-mediated transcriptional silencing.
SHARP, which interacts with the SMRT corepressor
that activates HDAC3, is required for Xist-mediated
recruitment of PRC2 across the X chromosome.
Fig. 2. Strategies to analyze the function of lncRNA association with proteins and DNA. (A) Methods to identify lncRNA–protein interactions
are described. RNA-based approaches (RNA pull-downs) allow to identify proteins interacting with a specific RNA. In vivo cross-linking (red
Xs) and purification under denaturing conditions ensure the isolation of proteins interacting with lncRNA in the cell. lncRNA–protein
complexes can be efficiently isolated using ectopically expressed RNA tagged with a specific RNA sequence (purple hairpin) and
subsequent purification through a RNA affinity matrix. Another efficient method involves the hybridization of long antisense biotinylated
probes and purification by streptavidin resins. Protein-based approaches (protein IP) rely on antibodies able to immunoprecipitate (IP) the
RNA-interacting protein of interest. Also in this case cross-linking strategies are recommended to catch-specific interactions. Techniques like
iCLIP or PAR-CLIP allow to identify not only RNA-interacting proteins but also to map RNA sequences in contact with proteins. To
determine the functionality of lncRNA-protein association, we suggest to perform biochemical analyses that allow identifying RNA
sequences or protein domains involved in lncRNA–protein interactions. The results obtained by this analysis will instruct in the engineering
of mutations or deletion at lncRNAs or proteins that serve to analyze the role of lncRNA–protein association in the cell. (B) Workflow to
determine the function of triplex in the recruitment of protein complexes to specific genomic sites. Upon the identification of RNA
sequences with ability to form triplex, biochemical analyses should be performed to determine which lncRNA sequences are critical for
triplex formation. The engineering of lncRNA mutants with impaired ability to form triplex will determine whether the association of
chromatin regulators with defined genomic sites depends on lncRNA-triplex. iCLIP individual-nucleotide resolution cross-linking and
immunoprecipitation; PAR-CLIP photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation.
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Remarkably, this and another study using similar
stringent conditions to identify proteins directly inter-
acting with Xist failed to detect PRC2 [15,31].
HOX antisense intergenic RNA (HOTAIR), a
lncRNA residing in the HOXC locus, is another
important example of the intimate link between
lncRNA and gene silencing [32]. Depletion of
HOTAIR by siRNA led to transcriptional activation
of the HOXD locus on chromosome 2 spanning over
40 kb, suggesting that HOTAIR is required to main-
tain a transcriptionally silent chromosomal domain
in trans. Accordingly, enforced expression of
HOTAIR in epithelial cancer cells induced genome-
wide retargeting of PRC2, leading to altered
H3K27me3 and gene expression [33]. HOTAIR has
been proposed to serve as modular scaffold of his-
tone modification complexes, including PRC2, and
thereby specifies the pattern of histone modifications
on target genes [33].
Another example representing the regulation of
chromatin state by lncRNA is pRNA, a 250–300 nt
lncRNA that is the product of processing of a 2-kb-
long transcript derived from the intergenic spacer
region of rRNA genes (IGS-rRNA) [34,35]. The for-
mation of heterochromatin at rRNA genes, which are
located in the nucleolus, depends on pRNA: LNA-
mediated depletion of pRNA prevents rRNA gene
silencing [36], whereas ectopic expression of mature
pRNA induces heterochromation formation and
silencing [34]. pRNA associates with TIP5 (Baz2a), a
component of the nucleolar remodeling complex
NoRC, that previous studies have implicated in epige-
netic silencing of rRNA genes [37]. A stem loop struc-
ture within pRNA is required for the association with
TIP5: point mutations destroying pRNA stem loop
impair the association of TIP5 with pRNA and the
recruitment of TIP5 to rRNA genes, whereas a com-
pensatory mutation that restores loop structure is suffi-
cient to guide TIP5 to rRNA genes [34,38]. pRNA
serves as modular scaffold to promote the association
of TIP5 with other factors such as poly (ADP-Ribose)
Polymerase 1 (PARP1) and transcription terminator
factor 1 (TTF1) [34,39]. Importantly, although the
unprocessed transcript IGS-rRNA abolishes the associ-
ation of TIP5 with TTF1, mature pRNA promotes
this interaction that serves to dock the complex at the
promoter of rRNA genes and to establish heterochro-
matin during embryonic stem cell differentiation [34].
These results suggest that the same lncRNA can pre-
vent or promote protein complex assembly and its pro-
cessing controls the switch between these functions.
Thus, lncRNA processing may represent an additional
level of lncRNA regulation by modulating distinct
features of the same lncRNA such as the assembly of
different protein complexes.
Two ncRNA, roX1 (3.7 kb) and roX2 (0.5 kb), are
essential for gene dosage compensation in Drosophila
[40]. These RNA associate with the ribonucleoprotein
male-specific lethal dosage compensation complex
(MSL), which comprises at least five proteins, MSL1,
MSL2, MSL3, MOF (males-absent-on-the first), and
MLE (maleless). The MSL complex assembles exclu-
sively in male flies, binds to hundreds of sites on the
male X chromosome, and increases transcription from
X-linked genes. Incorporation of roX1/2 into the MSL
complex is mediated by the RNA helicase MLE and
involves transient RNA-mediated interactions with the
core MSL complex. Biochemical and genetic evidences
have shown that roX1 and roX2 provide a scaffold for
arrangement of the MSL proteins and is prerequisite
for MLE localization to the male X chromosome
[41,42].
lncRNA recruitment to genomic DNA
Several mechanisms have been proposed for lncRNA-
mediated recruitment of chromatin regulators at
defined regions of the genome. lncRNA (a) can inter-
act with DNA through direct nucleic acid hybridiza-
tion, (b) can physically interact with DNA-binding
proteins, or (c) can exploit the 3D conformation of the
nucleus to search for targets. These mechanisms do
not exclude each other and may act together to target
lncRNA to specific genomic sites.
The triple-helix formation involves a double-
stranded nucleic acid such as duplex DNA and a sin-
gle-stranded nucleic acid such as RNA [43]. Triplex-
helices are formed by sequence-specific binding rules:
the single-stranded nucleic acid binds in the major
groove of the targeted duplex through sequence-
specific recognition of a polypurine!polypyrimidine
sequence (Hoogsteen or reverse Hoogsteen base-pair-
ing) [44]. Initial immunofluorescence studies using tri-
ple-helix-specific monoclonal antibodies have
suggested the existence of triplex structures in the
nucleus of insects, nematodes, and mammals [45]. Tri-
ple helix formation has been often evoked as a poten-
tial mechanism of lncRNA-mediated recruitment of
chromatin regulators to specific genomic sites. How-
ever, evidences for this mechanism are generally cir-
cumstantial and still lack a direct and robust
experimental proof. Indeed, the solely demonstration
of the ability of a given RNA to form triple-helix
in vitro cannot prove that this is the mechanism by
which protein complexes are recruited to specific geno-
mic sequences. Functionality of lncRNA triple-helix
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should be carefully proven and confirmation or rejec-
tion of hypothesis should be exploited through pertur-
bation experiments such as mutations in lncRNA
sequences implicated in triplex formation to validate
the binding to genomic sites and the recruitment of
chromatin regulators (Fig. 2B).
Fendrr is a lncRNA proposed to act via dsDNA–
RNA triplex formation at target regulatory elements
and to increase PRC2 occupancy at these sites [46].
This model was proposed based on the presence of a
purine-pyrimidine 40-nucleotide stretch motif that is
favorable for triplex formation. The binding of a syn-
thetic RNA oligonucleotide to double-stranded Foxf1
and Pitx2 promoter fragments in an in vitro-binding
assay in the presence of RNase H, which specifically
cleaves RNA–DNA hybrids, led to propose that Fen-
drr anchors PRC2 at its target promoters in cells
through triplex formation [46]. However, additional
investigations are required to confirm this triple-helix
model, in particular, whether recruitment of PRC2 to
target genes in cells requires Fendrr sequences impli-
cated in the formation of triple-helix in vitro.
The lncRNA PARTICLE was shown to afford both
a cytosolic scaffold for the tumor suppressor methion-
ine adenosyltransferase (MAT2A), and a nuclear
genetic platform for transcriptional repression [47].
PARTICLE represses MAT2A and it was proposed to
recruit the transcription-repressive complex proteins
G9a and SUZ12 (subunit of PRC2) through triplex
formation. This model was based on an in vitro-bind-
ing assay using surface plasmon resonance technology
that determined the ability of PARTICLE to form tri-
ple-helix with a synthetic dsDNA MATA2 sequence.
However, whether transcriptional silencing and recruit-
ment of repressors to MATA2 depends on PARTICLE
sequences implicated in triple-helix was not further
investigated.
The lncRNA MEG3 regulates the TGF-b pathway
genes and it was proposed to guide chromatin repres-
sor complexes (including PRC2) through formation of
RNA–DNA triplex structures [48]. EMSA assays and
circular dichroism spectroscopy analyses revealed that
several MEG3 sequences have the ability to form tri-
ple-helix with MEG3-bound genomic sites enriched in
GA sequences. Interestingly, MEG3 sequences able to
form triplex do not require a perfect identity with the
target DNA sequences. The association of one of these
RNA with MEG3-bound genomic sites was further
determined through pulldown assays in the presence of
RNase H using biotin-labeled oligos, which were
transfected or incubated with nuclei isolated from BT-
549 cells. However, as in the studies described above,
further investigations are required to determine
whether the recruitment of repressor complexes is
mediated by triplex formation. An interesting part of
this work was the analysis of triplex using an anti-tri-
plex dA.2rU antibody, which was raised against the
triplex derived from homopolymeric nucleic acids
(poly(rU).poly(dA).poly(rU)). Immunostaining with
this antibody revealed a signal that was higher in the
nuclear compartment than in the cytoplasm and
resistant to RNase H treatment. Dot-blot analysis
showed that this antibody recognized Poly (rU):Poly
(dA)-Poly (dT) and [(dCTT)]7: [(dGAA)]7 – [(dCTT)]7,
indicating that antibody reactivity is not restricted to
three-stranded configurations assembled with
homopolymeric nucleic acids but also can recognize
triplex DNA made with poly-purine/poly-pyrimidine
sequences. Interestingly, this antibody also showed a
strong affinity for Poly (rU)-Poly (dA). Certainly, an
in-deep analysis of the specificity of this antibody
using a larger panel of RNA:dsDNA sequences would
have been more informative. Moreover, there is a cer-
tain lack of information concerning the origin of this
antibody since its description was accompanied by a
citation of a work published 40 years ago [49] and
there is no indication whether this antibody was pur-
chased from a commercial source, or it was raised in-
house. Clearly, if this antibody turns out to be highly
specific for triple-helix as described by Mondal et al.
[48], it will be an important tool for the analysis of
lncRNA functionality.
Another example of triplex-mediated recruitment of
chromatin regulators is pRNA. A previous work has
shown that T0 sequences located at the 50- terminus of
pRNA can form triple helix at the promoter of rRNA
genes [50]. While RNase H, EMSA, and psoralen-
based assays demonstrate that the binding of pRNA
to the promoter of rRNA genes is neither via forma-
tion of RNA–DNA hybrids nor due to mediating pro-
teins [50], the sequence implicated in this putative
triple helix greatly deviates from the common triplex
model (G, A; purine motif) and, hence, further investi-
gations into the proposed triplex formation are
required [44]. The same work reported that the forma-
tion of triple-helix is required for the recruitment of
the de novo DNA methyltransferase DNMT3b to
rRNA genes [50]. Remarkably, the pRNA triple-helix
model is often reported in reviews as a mechanism for
the recruitment of NoRC complex to rRNA genes
[51–54]. However, there is no experimental evidence
supporting this mechanism. First, the original report
of pRNA triple-helix did not analyze whether NoRC
is recruited to rRNA genes via pRNA triplex. [50].
Second, a recent work showed that recruitment of
NoRC to rRNA genes does not require pRNA
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sequences implicated in triple-helix: deletion or muta-
tion of T0 sequences in pRNA efficiently guide NoRC
to rRNA genes and initiate de novo methylation and
formation of heterochromatin, a result that is also
consistent with previous studies showing the associa-
tion of DNMT3b with TIP5, a subunit of NoRC
[34,37]. Recent results have proposed that pRNA-
mediated targeting of TIP5 occurs through
DNA–protein recognition rules [34]. TTF1, a nucleolar
protein that binds to terminator (T) elements, includ-
ing the T0 sequences at rRNA gene promoter, was
previously identified as an interactor of TIP5 (TTF1
interacting protein 5) and required for the association
of TIP5 with rRNA gene promoter [55–57]. Biochemi-
cal analyses revealed that the association of TIP5 with
TTF1 tightly depends on the stem-loop structure of
pRNA, suggesting that the interaction of lncRNA with
sequence specific DNA-binding proteins is a driver for
recruitment of chromatin regulators to defined geno-
mic sites [34]. Recruitment mediated by the RNA–pro-
tein–DNA module has also been proposed for YY1, a
‘bivalent’ protein, capable of binding both Xist RNA
and DNA, an association critical to tether Xist RNA
to the future Xi and to nucleate the coating of Xist
RNA along the Xi [58]. A similar model can be also
applied to the recruitment of Drosophila MSL com-
plex, which includes rox1 and rox2, to MSL recogni-
tion elements (MREs) that is dependent on the
interaction with the CLAMP, a DNA-binding protein
that recognizes MREs [59]. A RNA–protein–DNA
module has also been proposed to explain the localiza-
tion of Xist and Firre: both lncRNA are thought to
interact with the hnRNPU/SAF-A DNA-binding pro-
tein, which is required for their localization to DNA
[11,60,61]. In the light of these results, we think that
the function of triplex for the recruitment of chro-
matin regulators to specific genomic sites remains still
circumstantial. The field of lncRNA would benefit on
the analysis of lncRNA mutants with impaired ability
for triplex formation to verify the requirement of tri-
plex structures for the recruitment of protein com-
plexes to specific genomic loci.
The 3D conformation of the nucleus has been recently
proposed as a potentially general mechanism by which
lncRNA search for genomic sites [11]. Several lncRNA
have recently been shown to use spatial proximity to
identify target sites. Chromosomal looping brings HOT-
TIP RNA in close proximity to the 50 HOXA genes and
HOTTIP yields a broad domain of H3K4me3 and tran-
scription activation at 50 HOXA locus through the asso-
ciation with WDR5-MLL complexes [62]. Recently, it
was shown that Xist coats the X chromosome by search-
ing in three dimensions: first it localizes to genomic sites
that are in close spatial proximity to its own transcrip-
tion locus and then spreads to newly accessible locations
[63,64]. Similarly, in Drosophila, high affinity sites, land-
ing platforms of MSL complex, have been found to be
enriched around topologically associating domain
(TAD) boundaries on the X chromosome and harbor
more long-range contacts in a sex-independent manner,
which might provide an advantageous location for the
MSL complex to spread to spatially close regions and
induce dosage compensation [65].
It is important also to take into consideration the pos-
sibility that the proximity-guided search and lncRNA
localization can occur across different chromosomes,
which are in close spatial proximity in the nucleus. This
mode of action might be used by HOTAIR, which is
transcribed from the HoxC locus but regulates the
expression of genes in the HoxD locus, present on a dif-
ferent chromosome [32]. Another example is provided by
the nucleolus, which forms a specific domain where
rRNA gene loci, which are spread across multiple chro-
mosomes, coalesce into a spatially organized compart-
ment. The spatial close proximity of rRNA genes might
facilitate pRNA, which is transcribed from active rRNA
genes during early S-phase, to guide in trans the NoRC
complex to establish heterochromatin of silent rRNA
genes after their replication in mid-late S phase [35,66].
Finally, Firre localizes across five distinct transchromoso-
mal loci, which reside in spatial proximity to the Firre
genomic locus on the X chromosome [60]. Both genetic
deletion of the Firre locus and knockdown of Firre-inter-
acting protein hnRNPU resulted in loss of colocalization
of these transchromosomal interacting loci, suggesting a
model in which lncRNA can interface with and modulate
nuclear architecture across chromosomes [60].
lncRNA are generally less abundant than mRNA.
Therefore, the 3D genome organization might facilitate
the recruitment of lncRNA to target genes if these are
located closed to lncRNA transcription locus where
transcript concentration is higher [67]. However, prox-
imity alone is not sufficient to explain interactions,
otherwise any genomic region in close proximity of
lncRNA genomic loci will be regulated. Indeed, the
Firre lncRNA interacts with specific DNA sites that
are in spatial proximity to the Firre locus, but does
not interact with all sites in spatial proximity [60]. The
combination of other mechanisms, such as DNA-bind-
ing interactions, must therefore contribute for proper
localization of the lncRNA to specific genomic loci.
Future studies will be required to dissect the interplay
of lncRNA and the dynamic nuclear organization at
the molecular level. The systematic perturbation of
lncRNA, including deletion/mutations of protein and/
or DNA-binding sequences, will help to determine
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their roles in the establishment of chromatin architec-
ture and epigenetic states.
Conclusions and perspectives
Multiple lines of evidences increasingly link mutations
and dysregulations of lncRNA to diverse human dis-
eases, including cancer [68]. The recent application of
next-generation sequencing to a growing number of
cancer transcriptomes has indeed revealed thousands
of lncRNA whose aberrant expression is associated
with different cancer types [4]. LncRNA expression
has been correlated with distinct gene sets that influ-
ence cell cycle regulation, survival, immune response,
migration, genomic stability, or pluripotency, which
determine the transformed phenotype of cancer cells
(we refer readers to several recent reviews that cover
the classification of cancer-related lncRNA in greater
details [4,69]). The tissue-specific expression of
lncRNA and the correlation with disease phenotype
might hold the promise of tailored therapeutic applica-
tions that fine-tune the regulatory networks of cancer
cells in a highly cancer type-specific manner [4]. How-
ever, an absolute requirement is a careful characteriza-
tion of individual lncRNA in terms of functions and
mechanisms, both in physiological and pathological
conditions. Deciphering the mechanistic diversity of
the many lncRNA, their influence on nuclear architec-
ture and their cellular roles will be important to under-
stand disease and facilitate the establishment of
diagnostic and therapeutic strategies.
In this review we have highlighted how the analysis of
lncRNA to assign the exact mode of action and func-
tional roles is more complex and difficult than that of
protein-coding genes. The study of lncRNA is still in its
infancy and to resolve the true in vivo functions of
lncRNA, the strengths and weaknesses of available tech-
niques have to be carefully weighed. The field of
lncRNA biology would benefit greatly from the develop-
ment of additional experimental strategies and dedicated
technologies that clearly dissect the pathways mediated
by lncRNA as molecular species and the molecular
mechanisms of lncRNA function. We indeed strongly
agree with the conclusion of Schmitz et al. [69] that ‘It is
now up to the responsibility of journal editors and
reviewers to enforce the high standards of investigation
that this new and exciting field of research deserves’.
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4. Discussion 
 In the present work we have shown that the chromatin state of rRNA genes, which 
are the genetic component of the nucleolus, has a crucial function in the process of 
ESC differentiation and is required to allow ESCs to exit pluripotency. During 
differentiation, the genome of ESCs undergoes massive remodeling, changing from 
an open euchromatic state to a more compact heterochromatic structure. This change 
in chromatin structure marks the exit from the pluripotent state and is linked to the 
acquisition of transcriptional programs that lead to specific lineage commitment and 
cell differentiation (Gaspar-Maia et al., 2011).  
 Together with the rest of the genome also part of rRNA genes experience the 
change in chromatin conformation and acquire heterochromatic features during 
differentiation (Savic et al., 2014). We have previously shown that formation of 
heterochromatin at the rDNA actually induces other parts of the genome to acquire a 
more compact structure (Savic et al., 2014). In particular, addition of mature lncRNA 
pRNA in ESCs was sufficient to specifically induce heterochromatin at rRNA genes 
as a consequence of TIP5 recruitment and this additionally resulted in the appearance 
of highly condensed regions at the periphery of the nucleolus. These results suggested 
that changes in the chromatin state of rRNA genes could affect the chromatin state of 
other regions of the genome, implying a broader influence of nucleolar chromatin on 
genome architecture. In fact, upon establishment of rDNA heterochromatin in ESCs, 
also other portions of the genome, and in particular repetitive sequences like major 
and minor satellites, experienced transcriptional repression acquiring heterochromatic 
marks like H3K9me2. The crosstalk between rDNA and pericentric heterochromatin 
is in line with previous results from our and other laboratories showing that TIP5 
depletion in NIH3T3 cells caused not only the reduction of rRNA gene silencing but 
resulted also in the loss of perinucleolar heterochromatin and reduction of silent 
histone marks at pericentric heterochromatin (Guetg et al., 2010; Postepska-Igielska 
et al., 2013). Furthermore the link between rRNA genes and chromatin architecture of 
the rest of the genome is also supported by previous results in Drosophila showing 
that deletion of rRNA repeats reduced heterochromatin content elsewhere in the 
genome and the extent of the rDNA deletion correlates with the loss of silencing in 
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much the same manner as mutations in known protein heterochromatin components 
(Paredes and Maggert, 2009). 
 Although the mechanisms through which rDNA heterochromatin formation guides 
spreading of genome compaction is not yet clear, these results highlight a crucial role 
for the nucleolar compartment in shaping genome architecture.  
 We have previously shown that in ESCs pRNA is absent due to impairment of 
processing of its precursor IGS-rRNA. Induction of ESCs differentiation resulted in 
activation of IGS-rRNA processing and accumulation of mature pRNA, leading to 
recruitment of TIP5 to rDNA and formation of heterochromatin (Savic et al., 2014). 
 In the present work we aimed to elucidate the mechanism of pRNA maturation in 
order to better understand the importance of rDNA heterochromatin formation in the 
context of ESC differentiation. Our results identified the RNA helicase DHX9 as 
essential for IGS-rRNA processing into pRNA in differentiated cells. In differentiated 
cells, DHX9 is localized within nucleoli and associates with TIP5. Remarkably, 
depletion of DHX9 in differentiated cells resulted in TIP5 displacement from 
nucleoli, decrease of TIP5 binding to rDNA promoters and reduction of 
heterochromatic marks at rRNA genes, suggesting an essential role for DHX9 in the 
recruitment of TIP5 to rRNA genes and establishment of rDNA heterochromatin.  
 Depletion of DHX9 in ESCs impaired the ability to differentiate without affecting 
their self-renewal capacity. In particular, induction of differentiation of DHX9 
depleted ESCs resulted in massive cells death implicating an essential role for DHX9 
in the first phases of differentiation. This was in line with previous data showing the 
importance of DHX9 in early development. Indeed DHX9 KO mouse embryos 
showed impaired gastrulation and did not develop further than E7.5 (Lee et al., 1998). 
Strikingly we found that introduction of mature pRNA in DHX9 depleted ESCs was 
sufficient to allow differentiation. This demonstrates that DHX9-mediated maturation 
of pRNA is a key event that allows exit from pluripotency. Additionally our 
observation of the switch in DHX9 localization from a spread nuclear distribution to a 
confined nucleolar positioning during differentiation and its increased binding to 
rDNA well correlate with the activation of IGS-rRNA processing, which takes place 
in nucleoli only upon ESCs differentiation. Nevertheless, it is still unclear what 
determines the change of DHX9 localization during differentiation and it will be the 
aim of future studies. 
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 The results described here depict a model in which DHX9 mediated IGS-rRNA 
processing represents the key step in the formation of rDNA heterochromatin and, in 
a larger scale, in the initiation of genome architecture remodeling that results from it. 
Although the set up of the described experiments does not allow us to directly 
distinguish whether impairment of ESC differentiation is due to up regulation of 
rRNA transcription or the lack of heterochromatin per se, we favor the latter case. 
Indeed, it is unlikely that cells with increased rRNA levels undergo cell death since 
ribosome biogenesis is well known to be positively correlated with cell viability and 
proliferation (Moss and Stefanovsky, 2002). Thus, our results suggest that the 
function of rRNA genes might not only be limited to the synthesis of rRNA. This 
model is in agreement with early studies showing that the fraction of silent rRNA 
genes present in each differentiated cell does not change its transcriptional state even 
under conditions of high metabolic activities, suggesting a role that is not related to 
the production of ribosomes (Conconi et al., 1989). This is also in line with our 
previous finding showing that the impairment of rDNA heterochromatin formation 
due to depletion of TIP5 in ESCs resulted in impairment of differentiation (Savic et 
al., 2014). Furthermore it was previously shown that reduction of rDNA 
heterochromatin in differentiated cells is linked with genomic instability in yeast, flies 
and mammals (Guetg et al., 2010; Peng and Karpen, 2007; Straight et al., 1999), 
suggesting that acquisition of rDNA heterochromatin during differentiation is 
essential to guarantee genome stability. Thus, our data favor a model in which the 
nucleolus is not only the cellular compartment where ribosomes are produced but it is 
also a central component of nuclear architecture that coordinates the balance between 
euchromatin and heterochromatin according to developmental stages. This is 
supported by other works showing that, during differentiation, repressed and 
heterochromatic portions of the genome contact either the nuclear lamina or the 
nucleoli (Peric-Hupkes et al., 2010). 
 Despite being necessary for IGS-rRNA processing, DHX9 is known to have only a 
catalytic domain with NTP hydrolytic activity enclosed between the two Rec-like 
domains and no nuclease activity has been reported to date (Bartova et al., 2008; Lee 
and Pelletier, 2016). Interestingly, our analysis of DHX9 interactome revealed a high 
enrichment for components of the spliceosome complex (i.e. U2 Small Nuclear RNA 
Auxiliary Factor 2 U2AF2, Splicing factor 3B subunit 3 SF3B3, pre-mRNA 
Processing Factor 3 and 8, PRPF3 and 8) suggesting that the splicing pathway might 
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be implicated in the processing of IGS-rRNA into pRNA. In fact the spliceosome was 
also the major hit obtained through cellular component and pathway analysis of IGS-
rRNA pulled-down proteins from ESCs, differentiated ESCs and NIH3T3 nuclear 
extracts. The involvement of spliceosome in IGS-rRNA processing is also suggested 
by the absence of any endo- or exonucleolytic enzyme in the analysis of IGS-rRNA 
interacting proteins. Moreover, Xrn2 (5'-3' Exoribonuclease 2) was the unique 
ribonuclease we identified as DHX9-associated proteins in three out of four 
experiments. However, a careful analysis revealed that Xrn2 is not implicated in IGS-
rRNA processing (data not shown). Thus our favorite hypothesis is that DHX9 
recruits or is part of a specific subtype of spliceosome complex involved in IGS-
rRNA processing and that this complex can assembly on IGS-rRNA only at the onset 
of ESC differentiation. The specificity of this complex is also supported by the 
absence, among the DHX9 and IGS-rRNA interacting factors, of the canonical 
DExH/RHA helicases of the spliceosome complex normally involved in pre-mRNA 
splicing (i.e. PRPF 2, 16, 22 and 43 (Jarmoskaite and Russell, 2014)). 
 The reason why DHX9 is absent in nucleoli and rRNA genes of ESCs still remains 
unknown and understanding this process will be aim of our future studies. It cannot be 
excluded at this point that posttranslational modifications of DHX9 or 
posttranscriptional modifications of IGS-rRNA could be essential to activate the 
processing. Very little is known about DHX9 PTMs. In particular two works have 
shown that DHX9 can be phosphorylated. In one case the N-terminal part of DHX9, 
corresponding to the dsRBD domain, can be phosphorylated by protein kinase R 
(PKR also known as EIF2AK2) as a response of the innate immune system to human 
immunodeficiency virus (HIV) infection. This modification results in the reduction of 
viral RNA binding by DHX9 and inhibits the capacity of DHX9 to enhance 
expression of genetic elements encoded by HIV (Sadler et al., 2009). DHX9 can also 
be phosphorylated by the DNA-dependent protein kinase (DNA-PK), a complex 
formed by the DNA binding protein Ku and the DNA-PK catalytic subunit (also 
known as XRCC7) that is involved in the non-homologous end-joining (NHEJ) 
pathway of DNA repair. Interestingly DHX9 phosphorylation by DNA-PK requires 
RNA and results in a different distribution of DHX9 in the nucleus (Zhang et al., 
2004). Though this study was conducted on cervical cancer HeLa cells in which 
DHX9 is singularly excluded from nucleoli and DNA-PK activity on DHX9 was 
shown only in vitro, it would be worth to investigate the role of DHX9 
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phosphorylation as a possible mechanism at the basis of DHX9 differential 
localization in ESCs and differentiated cells. Furthermore a possible effect of DHX9 
modification on its RNA binding ability, as suggested by the study on PKR, could 
also reinforce the possible regulation of the timing of IGS-rRNA processing due to 
the different DHX9 localization.  
 One of the most common RNA posttranscriptional modifications is the methylation 
of the nitrogen at the position 6 of the adenine purine ring (m6A), catalyzed by the 
enzymes methyltransferase-like 3 and 14 (MTTL3 and 14). Knock out of MTTL3 is 
embryonic lethal because implantation of the embryo is impaired. However ESCs can 
be derived from early blastocysts of Mettl3-/- mice and these show normal 
morphology but impaired differentiation due to stabilization of pluripotency factors 
mRNAs that lead to a “hyperpluripotent” phenotype (Batista et al., 2014; Geula et al., 
2015). A role for m6A was previously demonstrated in the context of regulation of 
gene expression through mRNA splicing, localization, and degradation, as well as in 
modulating the RNA binding capacity of m6A binding “reader” proteins (Dominissini 
et al., 2012). However all these works focus on the effect of m6A on mRNAs and very 
little is known about this modification on the non-coding transcriptome especially in 
the context of developmental processes. A recent work described that m6A is 
necessary for Xist mediated XCI during ESC differentiation (Patil et al., 2016). In 
particular in this work it was shown that depletion of adaptor proteins RBM15 and 
RBM15B that are responsible for METTL3 recruitment on Xist determine absence of 
adenine methylation and impairment of XCI. The role of m6A in inducing XCI is 
mediated by a reader protein belonging to the YTH family that is able to specifically 
recognize m6A on Xist and interact with repressor proteins involved in XCI like 
SHARP, LBR, HNRNPU and PRC2 components. This is the first example of 
functional characterization of m6A posttranscriptional modification in lncRNAs and 
highlights a system of “writer” and “readers” definitely akin to the epigenetic one. 
This suggests a possible “epitranscriptome” that could contribute together with the 
epigenome in establishing further layers of regulation of gene expression by 
posttranscriptional modification of mRNA and lncRNA (Dominissini, 2014).  
 Despite we did not identify any of the classical m6A reader proteins among the 
DHX9 or IGS-rRNA interacting factors we cannot exclude a role for this RNA 
modification in regulating the induction of IGS-rRNA processing during ESC 
differentiation. Thus further studies will be needed to address the existence of a 
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differential pattern of lncRNA posttranscriptional modification between ESCs and 
differentiated cells and the effects of these modifications. 
 
 Taken together, the results of our work revealed the importance of lncRNA 
processing in modulating chromatin structure. In particular, our work highlighted the 
cellular function of the nucleolar chromatin in seeding euchromatin and 
heterochromatin compartments as a key step in the maintenance of pluripotency and 
the initiation of differentiation processes. 
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